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Summary
Several lines of evidence suggest that there may be a distinction between the inner and outer 
myometrium. Magnetic resonance imaging has shown that the uterus of women of reproductive age 
consists of three layers. In addition, transvaginal ultrasound has revealed that peristaltic waves, 
during the course of the normal menstrual cycle, emanate only from the inner myométrial muscle. 
Finally histological findings have suggested that there is a three-fold increase in the nuclear density 
of the inner compared to the outer myometrium. In addition, trophoblast invasion is restricted to the 
inner third of the myometrium.
Based on these lines of evidence it was postulated that there could be a difference in extracellular 
matrix between inner and outer myométrial smooth muscle. To test this hypothesis, the distribution 
of different laminin chains, collagen IV and elastin were examined in the human uterus. In addition 
observations were made to determine whether there was tissue specificity of laminin type 
expression.
Forty-four hysterectomy specimens were collected, from women undergoing hysterectomy for 
benign conditions, representing all phases of the menstrual cycle. These also included specimens 
from patients who had been treated with intrauterine levonorgestrel (Mirena®). Cryo- and paraffin 
embedded sections were prepared. Immunocytochemistry was carried out using monoclonal 
antibodies directed to the ot2, (51, P2, and yl laminin chains, collagen IV, elastin, CD31 and the 
68kD neurofilament protein. Digital imaging, by microscopy and scanning, was undertaken and 
novel image analysis methods were developed to examine the myométrial distribution of 
extracellular matrix proteins. Elastin detection was confirmed by orcein staining.
As predicted collagen IV and the yl laminin chain were present in the basement membranes of the 
vascular smooth muscle, myométrial smooth muscle, vasculai' endothelium and endometrial 
epithelium. Qualitative observation revealed that the (52 laminin chain was much less widely 
distributed in the inner part of the smooth muscle. Reverse-transcriptase polymerase reaction was 
used to confirm the expression of the (52 and yl laminin chains. Quantitative comparison of the (52 
laminin chain and collagen IV distribution within the myometrium demonstrated the existence of 
layers of laminin type. A measurement of sectional thickness of this layering was devised. The 
sectional thickness of the inner layer was highly variable between individuals (7mm median, 2- 
15mm range). These results confirmed the existence of layering within the human myometrium.
The (52 laminin chain was also present in the vascular smooth muscle but variably expressed in the 
endometrial endothelium. The P1 laminin chain was uniformly distributed throughout the smooth 
muscle. It was also present in the endometrial vascular smooth muscle but absent from the 
myométrial vascular smooth muscle. The endothelial basement of the endometrium and 
myometrium contained the p 1 laminin chain. The ot2 laminin chain was present in the myométrial 
smooth muscle but absent fr*om the myométrial vascular smooth muscle and endothelium. These 
observations provided evidence that the vascular endothelium and smooth muscle of the 
endometrium are structurally different firom their counterparts within the myometrium.
After exposure to intrauterine levonorgestrel no differences were observed in the myométrial 
distribution of the different laminin chains and collagen IV. By contrast in the highly decidualised 
areas of the endometrium, extensive peri-cellular staining of laminin chains was observed.
It was hypothesised that layering of the muscle may also involve a variation in elasticity. As 
expected, immunoreactivity was observed in the internal elastic laminae and walls of the large 
myométrial arteries. Elastin was also present in the peri-vascular tissue particularly near the large 
vessels. The walls of the myométrial arterioles also contained elastin. In addition, elastin was 
present within the outer myométrial smooth muscle but was less abundant, or in some cases, absent 
fi'om the inner smooth muscle. More extra-vascular elastin was present in the outer myometrium in 
all cases. Quantitative analysis demonstrated a linear gradient in the myométrial distribution of 
elastin. However, these distributions did not correspond to the more distinct myométrial layering 
pattern of the P 2 laminin chain.
Although others have described an absence of elastin within the human endometrium, it was shown 
that elastin was restricted to the basal portion of the endometrial arterioles. Traces of elastin were 
also observed in 78% of cross-sections of lymphoid aggregates.
The results presented in this thesis suggest that there are important structural differences between 
the inner and outer myométrial smooth muscle. The anatomy of the human myometrium therefore 
appears to be more complex than previously reported. As a consequence of these findings it is 
postulated that the outer myometrium is more elastic than the inner and that the variation in 
basement membranes composition may influence the contractile properties of the muscle.
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Chapter. 1 Introduction
1.1 The human uterus
The uterus is a “pear shaped” organ with its rounded end directed upwards comprising the 
fundus and body of the uterus while its lower end forms the cervix. The uterus fits rather loosely 
into the bony pelvis where it is maintained in place by several ligaments. The uterus varies in 
size from 2.5-3.5cm in length in the pre-pubertal child to 6-8cm in the nulliparous adult to 9- 
10cm in the multiparous women. Uterine weight also changes from 50-70g in nulliparae to 80g 
or over in multiparae and at term it can achieve 500 to 1000 times greater capacity than in the 
nulliparous state, reflecting a weight increase up to llOOg. The two distinct parts of the uterus 
are the body or corpus and the cervix. The wall consists of three layers, an outer covering, the 
serosa; a middle muscular layer, the myometrium and a glandular tissue, the endometrium 
(Ramsey, 1994).
1.1.1 Organization o f  the myometrium
The myometrium is the thickest of the layers composing the uterine wall with the greatest 
concentration of muscle in the fundus. The protective and expulsive functions of the 
myometrium are accomplished first by the sheer bulk of smooth muscle composing it and then 
by the pattern of arrangement of the muscle. The myometrium consists of muscle cells, 
fibroblasts, blood and lymphatic vessels, immune cells and connective tissue (Garfield 
&Yallampalli, 1994).
The uterine wall of rats and rabbits is composed of an innermost layer, the endometrium, an 
inner circular layer and an outer longitudinal muscle layer. The outer longitudinal muscle layer 
of the myometrium consists of a network of bundles of smooth muscle cells that are generally 
orientated in the long axis of the uterus. The bundles interconnect and form a network over the 
surface of the uterus, with each bundle consisting of smooth muscle cells arranged in the long 
axis of the bundle (Garfield & Yallampalli, 1994). The muscle cells in the circular layer are 
arranged more diffusely and the bundle arrangement, when present, is not as apparent as that of 
the longitudinal layer. According to structural and functional studies the longitudinal layer is 
continuous with the circular layer (Osa & Katase, 1975).
During mammalian pregnancy the uterus increases tremendously in size, accounted for by an 
increase in the number of cells (hyperplasia) and then increases in muscle cell size (hypertrophy) 
(Garfield & Yallampalli, 1994). However, in the human uterus there is no distinct muscle 
organization like that seen in the rodent uterus.
1.1.2 The muscle cell
Smooth muscle cells (SMC) of the myometrium are generally thought to be long, spindle-shaped 
cells, ranging in size from 5 to 10pm in diameter in the centre of the cell and fr om 300 to 600pm 
in length (Csapo, 1962). The size of smooth muscle cells varies considerably between species. 
The plasma membrane of the smooth muscle cells, besides being a barrier between the 
intracellular compartment and the extracellular environment, also forms cell-to-cell contacts 
known as gap junctions. Uterine smooth muscle cells have an extensive system of sarcoplasmic 
reticulum, the major frmctions of which are those of a storage site of activator calcium (smooth 
endoplasmic reticulum) and a site for protein synthesis (rough endoplasmic reticulum) (Garfield 
& Yallampalli, 1994).
The major function of smooth muscle cells is contraction through the interaction of myosin and 
actin filaments (Somlyo, 1980). There are three groups of filaments classified on the basis of 
size, shape, location and composition. By far the largest number of filaments are the thin 
filaments (50-80À in diameter) containing actin and tropomyosin. The second type of filaments 
are the thick filaments (120-180Â in diameter) composed of myosin and the last type of 
filaments are the intermediate filaments (100A in diameter) containing vimentin or desmin 
(Chamley-Campbell a/,, 1979).
The notion that a smooth muscle cell is capable of synthesis of extracellular matrix (ECM) was 
originally proposed on the basis that it is the only cell type present in the media of mammalian 
arteries and therefore must be responsible for connective tissue elements, such as elastin collagen 
and glycosaminoglycans (Thyberg et a l, 1990). In human adult arteries, SMC have a highly 
differentiated contractile phenotype whereas in the embryo SMC are in a synthetic phenotype 
(Thyberg et al, 1990). In the synthetic state, SMC have a fibroblast-like appearance with an 
extensive rough ER, a prominent Golgi complex and a few myofilaments (Nakamura, 1988). 
They proliferate and secrete ECM components like collagen and elastin (Ross & Klebanoff, 
1967). In adults, the arterial media is made up of highly differentiated SMC arranged in 
concentric layers, with each cell encircled by a BM composed of collagen type IV, laminin, 
nidogen and heparan sulfate proteoglycans (Timpl, 1989).
As the vessels mature the synthetic organelles decrease in size and myofilaments occupy larger 
parts of the cytoplasm (Nakamura, 1988). Smooth muscle cells, in adult life, are able to return 
from a contractile to a synthetic phenotype (Thyberg et al, 1990), where the cells lose their 
contractility and gain the ability to secrete ECM components and divide, which is an important 
early event in athero genesis.
X,l,5 Myométrial contractions
The uterus contracts autonomously, rhymically and unceasingly throughout the menstrual cycle. 
The first studies of the contractions of the nonpregnant uterus were carried out in 1889 by 
Heinricius, In the past decades uterine activity was mainly studied by invasive catheter 
techniques. The major disadvantage of the intrauterine sensors used to record uterine activity 
was their profound impact on the uterine muscle (Mosler, 1968). This prompted a search for 
noninvasive techniques, such as magnetic resonance imaging (MRI) and ultrasound, for 
recording uterine contractility without direct contact with the organ. Trans-vaginal ultrasound 
proved to be the method of choice for analysis of myométrial peristalsis in women (Chalubinski 
et al, 1993).
Several groups, usmg ultrasonic techniques, have reported that in the non-gravid uterus 
myométrial peristalsis emanates fi'om the inner myometrium at an amplitude and fi'equency of 
the contraction that correlates with the phase of the menstrual cycle. The direction of propagation 
of the subendometrial myométrial contractions became progressively more consistent fiom 
menstruation to the periovulatory period, thereafter declining in the luteal phase. In the 
periovulatory period the predominant direction was fiom cervix towards the fundus. It must be 
noted that the characteristics of the subendometrial myométrial contractions are very different 
from the contractions of the entire myometrium, which are markedly dknmished during the 
periovulatory period (Lyons et al, 1991). The amplitude and frequency of the subendometrial 
contractions in the follicular and periovulatory phases increase towards ovulation. Short, 
asymmetrical myométrial waves are present during the luteal phase, but during menstruation 
propagated fundo-cervical subendometrial contractions waves were noted (de Vries et al, 1990; 
Lyons et al, 1991 ; Chalubinski et al, 1993; Kunz et al, 1996).
The mechanisms that govern the contractions of the inner myometrium are not understood. It 
appears likely that the symmetrical, high amplitude propagated contraction waves in the late 
follicular phase requiie electrical and mechanical coupling of myocytes in the inner myometrium 
(Brosens et al, 1998).
Although gap junctions expression is likely to be essential, mere expression is not sufficient to 
trigger co-ordinated contractions. Several cytokines have been identified which might modulate 
myométrial contractions. For example, epidermal growth factor, is not only a potent mitogen for 
myométrial smooth muscle cells but it can also induce uterine contractions (Gai'dner & Stancel
1989).
Kunz et al. (1996) demonstrated, by means of vaginal sonography of uterine peristalsis and 
hysterosalpmgoscintigraphy, that subendometrial cervico-fundal contraction waves could be
responsible for the rapid sperm transport through the female genital tract in the pre-ovulatory 
phase. Others have postulated that the asymmetrical myométrial peristalsis during the luteal 
phase serves to maintain the developing blastocyst within the uterine fundus. The role of fundo- 
cervical contractions during menstruation has not yet been elucidated, but one report noted 
hyperperistalsis in a woman suffering from excessive menstrual blood loss (Chalubinski et al, 
1993).
In vitro studies have also confirmed the functional polarity of the myometrium (Daels, 1974). In 
contrast to the in vivo observation, myométrial strips taken from the outer myometrium show 
spontaneous strong regular contractions which can be amplified by adrenaline or, to a lesser 
extent, by oxytocin (Brosens et al, 1998).
Contractions of the pre-term uterus (37 weeks) are local and synchronous whereas contractions 
at term (40 weeks) become increasingly more frequent, synchronous and intense while producing 
powerful propulsive contractions that propel the fetus through the birth canal (Garfield et al, 
1988).
The ability of myométrial cells to contract depends upon the ionic distribution across their 
plasma membrane. Sodium and calcium ions are higher outside the cell than inside, whereas 
potassium ions are higher within the cells (Kao, 1989), The sequence of contraction and 
relaxation of the myometrium results from the cyclic depolarization and repolarization of the 
muscle cells in the form of action potentials (Garfield & Yallampalli, 1994). The frequency and 
intensity of contractions are directly proportional to the regularity and duration of action 
potentials in each muscle cell and total number of cells that are active (Marshall, 1962).
The driving force for myométrial contractility is thought to be provided by propagated action 
potentials that arise from pacemaker regions (Marshall, 1962). However such pacemaker regions 
have not been experimentally identified. The electrical activity that arises from the pacemaker 
areas then excites surrounding non-pacemaker regions. Pacemaker cells are autonomously active 
smooth muscle cells in which the resting membrane potential varies as compared with non­
pacemaker cells (Lodge & Sproat, 1981). It has been proposed that any muscle cell can act as a 
pacemaker cell (Marshall, 1962).
1.1.4 Gap junctions as sites o f propagation o f action potentials
Since the myometrium is composed of billions of small muscle cells, a specialized mechanism of 
conduction must be present between the cells to coordinate their activity (Csapo, 1981). After the 
elimination of possible reasons for the propagation of action potentials, such as the innervation 
of the uterus, the effects of stimulants on contractility and the absence of a specific conduction 
pathway (comparable to the Purkinje fibre system in the heart) present in the myometrium, it was
concluded that electrical activity must propagate from cell-to-cell (Csapo, 1981) and that gap 
junctions serve as sites of propagation, at least in the mouse.
Gap junctions are intercellular channels that link neighbor cells and allow the passage of 
inorganic ions and small molecules (Garfield & Yallampalli, 1994). They consist of channels 
composed of proteins termed connexins that span the plasma membrane to form a pore (Saez et 
al, 1993). Each gap junction consists of a few hundred to thousands of channels each 
constructed from six connexin proteins (connexons) (Alberts et al, 1994). Two connexons join 
across the intercellular gap to form a continuous aqueous channel connecting the two cells 
(Alberts et al, 1994). In the myometrium a 43kD protein termed connexin 43 is thought to be the 
major component of the gap junction (Beyer et al, 1989).
Garfield et a l (1988) suggested that the changes in steroid hormones and prostaglandins that 
precede or accompany labour, regulate the presence of gap junctions. Progesterone appears to 
inhibit whereas oestrogen promotes gap junction synthesis in the myometrium (MacKenzie & 
Garfield, 1985). Prostaglandin synthesis inhibitors such as indomethacin and meclofenamate are 
known to alter the area of gap junction in the myometrium (Garfield & Yallampalli, 1994).
1.1.5 Vascular anatomy o f  the human uterus
The uterine arteries and one or more branches of the ovarian arteries penetrate the lateral margins 
of the uterine wall at an oblique angle and proceed directly to the middle layer of the 
myometrium where they ramify into an arcuate wreath (Okkels & Engle, 1938),
Blood supply to the endometrium arrives through the radial arteries, which arise from the arcuate 
arteries within the myometrium. The radial arteries, after passing through the myometrial- 
endometrial junction, split to form the smaller basal arteries and spiral arteries that supply the 
basal portion and the functional layer of the endometrium respectively (Rogers, 1998). The 
stroma and peri-glandular networks are supplied by capillaries that branch from the spiral 
arteries. Just below the endometrial surface the spiral arterioles break up into the prominent sub- 
epithelial capillary plexus, which drains into a number of venules that pass down through the 
endometrium collecting blood from other capillaries on the way (Rogers, 1998).
Following menstruation, the long precapillary channels grow from the remaining segments of 
spiral arterial coils deep in the basalis. The growth of the artery involves the formation of a 
media and adventitia around these precapillaries, thus converting them into arteries (Ramsey, 
1967).
All endometrial vessels are lined by a continuous single layer of endothelial cells arranged on a 
vascular BM. The wall of most blood vessels consists of three layers: tunica intima, tunica media 
and tunica adventitia (Zhang, 1999).
The spiral arteries, the most striking structural feature of the endometrial vasculature, have a 
distinct coiled appearance that becomes more pronounced during the secretory phase of the 
menstrual cycle (Rogers, 1998). These vessels also play a major role in placentation. The 
conversion of spiral arteries into utero-placental arteries depends upon two waves of 
endovascular invasion by trophoblast in the first two trimesters of pregnancy (Pijnenbourg et al.,
1990). At term the trophoblastic cells are characteristically buried in the vessel walls and 
wrapped in fibrinoid material (Pijnenbourg et a l,  1981). These changes are an essential part of 
placentation and the establishment of an adequate choriodecidual blood flow in normal 
pregnancy (Pijnenbourg et ah, 1990).
1.1.6 Innervation o f the human uterus
The female reproductive organs have an extensive autonomic innervation. The sympathetic 
nerves to the smooth muscle coats of the Fallopian tubes, uterus and vagina comprise a mixture 
of short adrenergic nerves fi*om the utero-vaginal ganglion formations and fibres in the inferior 
mesenteric ganglion (Stjemquist & Sjoberg, 1994). The adrenergic nerves are sensitive to the 
action of ovarian sex steroids (Thorbert, 1978). Oestrogen for example increases 
neurotransmitter (NA) content of individual adrenergic fibres, whereas progesterone causes a 
reduction (Falck et al., 1975). Due to steroid effects and additional mechanical effects exerted by 
the growing conceptus the uterus during pregnancy is said to undergo a complete and entirely 
physiological adrenergic denervation (Stjemquist & Sjoberg, 1994). A slow and incomplete 
restitution takes place post-partum. These changes may be functionally associated with the 
maintenance of pregnancy, initiation of labour and expulsion of the fetus during parturition 
(Stjemquist & Sjoberg, 1994).
1.1.7 Myométrial zonal anatomy
Myométrial zonal anatomy was first described with magnetic resonance imaging (MRI) (Hricak 
et al, 1983). In the uterus of women of reproductive age, three distinct layers can be seen on T2- 
weigthed images: a high-signal-intensity endometrial stripe, a medium-signal-intensity outer 
myometrium and in-between a low-signal-intensity junctional zone (JZ).
Various hypotheses have been put forward concerning the nature of the JZ. Hricak et al  (1983), 
suggested that the low-signal-intensity band seen on T2-weighted images represented the stratum 
basale of the endometrium, as vascular or physiological phenomenon at the myometrial- 
endometrial junction. A suggestion which was dismissed by Lee et al  (1985) and McCarthy et 
al. (1989) because the histological locations did not match. Haeraatoxylin and Eosin staining 
failed to reveal any significant differences in the light microscopic appearances between the 
junctional zone and the outer myometrium.
Lee et a l (1985) suggested that the JZ represented a physiological phenomenon such as blood 
flow, since it was indistinct or not visible ex vivo. Both Hriack et a l (1983) and Lee et al (1985) 
agreed that the JZ was not part of the endometrium, since thickness measurements of the high- 
signal-intensity layer accounted for the entire endometrium (stratum functionale and basale). 
Worthington et a l (1985) proposed that the JZ represents a layer of compact myometrium a 
proposal which was later supported by the findings of McCarthy et al. (1989), Scoutt et al 
(1991) and Brown et al., (1991).
In 1989 McCarthy and colleagues showed, by means of multiple cycles of uterine desiccation in 
an oven until there was no further reduction in the weight of the specimens, that the water 
content of the junctional zone was significantly lower than that of the endometrium and 
myometrium, the reason for which still remains unclear.
Although detailed studies (Farrer-Brown, et al,\91Q  a,b) on the arterial vasculature of the uterus 
have demonstrated that aU parts of the myometrium are well vascularised, an abrupt change 
occurs in the density of the arterial pattern. It has been claimed that the arterial density is greater 
in the subjacent myometrium than in the endometrium (McCarthy et a l, 1989).
Scoutt et a l (1991) reported that there was no difference in the distribution of components of the 
ECM such as, collagen (III, IV, V), laminin and fibronectin, between the JZ and the outer 
myometrium. However the antibodies used had no known chain specificity. Therefore the 
possibility of laminin type variation was not examined. The same study revealed that there is a 
three-fold difference in the percentage of nuclear area in the JZ compared with the outer 
myometrium, reflecting an increase in both size and number of nuclei. The reason for this 
remains unclear.
1.1.8 Structural myométrial zonal differentiation in response to ovarian sex steroids
Demas et al., (1985); McCarthy et al., (1986); Andreyko et al., (1988), reported that zonal 
dedifferentiation depends on gonadal hormones. In both premenarchal girls and postmenopausal 
women, the zonal anatomy is ofl;en indistinct, with a comparatively low-signal-intensity 
myométrial zone. Ovarian suppression with gonadotrophin-releasing hormone analogues leads to 
an MR appearance of the uterus mimicking that of postmenopausal women (Demas et al, 1985). 
Hormone replacement therapy (HRT) in postmenopausal women results in a re-appearance of 
the myométrial zonal anatomy.
Changes in the myométrial zonal anatomy can also be observed during pregnancy. Focal 
disruption of the JZ occurs in early pregnancy (Turnbull et al, 1995). In general, the JZ signal 
intensity increases and the zonal differences become indistinct (Willms et al, 1995), with the 
normal zonal anatomy gradually reappearing within 6 months of delivery.
1.1.9 Mechanisms controlling myométrial structure and polarity
In non-pregnant myométrial cells, oestrogen receptor (ER) expression is maximal in the late 
proliferative phase and declines sharply in the early secretory phase. An increase in ER 
immunoreactivity has been reported in the late secretory phase. Following an initial rise in 
progesterone receptor (PR) immunoreactivity in the proliferative phase, there is, by contrast, no 
significant change in the PR expression (Snijder et al, 1992).
No zonal differences in steroid receptor expression in the myometrium were reported (Brosens et 
al., 1995) however Richards et al  (1995) demonstrated, using immunocytochemistry and 
radioimmunoassay techniques, that the subendometrial myometrium expresses significantly 
higher numbers of ER than the outer myometrium.
The mechanisms underlying elevated ER expression in the JZ are not well understood and 
remain to be determined (Richards et al, 1995). There is, however, increasing evidence for a 
complex interaction between gonadal steroids and locally expressed cytokines in the 
myometrium (Brosens et al, 1998).
1.1.10 Junctional zone disease
Adenomyosis is a disease characterized by disruption of the endometrial-myometrial interface 
with loss of normal uterine polarity, with smooth muscle proliferation and an altered local 
immune micro-environment (Brosens & Brosens, 1998). Although the definition of adenomyosis 
appears straightforward, the precise histopathological criteria have been the subject of 
considerable controversy (Brosens & Brosens, 1998). The common approach is to use a 
minimum depth of myométrial invasion to define the condition. Current criteria range widely 
from the presence of glands and stroma 1mm below the endometrial-myometrial junction to as 
deep as one third of the total myométrial thickness (Azziz, 1989).
Despite the diversity of diagnostic criteria applied, adenomyosis is thought to be a disease typical 
of multiparous women in the late reproductive years and the perimenopause. JZ distortion can 
also be found in young nuUiparous women with heavy periods (Brosens, et al., 1998).
In recent years, ultrasound has been increasingly used to diagnose adenomyosis. Although 
adenomyotic uteri tend to be larger with asymmetrical thickening of the anterior and posterior 
walls, uterine morphometry alone is insufficient for the diagnosis (Brosens, et a l,  1995). In 
comparison with ultrasound, MRI has proved to be a useful non-invasive technique for the 
diagnosis of adenomyosis (Hricak et al., 1983).
The two cardinal symptoms of adenomyosis are excessive menstrual loss and dysmenorrhoea. 
Symptomatic relief can be achieved with conventional treatment such as mefenamic acid. As yet 
there is no evidence that any form of medical therapy is specifically effective, as the diagnostic
elusiveness of adenomyosis has precluded controlled clinical trials (Brosens & Brosens, 1998). 
At present, the most common treatment for patients unresponsive to medical treatment is 
hysterectomy.
1.2 Morphological changes of the human endometrium during the menstrual cycle
The morphology of the female genital tract is not static but during the years from the menarche 
to the menopause undergoes repetitive cyclical changes, controlled by the action of the ovarian 
hormones which are themselves under the control of the pituitary (Noyes et a/., 1950). These 
cyclical changes are most apparent in the endometrium, which is a tissue derived from the 
Müllerian ducts and consists of two layers, the fimctionalis located under the surface epithelium 
and the basalis underneath the fimctionalis (Ramsey, 1994).
In the peri-natal and pre-pubertal periods the glands and their supporting stroma proliferate and 
gradually mature (Ramsey, 1994). At menarche, menstruation is initiated and recurrent cycles 
commence, due to a coordinate and effective pituitary and ovarian stimulation. Each cycle 
consists of three phases, the follicular or proliferative phase, the luteal or secretory phase and 
finally menstrual shedding (Shearman, 1985).
1.2.1 The proliferative phase
Throughout the proliferative phase, the endometrial changes show a rather constant pattern and 
accurate dating of the endometrium is difficult (Russell & Fraser, 1998). Under the influence of 
oestradiol, various cells of the functional layer such as glandular, stromal and vascular 
endothelial cells, proliferate thus producing a measurable thickening of the uterine mucosa 
(Noyes e ta l,  1950).
Mitotic figures are seen throughout the proliferative phase, both in glands and the stroma (Noyes 
et al., 1950). The stroma which is originally compact becomes somewhat oedematous towards 
the middle of the phase. The oedema then regresses and the stroma becomes compact again 
towards the end of the proliferative phase (Noyes et al., 1950).
The surface and glandular cells acquire numerous ciMa and cytoplasmic extensions such as 
microvilli that will increase the overall cell surface and thus enhance excretory, secretory and 
absorptive functions (Russell & Fraser, 1998).
1.2.2 The secretory phase
In contrast to the proliferative phase, the oestradiol-primed endometrium during the secretory 
phase under the influence of progesterone undergoes rapid architectural and cellular changes 
sufficiently distinct to permit accurate dating (Hendrickson & Kempson, 1980). During the first 
36-48 hours after ovulation no appreciable changes occur within the endometrium (Noyes et al.,
1950). The secretory phase is characterised by the twin processes of glandular secretion and 
stromal differentiation.
On the 16* day of the cycle, sub-nuclear vacuolation of the glandular epithelium becomes 
prominent (Noyes et al., 1950). By the 17* day of the cycle the basal vacuoles are enlarged 
pushing the nuclei towards the apical end of the cell where they form an almost uniform row 
around the lumen. A few mitoses are seen since the epithelial cells generally lose their ability to 
divide with the onset of this specific differentiation brought by progesterone (Dallenbach & 
Hellweg, 1981). On the 18* day of the cycle, some nuclei return to the base of the cell (Noyes et 
al., 1950) and on the 19*-20* days of the cycle, apical glycoprotein-rich and 
mucopo lysacharide-rich cytoplasmic fragments are expelled into the glandular lumen by 
protrusion and eventual detachment with consequent loss of vacuolization of the supranuclear 
cytoplasm (Dallenbach & Hellweg, 1981).
Seif et al. (1989) in an immunohistochemical study reported the presence of a cycle-dependent 
sialoglycoprotein in the endometrium. The glycoprotein was absent in the proliferative phase but 
was present at maximal levels in the early secretory phase and persisted in slowly dinninishing 
amounts throughout the secretory phase of the cycle (Seif et al., 1989).
In another immunohistochemical study the presence of a large cell type surface glycoprotein 
called mucin-1 (MUC-1) in the endometrial epithelium was reported (Hey et al., 1994). Low 
levels of MUC-1 mRNA and protein were detected in the proliferative phase whereas the levels 
of both MUC-1 mRNA and protein increased m the early secretory phase.
A glycosaminoglycan (GAG) knovm as keratan sulphate was reported to be present in 
association with the glandular epithelium in the normal endometrium. Secretion appears to occur 
throughout the normal cycle with a highly significant increase in glandular biosynthetic activity 
fi-om the proliferative to the early secretory phase, resembling the pathway documented 
previously for the cycle-dependent sialoglycan protein (Seif et al., 1989).
Until this point there is little obvious morphological changes in the endometrial stroma compared 
to the changes that take place in the glandular epithelium but approximately on the 21^ day of 
the cycle, stromal oedema develops again reaching its maximum on the 22“^  day of the cycle, 
when secretion of oestrogen is also at its highest (Noyes et al., 1950),
As the oedema subsides on the ninth day after ovulation (23day o f a 28days cycle) groups of 
spiral arterioles become prominent due to enlargement of nuclei and increase of cytoplasm of the 
periarteriolar stromal cells. The first stromal cells to undergo differentiation to become decidual 
cells are the periarteriolar stromal cells and capillaries of the fimctionalis (Russell & Fraser, 
1998). Later, predecidual changes are seen in cells around the glands and below the surface
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epithelium and towards the latter part of the late secretory phase, the stroma consists of sheets of 
decidualised stromal cells which are infiltrated by granulated lymphocytes, especially uterine 
natural killer (NK) cells (Noyes, 1950).
If pregnancy fails to take place the corpus luteum begins to regress. As a result of the fall in both 
progesterone and oestrogen, the endometrium contracts, the glands coUapse, assuming a saw­
toothed appearance and the decidual stroma becomes vary dense (thirteenth day after ovulation) 
(Dallenbach & Hellweg, 1981).
1.2.3 Menstruation
Menstruation normally lasts 3-5 days during which time the endometrium rapidly fragments and 
degenerates with most of the surface shedding occurring within the first 24-48 hours (Ludwig et 
al, 1990). On the 28* day through to the second day of the following cycle the fimctionalis is 
characterised by degenerate, pseudo-decidual cells which rapidly lose their eosinophilic 
cytoplasm (Russell & Fraser, 1998). Lysosomal and other proteinase autodigestion are thought to 
destroy grandular and stromal cells and also vascular endothelium. During menstruation 
regressive changes begin in parts of the endometrium not shed that enable the glandular and 
stromal cells to survive and restore themselves in order to participate in the physiological 
buildup of the next cycle (Dallenbach & Hellweg, 1981).
Immediately after menstrual shedding ceases and before proliferation begins, a regenerative 
phase takes place, lasting l-2days (Dallenbach & Hellweg, 1981). During the regenerative phase 
the denuded endometrium becomes epithelialised. Re-epitheUzation is completed by the 5day of 
the cycle. The onset progress and duration of re-epithelisation vary fiom patient to patient 
(Dallenbach & Hellweg, 1981),
1.3 Levonorgestrel Intrauterine Releasing System (LNG-IUS)
One of the aims of this study was to examine the effect of a high dose exogenous intrauterine 
progesterone on the distribution of ECM in the human myometrium and endometrium. The 
levonorgestrel-releasmg intrauterine system (lUS) (LNG-IUS), which is the most extensively 
tested and most widely used lUS, has the frame of a Nova-T device on which a silastic capsule 
has been attached to the vertical arm, releasing 20pg per 24h from a total 52mg of 
levonorgestrel. The LNG-IUS was developed during the late 1970s and the 1980s, and it was 
first marketed in Finland in 1990 (Odlind, 1997). It is licensed for use as a contraceptive, for 
women suffering from menorrhagia and dysmenorrhoea.
1.3.1 Mechanism o f  action
The LNG-IUS is a highly effective, long-term, safe and reversible method of contraception. It is 
thought to exert its contraceptive effect by causing the cervical mucus to become thicker, thus
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impermeable to sperm, and by making the endometrium thin and inactive. (Nilsson et al., 1978). 
In addition the LNG-IUS is known to elicit a local foreign body reaction, comparable to that 
produced by sterile particles or objects with low biocompatabihty placed elsewhere in the body. 
{Ortm et a l,  1996).
1.3.2 Non-contraceptive beneficial effects
Excessive menstrual bleeding affects 10% to 15% of women in Western Europe. In Europe and 
other developed countries it is the most common cause of anaemia in fertile women (Sturridge & 
Guillebound, 1997). The LNG-IUS can help to improve both heavy and painful menses and 
increase haemoglobulin concentrations, by rendering the endometrium inactive and insensitive to 
the proliferative effects of oestradiol (Luukkainen et a l,  1990). Dysmenorrhoea is also generally 
improved (Bounds et a l,  1993).
1.3.3 Side effects
Hormonal effects including mood changes, headache, mastalgia, nausea, acne, and hirsutism 
have been reported in a minority of women maximally at three months of use by most studies. 
These effects were reduced with time (Andersson et a l,  1994; Luukkainen et a l,  1990).
In the first few months after insertion of the LNG-IUS, there is often a period of frequent, 
irregular bleeding or spotting (McGavigan & Cameron, in press 2000). During this period of 
time the number of bleeding “spotting” is usually increased, but the total volume of blood lost is 
nevertheless reduced as compared to the woman’s normal menstruation (AUonen, 1994). This 
irregular bleeding pattern could be an unwanted side effect, by many women. With prolonged 
use, menstrual blood loss is dramatically reduced and many women develop amenorrhoea or 
report extremely scanty but regular bleeds (Andersson K et a l,  1994; Kohnen et al, 1998).
1.3.4 Effects on the human endometrium
The effect the LNG-IUS on the endometrium has been considered to be dose-dependent (Xiao et 
al, 1990). However, the dose-response relationship is still incompletely understood, particularly 
with regard to side effects such as irregular menstrual bleeding, oligomenorrhoea and 
amenorrhoea (Zhao a/., 1995).
Several studies have shown that after exposure to LNG-IUS, the endometrial glands become 
atrophic, the epithelial cells inactive and the stroma decidualised. Locally released levonorgestrel 
causes atrophy of the glandular epithelium, the glands become scarce and the stroma shows 
pseudodecidual features (Silverberg et al, 1986). These effects on the endometrium are noticed 
as soon as 1 month after insertion and are maintamed for at least 7 years.
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Zhao and colleagues (1995) reported that the capillaries of the endometrium were dilated, 
occasionally accompanied by local thrombosis and the stromal inflammatory reaction included 
infiltration of polymorphonuclear leukocytes, lymphocytes and plasma cells.
It has also been reported that intrauterine administration of progesterone reduces the number of 
oestrogen receptors in the endometrium (Janne & Ylostalo, 1980). However, Lu et al, 1991, 
reported that the oestrogen receptors are not completely downregulated, at least on women 
maintaining scanty regular bleeding, while exposed to the LNG-IUS.
Kohnen and colleagues (1998) demonstrated an up-regulation of the endothelin receptor ETb in 
areas of abundant stromal basement membrane deposition after treatment with the intrauterine 
levonorgestrel, using hgand autoradiography. The same group also reported that there was 
variability in the pattern of endothelin receptor ETa.
1.4 The extracellular matrix and basement membranes
The extracellular matrix (ECM) is an intricate network of macromolecules composed of a variety 
of versatile proteins and polysaccharides that are secreted locally and assembled into an 
organized meshwork in close association with the surface of the cells that produce it. Two main 
classes of extracellular macromolecules make up the matrix, the glycosaminoglycans (GAGs) 
and the fibrous proteins. The later are of two fimctional types; the mainly functional, including 
collagen and elastin and the mainly adhesive such as fibronectin and laminin (Alberts et al, 
1994).
Until recently the ECM of vertebrates was thought to serve only as a relatively inert scaffolding 
to stabilize the physical structure of tissue. However, it is now well known that the matrix plays a 
far more active and complex role in regulating the behaviour of the cells that contact it by 
influencing their development, proliferation, migration, shape, function, gene expression and 
programmed cell death (Adams & Watt, 1993). There are at least three mechanisms by which the 
ECM can regulate cell behaviour. The first mechanism is through the composition of the ECM. 
The second mechamism is through synergistic interactions between growth factors and matrix 
molecules and the third mechanism is through the cell surface receptors that mediate adhesion to 
ECM components (Adams & Watt, 1993).
At the interface between an epithelial layer and connective tissue, the matrix is organized into a 
thin but tough mat that plays an important role in controlling cell behavior and is know as the 
basal lamina (Alberts et al, 1994). Basal laminae (BL), as revealed by electron microscopy, are 
thin (50-100mn), flexible sheet-like structures with an amorphous appearance (Timpl & Brown,
1996). They can be found underlying epithelial or endothelial cells or sheets as well as 
surrounding individual muscle cells, fat cells and Schwann cells (Alberts et al, 1994).
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The basal lamina is synthesized by the cells that rest on it and is composed of laminin, type IV 
collagen, entactin/nidogen, perlecan, fibronectin and agrin. Also associated with basal laminae is 
a group of basement membrane proteins including BM-40, SPARC and fibulins. (Yurchenko, et 
al, 1994).
With the transmission electron microscope, the basal lamina can be seen to consist of three parts. 
Two of the parts are constant, the lamina lucida adjacent to the basal plasma membrane of the 
cells resting on the lamina, and the lamina densa attached to the lamina lucida (Alberts et al  
1994). The third part, the lamina fibroreticularis is frequently missing but when present, is 
composed of collagen fibrils connecting the basal lamina to the underlying connective tissue 
(Chan et a l  1993). Some authors use the term basement membrane (BM) to describe all three 
layers while others use the terms basal lamina and basement membrane interchangeably.
The lamina lucida is an electron-lucent layer crossed by irregular filamentous strands that end on 
the cell plasmalemma (Chan et al, 1993) while the lamina densa is composed of a dense tliree- 
dimensional network of filamentous strands similar to and continuous with those of the lamina 
lucida (Inove & Leblond, 1988).
The two layers were initially thought to have distinct properties and different components. It has 
been stated that the lamina densa is mainly composed of type IV collagen (Yaoita et a l  1978) 
whereas the lamina lucida includes laminin, fibronectin and heparan sulfate proteoglycan (Chan 
& Wong, 1989). However, Laurie et al (1984) reported that both layers contain all the above 
substances, localised to a cord network, but in greater amount in the lamina densa than in the 
lamina lucida, a view that has been accepted in reviews by Abrahamson (1986) and Yurchenko 
& Schittny (1990).
Although this appearance (lamina densa, lamina lucida) has been considered a hallmark of 
basement membrane cross-sectional structure, according to Goldberg and Esgaig-Haye (1986), 
the layering may be an artifactual fixation-induced phase separation, as it is not observed in 
tfeeze-substituted vitreous specimens. In conventionally processed specimens that were fixed in 
gluteraldehyde-formaldehyde and dehydrated at room temperature, the basement membranes 
were composed of a lamina lucida and lamina densa consisting of muscle fibres and pre- 
ameloblasts, (Goldberg & Escaig-Haye, 1986). However, after slam fireezing and dehydration by 
fi-eeze substitution the basement membrane consisted of a lamina densa without a lamina lucida 
(Goldberg & Escaig-Haye, 1986).
In another study which examined the glomerular basement membrane, it was reported that after 
conventional processing a lamina lucida was present on both sides of the lamina densa but after 
fixation in gluteraldehyde-formaldehyde followed by freezing and freeze substitution no lamina
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lucida was observed on either side of the lamina densa (Reale & Luciano, 1990). Thus the 
authors were drawn to the same conclusion of Goldberg & Escaig-Haye, that the lamina lucida 
was an artefact due to fixation.
In 1993 Chan et al., working with mouse tissues, reported that the occurrence of the lamina 
lucida is due to rapid dehydration and not due to fixation. Hence the basement membranes are 
simply composed of a lamina densa that closely follows the plasmollema of the associated cells 
{Cimnet al, 1993).
Basement membranes have several biological roles. Firstly, they supply mechanical support for 
cell layers, secondly they form barriers between tissue compartments that impede the 
transmigration of cells and passively regulate the exchange of macromolecules, and thirdly serve 
as interactive surfaces for cells, providing adhesion, cells shape and migration signals. They also 
help in communicating information for the regeneration and differentiation of cells (Yurchenko, 
1994).
The evidence so far largely supports macromolecule self-assembly as the mechanism for the 
formations of BM. Protomers interact to foim an organized superstructure. The architecture of 
the superstructural axis is a direct consequence of interacting binding sites present on collagen, 
glycoproteins and proteoglycans. (Yurchenko et al, 1994). How the ECM macromolecules 
interact with each other in order to foim basement membranes will be discussed in greater detail.
1.5 The laminin family
Purification and characterization of a laminin molecule began in 1979 with the observation that 
the stroma of a tumor transplantable to the mouse, the Engelbreth-Holm-Swarm (EHS) tumor 
contained large amounts of basement membrane-like material (Aumailley & Smyth, 1998). 
Besides the presence of collagen IV, a noncollagenous component was present in substantial 
quantities, which was purified and identified as a large glycoprotein and named laminin (Timpl 
et al, 1979). Initially this was the only known laminin type but it was in fact the first member of 
a large family of laminin trimers.
Laminins are a family of multffunctional macromolecules with a specific localization in the 
basement membranes. They are heterotrimers, consisting of 3 different gene products, the a, p 
and Y chains (Burgeson et al, 1994), with a molecular mass of 140-400kD. So far, 5a (a 1-5), 3P 
(pi-3) and 2y (yl-2) chains have been cloned and sequenced. These assemble into at least eleven 
isomeric forms of laminin, namely: laminin-1 (a l, pi, yl); laminin-2 (a2, pi, yl); laminin-3 
(a l, p2, yl); laminin-4 (a2, p2, yl); laminin-5 (a3, p3, y2); laminin-6 (a l, p3, yl); laminin-7 
(a3, P2, yl); laminin-8 (a4, pi, yl); laminin-9 (a4, P2, yl); laminin-10 (a5, pi, yl) and laminin- 
11 (a5, P2, yl) (Aumailley & Smyth, 1998). An old nomenclature exists which rather
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confusingly uses the terms A and B to refer to laminin chains. For example laminin yl is known 
as laminin B2 with the old nomenclature.
In mammals, laminins play at least three essential roles. Firstly, they are major structural 
components of basal laminae, forniing one of two self-assembling networks. The other network 
is formed by collagen IV, to which other glycoproteins and proteoglycans of the BL attach. 
Secondly, laminins interact with cell surface components such as dystroglycan to attach cells to 
the extracellular matrix (ECM). Thirdly, they are signaling molecules that interact with cellular 
receptors such as integrins to convey morphogenetically important information to the cell’s 
interior (Miner et al, 1997).
1.5.1 Larmnin structure
All chains show a homologous domain structure, vrith an N-teiminal region and a C-terminal 
region. The amino-terminal region consists of two domain types; a cysteine-rich 60 amino acid 
domain (LE motifs) which occurs repeatedly and another cysteine rare area named domain VI 
(Figure,!). These LE motifs, according to the nomenclature adopted by the SWISS-PROT data 
Bank, are homologous to the epidermal growth factor (EGF) with the exception of the presence 
of 6 cysteine residues in the EGF instead of 8 residues in the equivalent laminin motif. These 
motifs, in turn, are arranged in rows and form domains III and V, which are either interspaced by 
or contain inserted laminin-specific cysteine-poor regions, known as domains IV. The presence, 
location and numbers of domains IV and VI, as well as the number of the LE motifs vary with 
the different laminin chains (Aumailley & Smyth, 1998) (Figure.!).
The carboxy-terminal region (domains I and II) on the other hand, is characterized by repeated 
heptad peptides typical of polypeptides that fold into coil-coded dimers or trimers (Aumailley & 
Smyth, 1998). Unique to the (3 chains, is the interruption of the repetitive heptad by a stretch of 
amino acids at the border between domains I and II, whereas the a  chains contain an additional 
domain. This domain is located at the carboxy-terminus, which is conserved between the chains 
and which in turn can be subdivided into 5 sequence repeats, G1 to G5 sub-domains (Figure.!) 
Lanhnins have a cross-shaped or T-shaped structure when visualized by transmission electron 
microscopy and rotary shadowing. The short arms vary in size and are contributed by the N- 
terminal regions of individual chains. The rod of the long arm consists of a triple coiled coil 
formed from the a-helical domains of all three chains (Timpl & Brown, 1996). Among the many 
potential a/p/y combinations between known chains, there is so far in vivo evidence of only 11 
different heterotrimers listed previously (Figure.!).
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Figure. 1 : The laminin family: 
Representation o f laminin heterotrimers.
Tlie a/(3/y associations identified to-date are 
listed and tlie variable domains. Picture 
reproduced from Aumailley & Smyth, 1998.
1.5.2 Synthesis and assembly o f laminin chains
The a/p/y trimers are formed intracellularly through chain selection, assembly and stabilisation. 
The first step is the formation of the stable, disulphide-linked p/y dimers via a 10-residue peptide 
localised to the C-terminal region of the laminin yl chain, p and y chain dimers and other 
intermediates were observed during biosynthesis, but apparently secretion in vitro occurred only 
after addition of an a  chain. The stability of the coiled-coils is thought to be determined by ionic 
interaction, which also control chain selection (Beck et ai, 1993). It was demonstrated by Sanes 
et al. (1990) that individual cells can produce several laminin isofonns simultaneously and 
deposit them together in the adjacent membrane.
The a  chain is then incorporated, a step which could be controlled by sequences located in the 
amino-terminal portion of domain II. Finally the formed heterotrimer is secreted. Assembly and 
stabilisation by disulphide bonds are probably required for translocation of the heterotrimers 
from the endoplasmic reticulum to the Golgi complex for glycosylation, before transfer to the 
extracellular space (Cooper et al, 1981).
For a l ,  pi, p2 or yl chains no extracellular processing has so far been reported, except for 
cleavage of the signal peptides. The terminal regions of the a2 and a3 chains are probably 
processed whereas the last 2G domains (G4 and G5) are cleaved off. (Ehrig et al, 1990; Paulsson 
ei al, 1991; Marinkovich et al, 1992; Burgeson, 1996).
1.5.3 Role o f laminins in basement membrane formation
Although collagen IV is an abundant structural component of mature basement membranes 
conferring stability, laminin plays an important role in basement membrane formation because of 
multiple interactions with itself and with other components such as nidogen, perlecan etc.
One model of laminin self interactions involves the formation of hexagonal networks 
(Yurchenko et al, 1985; 1992) by means of interactions between the amino-terminal globular
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domain VI. This assembly model was derived from studies with laminin 1 (Yurchenko & Cheng,
1993) and also applies to laminin 2 and 4 because both laminin isoforms posses three full short 
arms. In contrast the full sized iso forms laminin 5, a rod-like molecule whose short arms lack 
their domains, does not assemble in a manner similar to laminin 1 (Cheng et al, 1997).
It has been suggested that this assembly model does not apply to laminin isofonns containing a3, 
a4  or y2 chains because they lack domain VI (Cheng et al, 1997). Instead, a3 chain-containing 
laminins, laminins 5, 6 and 7, form dimers by establishing a disulphide bond between the amino- 
terminal region of laminin 5 with that of laminin 6 or 7 (Champliaud et al, 1996).
Laminin binds to nidogen via a high affinity interaction between an LE motif in domain III of the 
laminin yl chain, ylIII4, and the carboxy-terminal G3 domain of nidogen (Fox et al, 1991; Gerl 
et al, 1991; Mayer et al, 1993). Laminin and collagen IV interact indirectly via nidogen. 
Nidogen binds to collagen IV by its amino-terminal G2 domain and to laminin forming tertiary 
complexes thus allowing the connection of two major networks.
The one exception to laminin-nidogen interactions is laminin 5, where the y2 chain is present 
instead of the yl. Despite the high sequence identity in the y2III4 motif, nidogen cannot bind to 
laminin 5 due to a replacement of a single crucial amino acid (Mayer et al, 1995; Poschl et al,
1996). The integration of y2 chain containing iso forms with the basement membrane is 
facilitated by other specific interactions. Laminin 5 interacts with collagen VII (Chen et al,
1997) which is the major component o f anchoring fibrils where laminin 5 is also localised. It is 
also speculated that laminin 5 interacts with collagen XVII although experimental evidence is 
still lacking.
Ott et al (1982) demonstrated, using radioimmunoassays specific for the proteolytic fragment E3 
(globular shape located at G4-G5 domains) that more than 98% of the E3 fragment (Ftgure.2) 
binds to heparin hence it might contribute to perlecan binding to laminins, via the heparan 
sulphate chains located on perlecan. Perlecan is a large BM glycoprotein and has a large protein 
core around 480kD with a single polypeptide folded into 5-6 globular domains aligned in a 80nm 
long row. The 3 hepaian sulphate chains are connected to the core protein at one end (Paulsson 
et al, 1987). Laminin 1 seems to be the only laminin to bind directly to perlecan (Battanglia et 
al, 1992) whereas laminin 2 or 4 do not indicating that the laminin a l  and a2 chains differ 
functionally (Brown e/a/., 1994).
Timpl & Brown (1996) reported that ECM proteins fibulin 1 and 2 may be directly or indirectly 
involved in laminin interactions. Both fibulins bind to nidogen or fibronectin, fibulin 1 binds to 
nidogen G2 domain. On the other hand, fibulin 2 binds to nidogen G3 domain, possibly 
competing with laminin binding to nidogen (Sasaki et al, 1995). Additional interactions are
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possible with fibulin 2 interacting with domain IV of the laminin y2 chain and to a peptide 
sequence of the laminin a l  chain (Utani et al, 1997).
Not only integral basement membrane components but many other molecules such as proteases, 
serum amyloid A and P and growth factors have the propensity to bind to laminins which may 
affect their functions in the context of a basement membrane (Aumailley & Smyth, 1998).
1.5.4 Expression o f laminin chains
The eaiiiest studies on laminin chain expression showed that laminin appears at a very early 
developmental stage of the mouse embryo. Dziadek and Timpl (1985) reported that the pi and 
yl chains are detected within the 2-4 cell embryo. Two years earlier, in 1983 Cooper and 
MacQueen reported the presence of laminin containing the a l ,  p i and yl chains extracellularly 
at the 16-cell stage, whereas synthesis of collagen IV chain does not start before the blastula 
stage.
The importance of laminin in early development has recently been confirmed by deletion of the 
lammin yl (LAMCl) gene. The absence of laminin yl chain precludes the formation of laminin 
trimers and of a local lamina, leading to early embryonic lethality in both the mouse and 
drosophila. Early studies have failed to detect all of the 3 chains (in particular a l  chain), in some 
basement membranes of laminin expressing cell, in later developmental stages and in adult 
tissues. This finding initially suggested the possibility of laminin dimers lacking an a  chain. The 
possibility of laminin dimers has now been excluded by the identification of new a  laminin 
chains and by the use of better characterised chain-specific reagents, leading us to a more 
comprehensive picture of laminin chain expression and distribution (Aumailley & Smyth, 1998). 
Nevertheless, an exhaustive picture of cell and time specific deposition o f laminin isoforms is at 
the moment not available, restricting oui* knowledge to the chains for which precisely 
characterised reagents have been developed (Aumailley & Smyth, 1998).
The laminin a l  chain is expressed by newly forming embryonic epithelial cells. Ekblom et al 
(1991), showed that during kidney development the a l  chain is present in proximal renal tubules 
and in the glomerular mesangium but it is not present in the glomerular or vascular basement 
membrane.
On the contrary, the a2 laminin chain is predominantly synthesised by mesodermal derived cells, 
including mesanglial and myogenic cells (Schuler & Sorokin 1995; Sorokin et al, 1997a). a2 
chain-containing isoforms are typically present in the basal lamina of muscle and motor neuron 
synapses (Engvall et al, 1990; Sanes et al, 1990).
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The laminin a3 and/or a5 chains are expressed by epithelial cells (Ryan et al, 1994; Sorokin et 
al, 1990) whereas a4  chain synthesis might be restricted to endothelial cells (Sorokin et al, 
1994). Isoforms o f the a3 are present in the basal lamina of mature epithelium chain whereas 
isoforms of the a5 are present in the kidney, heart, muscle and lungs.
1.5.5 Laminins and cellular interactions
Soon after discovery, EHS laminin (laminin 1) was shown to have cell adhesion-promoting 
activity (Terranova et al, 1980). It is now well established that lammins are endowed with the 
property of controlling directly or indirectly cellular activities such as adhesion and migration, 
differentiation and apoptosis and gene expression (Aumailley & Smyth, 1998).
The first cell adhesion site described on laminin 1 corresponds to a 200kD pepsin-resistant 
fragment named PI (Ott et al, 1982, Timpl et al, 1983). This fragment is the target for several 
promiscuous RGD-binding integrins such as av(31 or av(33 (Aumailley et al, 1990b) (Figure.2), 
In the mouse laminin a l  chain an RGB sequence located on one LE motif of domain I lia  is 
responsible for the activity of PI (Aumailley et al, 1990a). In native lammin 1 the RGB 
sequence is cryptic and becomes accessible, in vitro, to cells only after proteolytic degradation of 
the adjacent domain I V a (Nurcombe et al, 1989; Aumailley et al, 1990b). However, in the 
human a l  laminin chain the equivalent sequence, RAD, has not been proven to be active.
The proteolytic fragment E8 (240 kD) (Figure.2) consisting of the carboxy terminal part of the 
triple-stranded helix formed by the a l ,  pi and yl chains and by the G1 to G3 domains of the a l  
chains, is the major cell binding domain of laminin 1 (Aumailley et al, 1987; Goodman et al, 
1987). It has been shown that unfolding of the fragment E8 coiled-coil conformation or 
proteolytic cleavage between the rod and the G domains leads to partial or complete loss of the 
cell adhesion activity respectively, without cell spreading (Deutzmann et al, 1990).
The activity of recombinant G domains also did not reproduce that of native lammin. Reactivity 
similar to that of the authentic molecule was restored only after reconstruction of a coiled-coil 
fold (Sung et al, 1993). Other investigated laminin iso forms, such as laminins 2,4 and 5 show a 
helical conformation-dependency for cell binding activity.
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Figure.2: Mapping of cell binding sites on 
laminin 1. The laminin proteolytic fragments 
with biological activity as well as the 
corresponding receptors are indicated. Picture 
reproduced from Aumailley & Smyth, 1998.
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Most cells use the a6p l integrin to recognize the long arm of laminin 1 (Aumailley et ai, 1990 
a,b) while certain cells such myoblasts or melanoma cells use the a7 p l integrin (Kramer et ai,
1991) {Figure, 2). Integrin a3(31 was initially thought to be a promiscuous receptor for several 
ECM proteins such as laminin, fibronectin and collagen (Takada et al, 1991; Hynes et al,
1992). Later studies though indicated a specificity restricted to laminin isoforms with the 
exception of laminin 1 (Carter et al, 1991). Another integrin potentially involved in cell 
anchorage to laminins is integrin a6(54, (De Luca et al, 1990) although most in vitro studies 
have failed to demonstrate a distinct binding of this integrin to laminins (Sonnenberg et al, 
1990) possibly because the affinity between a6p4 integrin and laminin may be too low to be 
seen in vitro.
Integrin a3p l may play a role in matrix assembly as chain deficient mice show a disorganization 
of the kidney and skin basal lamina (Kreidberg et al, 1996). Integrin a6(54 is thought to mediate 
stable anchorage of cells to laminins (Carter et al, 1994) since kératinocytes lacking the |34 
integrin chain have an increased mobility (Niessen et al, 1996).
However, integrins are not the only molecules mediating cellular interactions with laminins. 
Lammin 1 has a minor cell binding site assigned to the heparin binding fragment E3 
(Sonnenberg et al, 1992). Its interaction with cells is integrin-independent and is perturbed by 
heparin (Sorokin et al, 1992), an interaction probably mediated by a-dystroglycan, a component 
of the dystrophin-glycoprotein complex (Henry & Cambpell, 1996). The dystroglycan-laminin 
interactions are important for branching epithelial morphogenesis such as kidney, lung, or 
salivary gland (Sorokin et al, 1992) {Figure.2).
Furthermore, several galectins, cytosolic proteins involved in cell-adhesion and cell-signaling, 
(Barondes et al, 1994) interact with laminins and may control the spreading and migration of 
cells on specific domains o f laminins (Hall et al, 1997), but the exact mechanisms of these 
effects together with the ligand binding sites are unclear. Several synthetic peptides from the
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laminin a l ,  (31, (32 or yl chains also affect cellular interactions with laminin (Nomizu et al,
1997). However, whether they merely perturb the cell surface receptor or really mimic the 
activity of the authentic laminin molecule still remains to be shown (Brandenberger et al, 1996).
1.5.6 Laminin expression in the human uterus
Scoutt et al. (1991) undertook an MRI and histological examination of hysterectomy specimens 
and demonstrated a normal distribution of laminin throughout the myometrium, with no 
significant difference in the distribution between the junctional zone and outer myometrium.
An immunohistochemical study revealed that the interstitial matrix around stromal cells of the 
proliferative phase of the normal menstrual cycle, was unreactive with a monoclonal antibody 
against human laminin (Faber et al, 1986). However, in the secretory phase the stromal cells 
accumulated distinct cytoplasmic and pericellular laminin-immunoreactive material with the 
maximal amount of stromal cell-associated laminin observed around the stromal decidual cells of 
the late secretory phase. The same group observed that the epithelial basement membranes of the 
endometrial glands, vessels and smooth muscles contained lammin. They also claimed that in 
cystic and adenomatous hyperplasia the epithelial basement membrane could be visualized by 
laminin staining as a continuous band around the glands but no qualitative evidence was shown. 
By contrast, in atypical adenomatous hyperplasia the staining of basement membranes was often 
discontinuous (Faber et al, 1986).
Later, Aplin et al  (1988) in a immune fluorescence study of selected basement membrane and 
interstitial matrix components of human endometrium, reported that in the proliferative phase 
endometrium the only laminin immunoreactive structures were the walls of the blood vessels and 
the glandular basement membrane. However, in the mid and late secretory phase endometrium 
laminin staining was visible in the endometrial stroma as streaks and spots around the periphery 
of the cells (Aplin et al, 1988) in agreement with the results of Faber et al (1986). It was also 
reported that decidualising stromal cells produce laminin and other basement membrane 
components (Aplin et al, 1988).
In a study using the indirect iimnunofluoresence method, it was shown that laminin was localised 
exclusively in the basement membrane of endometrial glands and in the walls of blood vessels 
during the proliferative and secretory phases of the normal menstrual cycle (Iwahashi et al, 
1996). However, the results on the secretory phase reported by Iwahashi and colleagues (1996) 
do not agree with the findings of Faber et al (1986) and Aplin et al (1988). Strong staining was 
only recognized in the pericellular region of endometrial stromal cells in the decidua (Iwahashi 
et al, 1996).
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Stromal cell BM contain subunits a2, (31, (32, yl and low levels of a l  as was shown by 
immunofluoresence by Church and colleagues (1996). The glandular and vascular basement 
membranes of decidua tissue were reported to contain subunits a l ,  (31 and yl (Church et al, 
1996). By using Western blots, of decidual tissue, the presence of high molecular complexes 
containing a2, p i, p2, and yl were detected, indicating that laminins 2 and 4 are coexpressed by 
decidual cells (Church et al, 1996). In the non-pregnant cycle, a2  could not be detected in the 
proliferative phase but present in the late secretory in the perivascular areas where predecidual 
differentiation occurs. However, RT-PCR showed that a2 mRNA is present throughout the non­
pregnant cycle (Church et al, 1996).
1.6 Elastin
The elastic properties of many tissues such as the lung, dermis and large blood vessels are due to 
the presence of elastic fibers in the extracellular matrix (Rosenbloom et a l ,  1993). Elastic fibres 
have morphologically distinct structures specific to the organ or tissue. In elastic filaments, 
elastic fibres form interwoven rope-like filaments that branch and rejoin in a three-dhnensional 
network, whereas in the aorta they are organized as concentric sheets or lamellae. In elastic 
cartilage, large anastomosing fibres form a three-dimensional honeycomb-like pattern (Mecham 
& Davis, 1994).
Biochemical and ultrastructural analysis have shown that elastic fibres are comprised of two 
distinct components, an abundant amorphous component and a microfibrillar component 
(Rosenblomm, 1984). The amorphous component is a chemically-inert, insoluble and extremely 
hydrophobic protein called elastin that endows the fibre with the characteristic property of elastic 
recoil. The microfibrillar component consists of 10 to 12nm fibrils which are located primarily 
around the periphery o f the amorphous component, but also to some extent interspersed within it 
(Rosenbloom et a l,  1993). Because of their insolubility and theii* association with other 
extracellular matrix components, the composition of microfibrils has proven difficult to 
determine. Two glycoproteins appear to be true constituents of micro fibrils. The first is fibrillin, 
a 350kD glycoprotein and the second is a 31kD glycoprotein called microfibrils-associated 
glycoprotein (MAPG). Other proteins such as fibronectin, amyloid P component, vitronectin, 
lysyl oxidase and other components of reductive guanidine hydrochloride extracts also appear to 
be associated with microfibrils (Mecham & Davis, 1994).
1.6.1 Elastic fibre assembly
Relatively little is known concerning the detailed mechanism involved in fibre assembly. Elastin 
fibrillogenesis takes place at unique sites close to the cell membrane, generally in infoldings of 
the cell surface (Mecham & Davis, 1994). Microfibrils are the first visible components of elastic
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fibres and are found grouped in small bundles near the plasma membrane (Rosenbloom et al., 
1993). It has been demonstrated, by Jaques and Serafini-Francassini (1985), that newly 
synthesized elastin appears unevenly distributed on the surface o f the elastic fibres, often 
forming continuous strips of variable width arranged in a helical pattern around the fibre. This 
observation supports the possibility that the cell might control the orientation of the elastic fibre 
by secreting elastin over a specific cell surface. However these observations are not consistent 
with a noncontrolled passive process of elastic fibre assembly. Thus a special dynamic 
relationship between the elastiu producing cells and the elastic fibre has been proposed (Mecham 
& Davis, 1994). It has been suggested that microfibrils may be necessary only in the initial 
stages of elastic fibre assembly and that they are not required during the subsequent maturation 
of the fibre (Daga-Gordini et al, 1987).
Little in known about the intracellular trafficking of tropoelastin. Although the evidence to date 
(Damiano et al, 1984; Daga-Gordini et al, 1989) suggest that tropoelastin appears to follow the 
classical pathway of protein synthesis and secretion, few electron-dense vesicles or 
immunolabelled vesicles are observed in elastogenic cells (Mecham & Davis, 1994).
Examination of the cell-fi-ee translation product of elastin mRNA shows the polypeptide to 
contain a signal sequence of 24-26 residues (Karr & Foster, 1981) that is cleaved during 
translocation. The processed tropoelastin polypeptide chain enters the endoplasmic reticulum 
(ER) (Grosso & Mecham, 1988).
It has been shown that helper or chaperone proteins direct tropoelastin secretion and facilitate 
elastin assembly at the cell surface (Hinek et al, 1988). Evidence so far, suggests that a 
nonintegrm cell surface receptor complex consisting of three subunits mediates elastic fibre 
assembly (Hinek et al, 1988). Two of the subunits are integral membrane proteins. The third one 
is a 67-kD cell surface protein which binds via three separate sites to a hydrophobic sequence of 
elastin (VGVAPG), to the integral membrane subunits and to beta-galactosugars (Hinek et al,
1993). The intracellular motor that transports the tropoelastin-67kD complex appears to be 
intracellular actin (Mecham et al., 1991), which may be directed to membrane sites by cell- 
matrix receptors that interact with microfibrillar proteins.
The cytoskeleton of the elastin-producing cell may play a role in directing elastic fibre 
components to the appropriate membrane sites for secretion and assembly (Mecham & Davis,
1994). Evidence come from electron microscopy, which revealed the presence of microfilament 
bundles in the cytoplasm adjacent to regions of association between the developing elastic fibres 
and the surface of the elastin-producing cell (Mecham & Davis, 1994). Furthermore, Mecham et
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al. (1991), showed that both the distribution of the receptor on the cell surface and the affinity of 
the receptor for elastin were influenced by the underlying cytoskeleton.
At the plasma membrane, tropoelastin remains bound to the 67-kD protein until an interaction 
with the micro fibril induces the transfer of tropoelastin to the growing fibre (Rosenbloom et al.,
1993). The domain on tropoelastin that mediates interactions with microfibrils is unknown, 
although the carboxy-terminal end of the protein has been suggested to serve such a function 
(Brown et al., 1992). In this part of the molecule, the only two cysteine residues in elastin are 
found where they form a disulfide bond that stabilizes a positively charged pocket suitable for 
binding acid micro fibrils (Brown et al., 1992). Furthermore, experiments conducted to study the 
synthesis and secretion of tropoelastin by chick embryo artery walls, have provided biochemical 
evidence suggesting that tropoelastin may follow a secretory pathway from the rough ER to the 
plasma membrane (Saunders & Grant, 1985). Since tropoelastin appears to undergo little, if any, 
post-translational modification and no glycosylation, the necessity o f the newly synthesized 
tropoelastin to follow a Golgi-dependent pathway is brought into question (Mecham & Davis,
1994).
1.6.2 Elastin expression in the human uterus
When the elastic tissues of the non-pregnant human uterus are viewed by scanning electron 
microscopy, they resemble the structure of a sponge (Leppert & Yu, 1991). Elastin within the 
uterus is thought to provide the dynamic function of the tissue and play a significant role in 
pregnancy, labour and postpartum period (Woessner & Brewer, 1963). The uterine elastic 
membranes consist of continuous sheets with a smooth surface on which small fibrils are 
attached (Leppert & Yu, 1991). Thin flat sheets of elastic membranes (0.1-0.4pm in thickness) 
with a relatively smooth surface are observed in the myométrial uterine wall. No specific pillars 
are seen between the lamellae whereas fibrous pillars are seen to connect the elastic lamellae of 
the aorta (Leppert & Yu, 1991).
According to Gunja-Smith (1985), during pregnancy the elastin content of the human uterus 
increases four to fivefold from the nuUiparous to the multiparous uterus. An early MR study of 
water content and relaxation properties of the uterine junctional zone, also using 
immunocytochemistry for the localization of elastin claimed that both the content and nature of 
elastin did not differ between the junctional zone and the adjacent myometrium (McCarthy et al. 
1989).
In an immunohistochemical study, examining the localization of fibrillin-1 and elastin in human 
endometrium and decidua during the menstrual cycle and pregnancy, elastin was claimed to be
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absent from all tissues whereas fibrillin was present throughout the menstrual cycle (Fleming & 
Bell, 1997).
Malak & Bell (1994), failed to demonstrate the presence of elastin in fetal membranes, using 
histochemical, immunohistochemical, immunofluoresence and electron microscopy techniques. 
Fibrillin-containing microfibrils were detected as longitudinal bundles that were primarily found 
in the fibroblast and reticular layers. Based on the above results they proposed that the fibrillin- 
containing microfibrils provided the required elasticity to the fetal membranes. Nevertheless, 
Hieber et al. (1997), in a biochemical and histopathologic study, demonstrated that human fetal 
membranes synthesize and deposit elastic fibre, concluding that an elastic system, consisting of 
elastic and fibrillin-containing microfibrils provides a probable molecular basis for the elastic 
properties of the human fetal membranes.
I.7 The collagen family
The CO Hagens are a large, diverse family of proteins which account for about one third of the 
total protein mass in vertebrates. To date, nineteen different vertebrate coHagens referred to, as 
types I-XIX have been identified (Timpl & Brown, 1995). The triple helix, a special secondary 
structure formed from three polypeptide segments aligned in parallel, is the common structural 
hallmai'k of co Hagens (Piez, 1984). A further characteristic, is their exclusive localization in 
extracellular matrices where they perform various structural functions, since they differ in their 
modular structure, supramolecular organization and function (Timpl & Brown, 1995).
The basic subunits of the collagens are the a  chains, which vaiy in size (from 600 to 3000 amino 
acid residues) and contain one or more polypeptide segments with multiple Gly-Xaa-Yaa 
sequence repeats that form the triple helix (Timpl & Brown, 1995). The presence of several non- 
triple-helical protein molecules in the a  chains of collagens, not only gives them a greater 
module diversity than any other protein family known so far but it also makes it difficult to 
classify them into distinct subfamilies (Timpl & Brown, 1995). The major collagens are types I,
II, III found in bone, skin and cartilage tissue. Type IV is present in the BM whereas type V 
forms heterotypic fibrils with type I or types I and III collagens in bone, tendon and blood 
vessels. Type VI collagen is present in most connective tissue, type VII collagen in the major 
component of anchoring filaments whereas type VIII collagen is the major component of 
Descemet’s membrane (one of the five layers of the cornea). Finally type IX collagen is the 
prototype of a sub-family of collagens called FACIT collagens that include types XII, XIV, XVI 
and XIX. They are found in cartilage, invertebral disc and vitreous humour (Timpl & Brown
1995).
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So far, three groups of collagens are known; the fibrillar collagens, the non-fibrillar and the 
novel collagens. As this study involved examination of collagen IV, it is the only type of 
collagen discussed in further detail.
1.7.1 Collagen IV structure
Collagen type IV, of the chain composition [al(IV)]za2(IV), is the principal collagenous 
constituent of basement membranes (Timpl & Brown, 1995) and is considered to be responsible 
for the mechanical stability of BM (Hudson et al, 1993). Each monomer is thought to consist of 
two a l  chains (185kD) and one a l  chain (170kD). Unlike the interstitial collagens, each triple­
helical chain is longer and more flexible (Dolz et al, 1988) and is interrupted by variably sized 
breaks in the Gly-X-Y sequence characteristic to collagens (Yurchenko, 1994).
Variant type IV collagen a3, a4  and a5 chains have been identified (Hostikka, 1990). Both the 
a3 and a4 chains are found in lower amounts relative to the a l  and a2 chains, in the renal 
glomerular (GBM) and pulmonary alveolar BM. The a5 chain is also present in the GBM 
(Yurchenko, 1994).
In ultrastructural studies, the isolated [al(IV)]za2(IV) molecule appears as a 300-nm-long 
flexible thread (Kiihn, 1994). At the C terminus, a ~10-nm-long globular domain (NCI) is 
derived from all three chains (two a l  chains and one a2 chain) that is not processed (Yurchenko,
1994). Each subglobule possesses six cysteines divided among pairs of homologous disulfide- 
stabilized loop-like repeats (Siebold et al, 1988). The N terminal region (7S domain) is 28-nm- 
long, rich in cysteines and lysines, representing another major structural site in BM collagen 
(Timpl et al., 1981).
The sequence of the a5 chain is particularly homologous to the a l  chain, with preservation of 
the 7S domain, interruptions in the triple helix and the cysteine structure of the C terminal 
globular domain (Hostikka et al, 1990). The recently described a6 chain (Zhou et al, 1993) of 
collagen IV has been found to be the triple helical partner of the a5 chain. A further collagen, 
type VII consists of three al(V II) chains with different domain structure to collagen IV and is a 
constituent of anchoring filaments (Timpl & Brown, 1995).
1.7.2 Collagen IV assembly
Collagen IV, of the composition [al(IV)]za2(IV), is a network-forming collagen and a 
ubiquitous component of BM. A network model for the organization of collagen IV monomers is 
based on at least two different interaction sites involving assembly via the N and C termini. The 
initial step, in the assembly via the N terminus, is an antiparallel 25-nm overlap of two 
molecules, controlled by hydrophobic interactions, so that two intermolecular crosslinks, a
disulfide bond and a non-reducible lysine-derived aldimine bond can be formed (Kiihn, 1994). In
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a following step, the dimers aggregate to tetramers again stabilized by intermolecular covalent 
bonds (Siebold et al, 1987).
During end-to-end aggregation of two molecules, via their C terminus, a hexameric complex is 
formed which stabilizes the hydrophobic interactions between the NCI domain and leads to a 
stable and highly ordered arrangement (Siebold et al, 1988).
A third interaction, the process of which is not clear yet, has been proposed as part of collagen 
assembly. It is thought that the third interaction occurs after formation of the tetramers. Triple­
helical domains interact laterally, preferentially with the C-terminal half of the molecule, 
whereby superhelices are formed (Kuhn, 1994). The end result of this process is that it brings the 
C terminus of two molecules m the correct position relative to each other, so that disulfide 
exchange between NCI domains can occur and hexamers can be formed (Kiihn, 1994). 
Discriminatory molecular interactions must operate during the assembly of the superstructure, 
including formation of triple helical monomers, end-to-end associations of monomers and 
supercoiling (Hudson et al, 1993). The specificity for assembly of triple helical monomers 
(chain selection) as well as for end-to-end associations at the C terminus, appear to reside within 
the NCI domain (Mariyama et al, 1992). The specificity for end-to-end associations at the 
amino terminus that govern assembly of tetramers and supercoiling is unknown (Hudson et al,
1993).
1.7.3 Collagen IV interaction with cells
Collagen IV plays an important role in the interaction of basement membranes with cells. The 
cell binding site of the human [al(IV)]2a2(IV) molecule is located about 100 nm away from the 
N terminus (Kiihn, 1994). This area not only contains the recognition site for the two integrin 
receptors al(31 and a2p l (Vanderberg et al, 1991) but also is the area in which the triple-helical 
domain is stabilized by intramolecular disulfide bonds (Kiihn, 1994). Both integrins al(51 and 
a2p l bind to other collagen types (I, II, III) indicating the versatility of these receptors (Timpl & 
Brown, 1995).
According to Eble et al (1991), the essential amino acids of the al(31 integrin recognition site 
are Arg461 of the a2(IV) chain and Asp461 of the two al(IV ) chains. For the a2p l recognition 
site Arg and Asp are again the essential residues. Both chains of collagen IV are also involved in 
the interaction with a2p l (Kiihn, 1994).
The part of the N terminus where the binding sites are located, according to Kiihn (1994) is more 
exposed and less protected than the C terminal half of the triple-helical domain, which is 
involved in lateral aggregation and formation of superhelical structures.
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1.7.4 Collagen IV expression in the human uterus
In an immunohistochemical and ultrastructural study human decidual cells of the early and late 
pregnancy were studied (Wewer et al, 1985). It was found that the most prominent cell type in 
decidual tissue of both early and late pregnancy were large, mature epithelioid cells with a 
distinct pericellular BM containing at least laminin, type IV collagen, heparan sulphate 
proteoglycan and fibronectin (Wewer et al, 1985).
In 1988, in a immunohistochemical study of human endometrial extracellular matrix during the 
menstrual cycle and first trimester of pregnancy, it was reported that decidualising stroma cells 
produce BM components such as type IV collagen, laminin and others, which become organized 
into a pericellular halo (Aplin et al, 1988). In the proliferative phase endometrium the only 
immunoreactive structures were blood vessel walls and glandular BM, but by mid and 
particularly late secretory phase, staining with collagen IV was visible in endometrial stroma as 
streaks and spots around the periphery of the cells (Aplin et al, 1988). Similar observations were 
made on decidual stroma cells.
According to the in situ hybridization results of Autio-Harmainen et al  (1991), the stroma of 
large fibrotic villi and small villi stained intensely for type IV collagen whereas the stroma of the 
poorly vascularized villi with loose stroma stained more faintly. Decidual cells, endometrial 
stromal cells and cells in the wall of spiral arteries all expressed mRNA for type IV collagen 
(Autio-Harmainen et al, 1991).
In a study using in situ hybridization to investigate the expression of 70kD collagenase and the 
al(IV ) collagen chain in cells o f the early human placenta and gestational endometrium, it was 
found that the cells of trophoblastic columns, stromal cells of villi in cells of decidua and 
endometrial stroma all expressed mRNA for these proteins (Autio-Harmainen et al, 1990).
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Aims and Objectives
1. To expand recent preliminary findings, obtained within the Department of Obstetrics & 
Gynaecology, which suggested the existence of layering in the myométrial distribution of the 
[32 laminin chain. A subsidiary aim was to determine whether these gradients are modulated 
during the normal menstrual cycle and after exposure to intrauterine levonorgestrel 
(Mirena®).
2. To determine whether there is tissue specificity in laminin chain expression within the human 
uterus, by comparing the yl chain and collagen type IV with the a l ,  (31, P2 laminin chains.
3. To determine whether the extracellular matrix expression changes during the course of the 
menstrual cycle and after exposure to exogenous progestagen (Mirena®).
4. To examine elastin expression in the smooth muscle and vascular smooth muscle of the 
human endometrium and myometrium. To determine whether there is a gradient of elastin 
distribution in the human myometrium similar to that observed with the |32 laminin chain and 
if it is modulated during the normal menstrual cycle and after exposure to exogenous 
progestagen (Mirena®).
5. To devise quantitative methods of analysing matrix distribution within histological sections.
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Chapter.2 Materials and Methods
2.1 Solutions and buffers
3% BSA (Bovine Serum Albumin)
0.3g of BSA (Sigma, A-7638 Essentially Globulin Free) was dissolved in 10ml of phosphate 
buffer saline (PBS).
0.1% calcium chloride
lOOmg of calcium chloride was dissolved in 100ml of distilled water. The solution was stored at 
room temperature (R.T.).
0.01% calcium chloride
1ml of 0.1% calcium chloride was dissolved in 9 ml of distilled water. The solution was stored at 
R.T.
Citrate buffer (pH6.0)
2.1 g of anhydrous citric acid (BDH, Prod.279844E) was dissolved in IL of distilled water 
(DH2 O). The pH was adjusted to pH6.0 using 2M sodium hydroxide. The solution was then 
stored at 4-8°C,
Concentrated (lOx) N-Morpholino~propane-sulphonic acid (MOPS)
41.2g MOPS was dissolved in 1600ml of O.IM sodium acetate. The pH was adjusted to pH7 
with ION sodium hydroxide. 20ml of 0.5M Ethylenediaminetetra-acetic-acid disodium salt 
(EOTA) was added and the final volume was adjusted to 2L with distilled deionised water 
(ddHgO). The MOPS buffer solution was autoclaved and stored at 4-8°C.
Distilled Deionised Water (ddH2Ü) treated with diethylpyrocarbonate (DEPC)
SOOpl of DEPC (Sigma, D-5758) was added to 500ml of distilled water. The solution was 
autoclaved and then stored at 4-8°C.
0.5M Ethylenediaminetetra-acetic-acid disodium salt (EDTA)
186g of EDTA was dissolved in IL of ddHgO. The pH was adjusted to pH8 and the solution was 
autoclaved and then stored at 4-8°C 
0.0 IN  hydrochloric acid (pH2.5)
890pl of hydrochloric acid (Sigma, H-7020) was added to 1000ml of distilled water in a fiime 
cupboard wearing a protective mask and special gloves. The solution was stored at R.T.
0.2Mphosphate buffer
24g of sodium phosphate (Sigma, S-0751) was dissolved in IL of distilled water. The solution 
was stored at R.T.
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Pepsin solution
5 mg of pepsin (Sigma, P-6887) in 60ml of O.OIN hydrochloric acid (pH2.5).
0.01% Protease solution
O.Olg of protease (Sigma protease type XXIV, P-8038) in 0.01% calcium chloride 
Phopshate Buffer Saline (PBS) (pH 7.5)
6.0g of monobasic sodium phosphate (Sigma, S-0751) and 45.Og of sodium chloride (BDH, 
Prod.l0245K) were dissolved in 5L of distilled water. The pH was adjusted to pH7.5 with lOM 
sodium hydroxide. The solution was then aliquoted in 2.5L bottles, autoclaved and stored at 4- 
8°C.
O.IM Sodium acetate
27.2 g of sodium acetate (Sigma, S-8750) in 2L of water. The solution was stored at R.T.
Ix Tris Borate buffer (TBE)
100ml of 5xTBE added to 400ml of distilled water and stored at 4-8°C.
5x Tris Borate buffer (TBE)
136.25g of Sigma 7-9® (Sigma, T-1378), 69.7g of Boric acid (Sigma, B-7901), 18.75g EDTA 
(BDH, Prod. 10093) were dissolved in 5L of distilled water. The pH was adjusted to pH8.3 with 
5M NaOH. The solution was stored at 4-8°C.
50mM Tris (pH7.6)
In IL of distilled water 6.10g of Sigma 7-9® (Sigma, T-1378) was dissolved and the pH was 
adjusted to pH7.6 with HCl.
0.1% Triton-X
lOOpl of Triton (Sigma, X-100) was dissolved in 100ml of PBS.
2.2 Tissue Collection and Patient Information
Full thickness endometrial and myométrial specimens (n~44) were collected from women 
undergoing routine hysterectomy at the Glasgow Royal Infirmary, Western Infirmary and the 
Southern General Hospital. The specimens were taken from the operating theatre to the 
Pathology Department immediately after the removal of the organ. Initially no defined tissue 
collecting protocol was used and the receiving Pathologist was asked to provide a frill thickness 
endometrial and myométrial specimen. Later in the study all specimen were collected according 
to a defined tissue collecting protocol {Appendix,!). Prior to surgery all patients gave consent to 
allow uterine biopsies to be used for research {Appendix,2) and after surgery relevant patent 
information was collected using a patient record form {Appendix.3). The stage of the cycle was 
recorded on the Pathology Report received from the Department of Pathology for each patient.
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Additional Haematoxylin and Eosin stained sections were examined by a pathologist (Dr.Colin 
Stewart) to verify the stage cycle and also to look for evidence of abnormalities.
2.2.1 Tissue processing
Where possible tissue samples were collected for preparation o f frozen and paraffin embedded 
sections. For frozen sections, the tissue was snap frozen in liquid nitrogen and then stored in -80 
°C. For paraffin embedded sections, the tissue was placed in a plastic universal bottle containing 
10% Buffered Formaldehyde Solution (Chemix UN No.2209) in the day of collection. The 
following day it was taken to the Department of Pathology where it was further processed.
2.2.2 Tissue cutting
Five micrometer thick frozen sections were cut using an OTS/AS cryostat (Bright Instrument 
Company Ltd. Huntingdon England) and a Leica CM 1800 cryostat (Leica UK Ltd. Bedforshire, 
England). For paraffin embedded sections (5pm thick) a Leica RM 2135-Rotary Microtome was 
used (Leica UK Ltd. Bedforshire, England).
2.3 Haematoxylin and Eosin staining (H+E staining)
Haematoxylin and Eosin staining of both frozen and paraffin embedded sections was carried out 
at the Department of Pathology, using an automated slide stainer (Stainette 23, Reicart Jung, 
England).
2.3.1 Characteristics o f antibody supplies
When a new batch of antibody was purchased the following preliminary work was undertaken to 
define immunocytochemistry procedures to be used. An antibody dilution series (1-lOpg of 
protein per ml of antibody) experiment was carried out to decide the optimum dilution at which 
the antibody should be used. The optimum dilution for an antibody is the highest at which 
specific immunoglobulin can saturate the available antigen, leaving some unbound antibody in 
the solution to ensure continued binding. The final dilution at which the antibody was used was 
decided on the basis o f a clear background, absence of non-specific staining and the intensity of 
specific staining. The effect of quenching the endogenous peroxidase activity, before the primary 
antibody step or after the secondary antibody step, was also tested. Segments of tissue expression 
no antigen were used to determine optimum conditions of reagents. Finally, if the antibody in 
question was known to be reactive with paraffin embedded tissue, experiments were undertaken 
to determine if pre-treatment for antigen retrieval was necessary or not.
2.3.2 Antigen retrieval in fixed tissues
Antigen retrieval is applied to aldehyde-fixed tissues in which the antigenicity has been reduced 
by the formation of hydroxy-methylene bridges between components of the amino acid chains of 
proteins. Protease digestion, trypsin, pepsin pre-treatment and microwave heating were used.
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Sections to be protease treated the were deparaffinised, rehydrated and placed in a solution o f 
0.01% protease (Sigma protease type XXIV, P-8038) containing 0.01% calcium chloride. The 
solution of calcium chloride was pre-warmed in a water bath at 37°C for at least one hour. Just 
before the sections were placed in the calcium chloride solution, the protease was added. The 
sections were incubated in the protease solution for lOmins always at 37°C. The action of the 
enzyme was stopped by placing the slides in running tap water for 5mins and then in PBS for a 
further 5mins, at R.T.
Sections to be trypsin treated were deparaffinised, rehydrated and incubated in a solution of 
0.1% trypsin (Sigma, T-8253) in Tris buffer (pH.7.6) containing 0.1% calcium chloride, as 
above. The slides were incubated in the trypsin solution for 15mins at 37”C. The action of the 
enzyme was stopped by washing the slides in running tap water for 5-lOmins.
Sections to be pepsin treated were deparaffinised, rehydrated and placed in a solution of 2- 
lOmg/ml of pepsin (Sigma, P-6887) in O.OIN of hydrochloric acid (pH2.5). The solution of 
hydrochloric acid was pre-warmed in a water bath at 37°C for at least one hour. Pepsin was 
added just before the slides were placed in the hydrochloric acid solution. The slides were 
incubated in the pepsin solution for 30mins always at 37°C. The action of the enzyme was 
stopped by washing the slides gently several times in distilled water.
For specimens to be pre-treated by microwave heating, a pressure cooker containing IL of citrate 
buffer (pH6.0) was placed in a microwave and brought to boil (15mins on full power). When 
boiling, a rack containing the section was placed in to the buffer inside the pressure cooker. The 
microwave was set for 8mins on full power, 3mins to reach pressure and 5mins at pressure. 
When the procedure was completed, the pressure cooker was carefully removed from the 
microwave wearing protective gloves and facemask. The cooker was depressurised and the 
sections were left to cool for 20mins (inside the pressure cooker). The slides washed once in 
distilled water and once in PBS for 5mins each time.
2.3.3 Immunocytochemistry (ICC) for frozen sections
Sections (5pm thick) of endometrial and myométrial tissue were fixed in acetone (BDH, 
Prod.l00034Q) for 10 min, rinsed (1x5min) in PBS, treated with 0.5% hydrogen peroxide 
(Sigma, H-1009) in methanol (BDH, Prod.l0158BG) for 30min and then rinsed (2xl0min) in 
PBS. For some antibodies the latter step was carried out before the addition of the primary 
antibody and for others after the addition of the secondary antibody, depending on the 
preliminary results {Table,!). Non-specific binding sites were blocked by incubation in 20% goat 
serum plus 20% human serum (Sigma, S-7023) diluted in PBS, for 30min inside a humidified 
box at R.T. The sections were incubated with the appropriate monoclonal antibody {Table,!) at
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the appropriate dilution {Table, 1)^  determined in preliminary work, in 2% goat serum, overnight 
at 4°C inside a humidified box. A monoclonal mouse antibody (Dako, X-0931) was used as a 
negative control at 1:200 in 2% goat serum. Sections were rinsed (2x5min) in PBS and incubated 
in secondary biotinylated anti-mouse antibody (Dako) diluted at 1 ;200 in 2% goat serum plus 5% 
human serum, for 30min inside a humidified box at R.T. This was followed by further rinsing 
(2x5min) in PBS and incubation with peroxidase-conjugated streptavidin (Dako, P0397) for 
30min inside a humidified box at R.T. The sections were rinsed (2x5min) in PBS and incubated 
in DAB solution, made by adding a 3-3' Diaminobenzidine tablet (Sigma, D-5905) in 15ml of 
Tris buffer plus 12pl of 30% (w/w) hydrogen peroxide (Sigma, H-1009), for 10 min at R.T. Then 
the sections were washed in PBS, (1x5min) in running tap water (1x5min) and stained with 
haematoxylin (Sigma, GHS-2-16) for 15sec. Finally, the sections were dehydrated through a 
series of ethanol solutions (70%-100%, a few seconds in each) to xylene (BDH, Prod. 102936H) 
(a few seconds), mounted in DPX (BDH, Prod.360294H) and viewed by bright field microscopy.
2.3.4 Immunocytochemistry (ICC) for paraffin embedded sections
Sections (5pm thick) of endometrial and myométrial tissue were placed in the oven (56°C) for at 
least 35min, rehydrated (5min in each alcohol from 100% to 70%) and washed in PBS for 5min. 
The procedure used was the same as that of the frozen sections.
The paraffin embedded sections were dehydrated through a series of ethanol solutions (70%- 
100%, 5min in each) to xylene (BDH, Prod. 102936H) (a few seconds), mounted in DPX (BDH, 
Prod.360294H) and viewed by bright field microscopy.
Half way through the study another biotinylated secondary antibody (Vector) was used due to 
technical problems arising from the batch quality of the conjugate. This biotinylated anti-mouse 
secondary antibody (BA-2000) was raised in horse serum, so for all antibody dilutions as well as 
for blocking of the non-specific sites horse serum was used instead of goat serum. In addition an 
avidin/biotin kit (Vectastain ABC Elite kit, PK6100, Vector) was used in the place of the 
streptavidin peroxidase (Dako). For the preparation of the avidin/biotin solution in 2.5ml of PBS 
1 drop of solution A and 1 drop of solution B were added. As with the streptavidin solution, the 
avidin/biotin solution was also prepared at least 30mins before it was used.
2.3.5 Histochemical staining for elastin
Additional sections were stained with orcein according to the Modified Taenzer-Unna Orcein 
method (Drury & Wallington, 1967). Orcein staining is not entirely selective for the elastic fibre 
system, it also stains nuclei and collagen components. The resorcin-fuchsin method according to 
WEIGERT in combination with the picrofuchsin method according to VAN GIESON and the 
nuclear staining technique according to WEIGERT (Elastica kit acc. to VAN GIESON, Merck
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1.15974) was also used but produced a less distinct density difference between uterine tissue and 
elastic components, therefore it was not pursued.
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2.4 Photo-microscopy and digital image capture
Microscopic examination of all sections was carried out using an Olympus BX50 microscope 
equipped with x4, xlO and x40 lenses. 35mm photomicrographs were produce with an Olympus 
C-35AD-4 camera, using a 64T colour slide film (Kodak). Neutral density filters (ND25, ND6) 
were used to adjust exposure. The speed and exposure parameters were 64 I.S.O (International 
Standards Organization) and 0.1-1 sec, respectively.
A second Olympus BX50 microscope equipped with x4, xlO, x20, x40, xlOO lenses, connected 
to a 3-CCD color camera (JVC) was used for digital hnage capture. Computer visualisation of 
the images was achieved with an hnage analysis program (Image-Pro Plus 4.0). Four neutral 
density filters were used the ND6, ND25 and a 0.40 Wratten ND gelatin filter to adjust the 
brightness of the image, while maintaining a constant colour. Images of a lO^im stage 
micrometer (Graticules, Ltd) were recorded at x4, xlO, x20 and x40 magnification and used as 
spatial calibration objects. All digital images were saved in uncompressed tif format to preserve 
the original image data.
2.4.1 Scanning o f microscopic slides to obtain low magnification images 
Microscope slides, where the a2, p i, P2, yl laminin chains and collagen IV had been 
immuno localised, were scanned using an Epson GT 9500 scanner. The slides were positioned on 
the scanner facing downwards. The images were imported to Adobe Photoshop 4.0 of 5.5 using 
the TWAIN 32 interface program. Constant exposuie and contrast settings were used.
The slides counterstained with and without Haematoxylin were scanned as a “RedGreenBlue” 
(RGB) image at a resolution o f 1200 dots per inch (dpi). In the case of slides without 
Haematoxylin staining, the gamma contrast value was increased to the maximum (value of 50) 
resulting in a lightened hnages with increased contrast.
In later studies slides where elastin had been localised without Haematoxylin staining, were 
scanned (Medical Illustration, Glasgow Royal Infirmary) using a 35mm slide scanner. All slides 
were scanned as RGB images at a resolution of 2700dpi and with uniform contrast and exposure 
settings. All images were saved in tif format.
Spatial calibration was undertaken using the Image Pro-Plus 4.0 program. A scanned area from a 
precision ruler was used as a calibrating object for the images obtained fr om the flatbed scanner 
(1200 dpi). For the low magnification scans obtained from the slide scanner (2700 dpi) a 35mm 
slide of the lOmicron-stage micrometer was scanned (2700 dpi) and then used as a calibrating 
object.
38
2.4.2 Line profiles
Low magnification scanned images of microscope slides where different laminin chains (n=16 
for anti-beta 2 and n=3 for gamma 1), collagen IV (n=15) and elastin (n=10) had been localised 
without Haematoxylin, were opened in Image-Pro Plus (Image Analysis program). The blue 
color channel was selected, to produce an 8 bit monochrome image with suitable density 
information. A rectangular area of full or partial myométrial thickness was manually selected. 
Two vertical lines, specifying the rectangular area to be analysed, were placed on the image 
{Figure,3). The image intensity across the calculated for each pixel row. The length and width of 
these lines depended on the condition of the tissue and type of examination (e.g. full thickness, 
transition between inner and outer myometrium). Areas with artefacts and holes were avoided. 
Regions of interest were defined by placing two movable boundary markers on the line profile 
{Figure,3). The upper-limit marker represented the start point of the line profile (e.g. serosa, 
outer myometrium) and the lower-limit marker was used to define the transition point between 
the endometrium and the myometrium, the numerical value of which was reported. These lines 
were also used to investigate the significant features, such as peaks and troughs, throughout each 
data set. The calibrated spatial data was expressed in mm and the intensity values were stated in 
arbitrary units (0-255).
From the Line Profile: Report menu the Table option was then selected and the line profile data 
were also displayed in a tabular form {Figure,!), Both the line profile graph and the tabular data 
where transferred to a spreadsheet (Excel, Microsoft). The grey level data were inverted 
(subtracted from 255) so that the dense regions had high values. An XY Scatter chart was 
created. The X-axis o f the chart represented the distance across the tissue and the Y-axis 
measured the density of the staining in arbitrary values (inverted grey levels).
The image was subsequently annotated by drawing a rectangular box over the selected areas. 
Additionally a thin horizontal line was drawn to delineate the endometrium/myometrium 
boundary (elastin sections) or the inner/outer myometrium boundary (laminin sections). The 
annotated image was saved in tif format and stored for future reference.
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Figure.3 Captured screen image from Image Pro-Plus 4.0 program showing the line 
profile data in tabular form and a low-magnification image of a full thickness endometrial 
and myométrial section, with the vertical lines referred to in the text.
w^ aaauw
Figure.4 Captured screen image fi’om Image Pro-Plus 4.0 program showing the line 
profile data in tabular form and a low-magnification image of a full thickness endometrial 
and myométrial section.
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2.4.3 Editing digital images
Digital images captured at various magnifications were edited within Adobe Photoshop 4.0 or 
5.0. Scanned images used for quantitative analysis were not manipulated in any way. The color 
balance of the images was adjusted by manually selecting a background region of the section 
image with no tissue, in order to produce a consistent white colour background. From the digital 
images o f the orcein staining, monochrome images were produced by thresholding the darker 
areas. The images were then annotated, by adding the corresponding letter and scale bar. The 
annotated image was then saved in tif format and inserted into Microsoft’s Word document 
where they were rescaled and a border was placed around them.
2.4.4 Quantitative analysis o f  elastin distribution
Eleven full thickness paraffin embedded myométrial sections, where elastin was 
immuno localised without Haematoxylin counterstaining, were selected on the basis o f tissue 
quality (i.e. fewer holes and artefacts present). Digital images were produced by scanning the 
sections at a resolution of 2700dpi with constant exposure and contrast settings. Density profiles 
for the intensity o f elastin immuno localisation were produced using the method described above. 
Because the length of the myométrial specimens (n=ll) varied, two methods of combining the 
data sets from all sections were then applied to average the distribution of elastin throughout the 
myométrial length. The first method involved simple averaging o f data from myométrial 
sections. In the first method, the data sets were aligned using the position of the outer 
myometrium and truncated at a length equal that of the shortest myométrial specimen (18.8mm). 
This method restricted the analysis to the outer myometrium. A combined horizontal average 
was calculated for all the tissue sections at given myométrial lengths.
In the second method the data sets were normalised by width. All myométrial sections (n=ll) 
were arithmetically divided into an equal number of slices (n=93) within a width range o f 219- 
300pm. The width (219-300pm) of the slices varied between the 11 myométrial sections and 
depended on the myométrial length of the individual sections. As the calculation of the 
consecutive slice average involved smoothing of the data, over-smoothing o f the data was 
avoided by selecting a width range o f 219-300pm.
Patterned data sets were generated (Minitab) to label each of the 3,000 pixels with a particular 
slice number. The mean slice value was calculated for all patients (Minitab). The Pearson 
correlation coefficient was calculated and a line regression analysis was carried out (Minitab). A 
fitted line plot was generated displaying either the 95% confidence interval (C.I) or the 95%
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prediction interval (P.I). A liner and quadratic fit were compared (Polnom, Simfit 
http://biomed.man.ac.uk/simfit/).
2.4,5 Quantitative measurement of laminin p2 chain
As it was not possible to produce full thickness myométrial frozen sections of very high quality 
the analytical method devised was based on the transition from inner to outer myometrium rather 
than the whole myométrial length.
Eight high quality frozen sections without cutting artefacts or holes were selected. In these 
sections the laminin (32 chain was immunolocalised without Haematoxylin counterstaining. 
Digital images were produced by scanning the sections at a resolution of 1200dpi with constant 
exposure and contrast settings.
Density profiles for the intensity of the laminin (32 chain immunolocalisation were produced 
using the same methods as that for elastin. An objective data averaging technique was used to 
define the point at which the intensity o f the immuno-reaction started to decline, moving from 
the inner towards the outer myometrium. A region of outer myometrium at least 1.25mm from 
then edge of the sections and approximately 7mm in length, was selected and an average density 
value was calculated for the outer part of the muscle. The raw data set was then smoothed, by 
calculating the running average, to extract the underlying trend in the data. The running average 
was calculated from the outer towards the inner myometrium (Excel). The degree of smoothing 
used was set by comparing different smoothing widths ranging from 20-300 pixels (0.42- 
6.4mm). A smoothing width of 30 pixels (0.64mm) was shown to produce a reliable estimate of 
the transition point. The point, at which the edge of the smoothing window achieved the same 
value as the outer average, was determined. The position of the centre of the smoothing window 
was then used to calculate the sectional width. This method defined the position where the 
immuno-reaction intensity began to decline in the outer muscle. The distance between this point 
and the endometrial-myometrial junction was defined as the sectional thickness of the inner 
myometrium.
Averages were calculated for the myométrial distribution of the (32 laminin chain and collagen 
IV. All smoothed data sets for the (32 laminin chain (n=13) and collagen IV (n=12) were aligned 
separately using the position of the endometrial/myometrial boundary and truncated at a length 
equal to that of the shortest specimen (12.02mm for the (32 laminin chain and 11.51mm for 
collagen IV). A combined average was calculated for all the tissue sections throughout the 
muscle.
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The sectional thickness was calculated from the average data set for the p2 laminin chain using a 
similar method as that described above. The region of outer myometrium selected was 
approximately 3.5mm in length and an average value density value was calculated for the outer 
part of the muscle.
The ratio of the p2 laminin chain to collagen IV was also calculated (Excel). Linear and 
quadratic fits were applied to the ratio of the P2 laminin chain to collagen IV (Excel). The 
sectional thickness was defined, using the method described above and when the quadratic 
function reached the maximum.
2.5 RNA Isolation
Total RNA was extracted from four hysterectomy specimens. Immediately after the surgery, the 
uterus was taken to Pathology, where a full thickness endometrium and myometrium mid corpus 
slice (~lcm thick) was cut off, by the receiving pathologist, and transferred to the lab in an RNA 
stabilising solution (RNAlater Ambion, Cat.#7021). The endometrium was removed, under 
sterile conditions, and discarded. The remaining myometrium was weight and placed into five 
times the volume of RNAlater solution, stored at 4°C and processed within a month from the 
date of collection.
Total RNA was isolated from each sample using the Trizol (Life Technologies, Cat.No. 15596) 
according to the manufacturer method. The tissue was chopped into smaller pieces and 
homogenised in 1ml o f Trizol (per 50-100mg of tissue) using a homogenizer for 50sec. The 
homogeniser head was cleaned with double-distilled water (DDW) and 70% alcohol before and 
after the processing of individual samples.
The homogenised sample was aliquoted in 1ml amounts (5-12 tubes), incubated for 5min at 15- 
30°C. 0.2ml of chloroform (per 1ml of Trizol) was then added to each tube. The tubes were 
shaken vigorously by hand for 15sec, incubated at 15-3°C for 2-3 min and centrifuged (13,000 
rpm) for 15min at 2-8°C. Following centrifugation the mixture was separated into a lower red, 
phenol-chloroform phase, an interphase and a colourless upper aqueous phase. The aqueous 
phase was careftilly transferred to new tubes using a fine plastic pipette and then 0.5ml of 
isopropyl alcohol (per 1ml of Trizol used in the initial homogenisation) was added. Samples 
were incubated for lOmin at 15-30°C and centrifuged (13,000 rpm) for lOmin at 2-8°C. The 
supernatant was removed and each RNA pellet was washed once with 1ml of 70% ethanol (per 
1ml of Trizol used in the initial homogenisation). Each sample was mixed by vortexing so that 
the pellet could be seen floating in the solution. At this point all samples were stored at -70°C. 
After thawing the samples were centrifuged (10,000 rpm) for 5min at 2-8°C, the pellets were
43
allowed to dry for approximately 20 min. The RNA was dissolved in DEPC treated DDW. The 
amount of DEPC DDW used depended on the size of the pellet, but no less than 15 pi was used. 
All samples were vortexed, centrifuged and incubated for 5min at 65°C (Techne Dri-Block DB 
IM, Genetic Research Instrumentation, Essex, Enlgand). The last three steps were repeated one 
more time. All aliquots (5-12 tubes) were combined into one tube and kept on ice.
2.5.1 Quantification of RNA
lOpl of the RNA sample was added to 990pl of double distilled water in a microcentrifuge tube. 
This solution was vortexed and transferred into a silica cuvette using a disposable plastic pipette. 
The absorbance of the solution at 260nm and 280nm was measured using a spectrophotometer. 
The absorbance of the solution at 260nm and 280nm is directly proportional to the concentration 
of RNA present in the sample. The ratio of absorbance values obtained is an index of the purity 
of the RNA sample. A ratio of 2.0 represents a pure RNA sample with very little contamination. 
The amount of RNA present in 1ml of a sample was calculated by multiplying the absorbance at 
260mn by 40, since an optical density of 1 represents 40mg of RNA. The total amount of RNA 
present was calculated by multiplying the above value by the dilution factor.
2.5.2 Electrophorised examination for RNA samples
The RNA gel was prepared by dissolving 1.2g of agarose in a solution containing 73ml of DDW 
and 10ml of lOx MOPS. The solution was microwaved at P70 for 2.5min, gently swirling every 
20sec. Seventeen millilitres of formaldehyde were added to the above solution and then it was 
left to cool down for approximately 20min. The above solution was poured into a sealed gel plate 
containing a plastic comb, 60ml of and the gel was left to set for 30min. The gel was placed in a 
G-lOO gel tank, and filled up with IxMOPS solution. lOpl of loading buffer was added to the 
RNA samples, and the tubes were vortexed and incubated at 65°C for lOmin before the RNA 
samples were loaded onto the gel wells. The samples (5pi) were electrophorised at 60V for 2- 
2.5h. The presence 18S and 28S bands were examined using a transilluminator (TC-312A, 
purchased from Spectroline, U.K.) A photograph of each gel was taken, using a direct screen 
instant camera (DS 34, purchased from Polariod, U.K.) with a 0.7x Hood (DS H-7, Polariod, 
U.K.). All samples were aliquoted in lOpl aliquots and stored at -70 °C.
2.5.3 Reverse transcriptase-polymerase chain reaction analysis of anti-beta 2 (C4) and 
gamma 1 (1)18) laminin chains
Anti-beta 2 (C4) and gamma 1 (D18) laminin chain mRNA expression was examined by reverse 
transcriptase-polymerase reaction (RT-PCR) using a one step reaction (Qiagen OneStep RT-PCR
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kit, Cat. No. 210212). Total RNA was extracted (see RNA Isolation) from human myométrial 
tissue.
RT-PCR was performed in a reaction volume of 50pl {Table.2). A volume 10% greater than the 
required, for the total number of reactions, was prepared according to Table, 2. A  negative 
control, lacking the template RNA, was also included in every experiment. The Master mix was 
vortexed and the appropriate volumes were dispensed into PCR tubes. The template RNA was 
then added to the individual PCR tubes, vortexed and overlaid with one drop of mineral oil. 
While the PCR tubes were still on ice, the RT-PCR program was initiated but the PCR tubes 
were not placed into the thermal cycler until it had reached a temperature of 50°C.
For amplification of the anti-beta 2 laminin chain, the sense primer 5 [prime] 
GCTCGGCAGTTGGATGCTCTC 3 [prime] and the antisense 3 [prime]
GCCCGCTCATTTTCCTCATAG were used. For amplification of the gamma 1 laminin chain, 
the sense 5 [prime] CAAAGCCAAAGATGAAATGAA 3 [prime] and the antisense 3 [prime] 
AGAGGAGTGGGGGTCTGAAAA 5[prime] were used. All oligonucleotides were synthesised 
by Operon Technologies, Inc. The sequence of both sense and antisense primers were kindly 
provided by John Aplin (St.Mary’s Hospital, Manchester). The amplification conditions are 
summarised in Table, 3.
After amplification, the PCR products were electrophorised on a 1% agarose gel for 1.5h at 80V. 
For the preparation o f the gel Ig of agarose (BRL, 5405510UB) was dissolved in 100ml of 
IxTBE, The solution was microwaved at P70 for 2.5 min, gently swirling every 25 sec. Ipl of 
ethidium bromide (Sigma, E l510) was added to the solution which was left to cool for 
approximately 20min before it was poured into the gel tray and left to set for about 30 min. The 
gel was placed into G-lOO tank and filled with IxTBE.
Table, 2 Reaction components for one-step RT-PCR
Component Volume/reaction
Master Mix
RNase-free water Variable
5x OneStep RT-PCR Buffer * lO.Opl (C4) & 6.0pl(D18)
dNTP Mix 2.0pl
Primer A (sense primer) Ipl
Primer B (antisense primer) Ipl
OneStep RT-PCR Enzyme Mix 2.0pl
Template RNA
Template RNA Variable!
Total Volume 50.0
*Contains 12.5 mMMgCl^. The final concentration in the Master mix is 2.5 mM MgCU. For the anti-beta 2 oligonucleotide 2.5 mMMgCh were 
required but 1.5 mMMgClifor the gammal oligonucleotide, 
f  A final concentration o f 2pg  w o i  used per reaction.
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Table.3 Thermal cycler conditions
Step Temperature
Reverse transcription 30min 50T
Number o f  cycles 1
Initial PCR activation step 15min 95T
Number o f  cycles 1
Dénaturation Imin 94°C
Annealing Imin 5TC  (C4)-51°C(D18)
Extettsion Imin 72T
Number o f  cycles 30
Final extension lOmin 72°C
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Chapter.3 Results
3.1 a2, |31, (32, yl laminin chains and collagen IV expression in the human uterus
Frozen sections from thirty-two normal specimens (4 menstrual, 15 proliferative, 11 secretory, 1 
inactive, 1 postmenopausal) and 12 exposed to exogenous progestagen (Mirena®) for a period of 
10 weeks to 9 months, were stained with antibodies directed to the a2, (31, (32, yl laminin chains 
and collagen type IV. The original tissue bank consisted of 70 specimens but due to a freezer 
failure ahnost half of the tissue bank was lost, together with cut frozen sections.
3.1.1 a2, pif P2y yl laminin chains and collagen IV expression in the myometrium and 
endometrium o f normal uteri
Low magnification scans o f sections where the (32 laminin chain {Plate. 1 A) had been 
immunolocalised revealed myométrial layering. This was in contrast to the more uniform 
myométrial distribution of the yl laminin chain {Plate. IB) and collagen IV {Plate. 1C). 
Microscopic images allowed higher resolution examination of the a2, (31, (32, yl laminin chains 
and collagen IV distribution. In the myometrium collagen IV was widely distributed throughout 
the smooth muscle {Plate.2A) and was also present in the vascular smooth muscle and stroma 
surrounding the blood vessels of both the inner and outer myometrium {Plate.2A^B). Collagen 
IV was immunolocalised in the glandular BM and blood vessels of the endometrium 
{Plate.2C,D). It was also present in the endometrial stroma of the superficial {Plate.2C) and 
basal part {Plate. 2D) of the endometrium.
The yl laminin chain was immunolocalised in the smooth muscle and vascular smooth muscle of 
the inner myometrium {Plate,3A). In the outer myometrium the yl laminin chain was present in 
the smooth muscle and vascular smooth muscle but was absent from the stroma surrounding the 
blood vessels {Plate.3B) in contrast to collagen IV {Plate.2B). In the endometrium the yl 
laminin chain was present in the glandular BM, capillaries and arterioles {Plate3C,D) but was 
absent from the endometrial stroma o f both the superficial {Plate.3C) and basal part of the 
endometrium {Plate.3D).
In the inner myometrium the (32 laminin chain was present in the smooth muscle and vascular 
smooth muscle {Plate.4A). In the outer myometrium the (32 laminin chain was immunolocalised 
in the smooth muscle and vascular smooth muscle {Plate.4B) but was absent from the stroma 
surrounding the blood vessels {Plate.4B). There is an obvious increase in intensity of staining 
between the smooth muscle of the inner {Plate.4A) and outer myometrium {Plate.4B). This
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difference illustrates the gradient of the P2 laminin chain expression within the human 
myometrium and can be clearly seen in a low magnification scanned image {Plate. I A).
In the endometrium the P2 laminin chain was restricted in the basal portion o f the glandular BM 
of the superficial endometrium {Plate.4C). The P2 laminin chain was also present in the spiral 
arterioles, variably present in the capillaries of the endometrium but absent from the stroma o f  
both the superficial and basal part of the endometrium {Plate. 4QD).
Plate. I: Laminin p2  ^ y l chains and collagen IV distribution in uterine sections
Laminin p2 chcùn Laminin yl chain Collagen IV
m
Plate I : Low magnification scanned images of endometrium and myometrium from cryosections. (A-C) Secretory 
phase specimens where laminin p2 (A), y I chains (B) and collagen IV (C) have been localised The blue colour is 
Haematoxylin staining of the nuclei. The dotted line marks the boundary between endometrium (e) and myometrium 
(m). In (B) and (C) part of the endometrium is seen to invade the subendometrial myometrium There is a gradient 
in the myométrial smooth muscle expression of the (32 laminin chain (A) in contrast to the more expression of the yl 
laminin chain (B) and collagen IV (C). Within the inner myometrium, blood vessels are stained with the P2 laminin 
chain. Scale bar = 5mm.
48
Plate 2: Collagen type IV distribution in the human myometrium and endometrium
A
Plate 2l Collagen IV in a ubiquitous component of the basement membrane and. It was therefore expected to be 
uniformly distributed throughout the myometrium and endometrium and so acted as an internal control (A) In this 
proliferative phase specimen, collagen IV is expressed within the smooth muscle (sm) of the inner myometrium, 
capillaries (c), vascular smooth muscle (vsm) and the peri-vascular stroma. (B) Collagen IV is present in the smooth 
muscle (sm) and vascular smooth muscle (vsm) of the outer myometrium in this proliferative phase specimen. It is 
also present in the smaller arteries as well as in the stroma surrounding the blood vessels. (C) In the endometrium of 
this proliferative phase specimen, collagen IV is present in the glandular basement membrane and in the capillaries 
Collagen IV is also present in the endometrial stroma in a punctuate pattern. (D) Collagen IV is present in the 
glandular basement membrane and in the capillaries of this proliferative phase specimen. Due to the higher cellular 
density of the basal stroma, collagen IV is more widely distributed (C). Scale bar (A,C,D) = 100pm, (B) = 200pm.
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Plate 3: yl laminin chain distribution in the human myometrium and endometrium
m m
w m
Plate S’. The yl laminin chain is present in most of the laminin types. It was therefore expected to be found in all 
the components of the myometrium and endometrium, wltere BM were present and hence acted as an internal 
comtrol. (A) The yl laminin chain is present in the smooth muscle {sm) and the vascular smooth muscle (vsm) of the 
inner myometrium but is absent from the stroma surroimding the blood vessels, in this proliferative phase specimen 
(B) In the outer myometrium the y I laminin chain is present in the smooth muscle (sm), vascular smooth muscle 
(vsm) but is absent from the peri-vascular stroma in this weakly proliferative phase specimen. (C) In the basal 
endometrium of this menstrual phase specimen, the yl laminin chain is present in the glandular basement membrane 
and the blood vessels but is absent from the endometrial stroma. (D) Part of the endometrium (e) and 
subendometrial myometrium (m) from the same specimen as (C) are visible. The yl laminin chain is present in the 
glandular basement membrane and capillaries but is absent from the endometrial stroma. The smooth muscle of the 
myometrium (m) is shown to express the yl laminin chain. Scale bar (A,C,D) = 100pm, (B) = 200pm.
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Plate, 4: P2 laminin chain distribution in the human myometrium and endometrium
c
Plate. 4: Layering in the myométrial distribution of the p2 laminin chain is observed by direct microscopic 
observation of tissue sections (A) In the inner myometrium of this menstrual phase specimen, the (32 laminin chain 
is present in the vascular smooth muscle as seen in this branching arteriole {ba) and only weakly expressed in the 
smooth muscle (sm). The (32 laminin chain is also present in the capillaries (c). Part of the basal portion of the 
adjacent endometrium (e) is present. (B) In the outer myometrium of the same specimen as (A), the P2 laminin 
chain is expressed in the smooth muscle (sm). The P2 laminin chain is also present in the vascular smooth muscle 
(vsm) but absent from the peri vascular stroma Note the difference in the intensity of staining between the smooth 
muscle of the outer and iimer myometrium. This illustrates the myométrial layering of the (32 laminin chain which is 
shown in PlateAA. (C) In the endometrium the (32 laminin chain is present in the vascular smooth muscle as seen in 
the spiral arteriole (sa) but is absent from the endometrial stroma in this secretory phase specimen. The (32 laminin 
chain expression is restricted to the basal portion of the glandular basement membrane. (D) In the basal 
endometrium of this weakly proliferative phase specimen, the P2 laminin chain is present in the glandular basement 
membrane, the vascular smooth muscle as seen in the spiral arteriole (sa). The (32 laminin chain is absent from the 
endometrial stroma but present in the smooth muscle (sm) of in the inner myometrium. Scale bar (A,C,D) = 100pm, 
(B) = 200pm.
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The {31 laminin chain was present in the smooth muscle of the inner myometrium {Plate, 5A) as 
well as in the endothelium of the blood vessels {Plate,5A). In the outer myometrium the pi 
laminin chain was expressed in the smooth muscle but absent from the stroma surrounding the 
blood vessels {Plate,5B). The pi laminin chain was also present in the endothelium of blood 
vessels in the outer myometrium {Plate, SB) but absent from the vascular smooth muscle 
{Plate,5B).
In the endometrium, the pi laminin chain was immuno localised in the glandular BM and 
endometrial stroma (Plate.5C,D). The pi laminin chain was also present in the capillaries and 
particularly obvious in the vascular smooth muscle of the arteries {Plate. SCfD), The myométrial 
distribution of the pi laminin chain is heterogeneous {Plate, SC^D),
In the inner myometrium, the a2 laminin chain was present in the smooth muscle but absent 
from the stroma surrounding the blood vessels and the vascular smooth muscle {Plate, 6A). In the 
outer myometrium the a2 laminin chain was present in the smooth muscle but absent from the 
vascular smooth muscle {Plate, 6B). The a2 laminin chain was also absent from the vascular 
endothelium and per-arteriolar stroma {Plate, 6B).
In the endometrium, the expression of the a2  laminin chain was restricted in the basal portion of 
the glandular BM {Plate,6C). There was no stromal expression o f the a2 laminin chain stroma 
in either the superficial {Plate, 6C) or basal {Plate,6D) part of the endometrium.
Due to the absence of the a2 and pi laminin chain from the vascular smooth muscle and peri­
vascular stroma, structures presumed to be of neural origin appeared to express the a2 and pi 
laminin chain antigen {Plate, 7AyB). Immuno localization carried out in 13 frozen sections (2 
menstrual, 9 proliferative, 2 secretory) with the 68kD neurofilament protein, confirmed that these 
structures where indeed either nerve fibres or nerve bundles. Nerve bundles were observed in the 
myométrial smooth muscle {Plate, 7C) as well as thin fibres innervating the large blood vessels 
of the outer myometrium {Plate. 7D).
The distribution o f the a2, p i, P2, yl laminin chains and collagen IV remained the same within 
the endometrial stroma and glandular BM during the course of the normal menstrual cycle (not 
shown). However, a denser distribution of ECM was observed around the endometrial blood 
vessels of the secretory phase sections {Plate, 8 A-C)
The above findings are summarised in tabular form {Table.4). These results illustrate a clear 
pattern of tissue specificity o f laminin chain expression. No staining was observed in the 
negative controls (not shovm).
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Plate. 5: p i  laminin chain distribution in the human myometrium and endometrium
Plate. Si (A) In the inner myometrium of this secretory phase specimen the pi laminin chain is present within the 
smooth muscle (sift) and endothelium (en) of the blood vessels. (B) The p 1 laminin chain is expressed in the smooth 
muscle (sift) of the outer myometrium and endothelium (era) of the blood vessels but absent from the vascular 
smooth muscle (vsm) of this proliferative specimen. (C) In the basal endometrium of this secretory phase specimen, 
the pi laminin chain is present in the glandular basement membrane, capillaries (c) and arterioles (a). The pi 
laminin chain is also present in the endometrial stroma. (D) In the superficial endometrium of the same specimen, 
the p 1 laminin chain is present in the glandular basement membrane, vascular smooth muscle of the arterioles (a) 
and in the endometrial stroma The stromal distribution of the p 1 laminin chain is heterogeneous. The P1 laminin 
chain expression is widespread within the basal portion of the endometrium (lower bottom comer); punctate in 
certain areas (upper right comer) and less widely distributed in others. Scale bars (A,C,D) = 100pm, (B) = 200pm.
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Plate. 6: o2 laminin chain distribution in the human myometrium and endometrium
Plate. 6\ (A) In the inner myometrium of this secretory phase specimen, the a2 laminin chain is present in the 
smooth muscle (sm) but is absent from the vascular smooth muscle (vsm) and the stroma surrounding the blood 
vessels. (B) The a2 laminin chain is expressed in the smooth muscle (sm) but is absent from the vascular smooth 
muscle (vsm) of the outer myometrium in this proliferative specimen. (C) In the endometrium of this menstrual 
phase specimen the a.2 laminin chain is restricted to the basal portion of the glandular basement membrane but 
absent from the endometrial stroma. The point of transition is particularly obvious in one glandular cross-section 
(arrow). The a2 laminin chain was not present in the endometrial blood vessels. Part of the smooth muscle (sm) 
from the subendometrial myometrium is seen to express the a2 laminin chain. (D) The a2 laminin chain is present 
in the basal portion of the glandular basement membrane but absent from the endometrial stroma in this menstrual 
phase specimen. The point of transition is particularly obvious in one glandular cross-section (arrow). The a2 
laminin chain is also expressed in the smooth muscle (sm) of the subendometrial myometrium. Scale bars (A,C,D) = 
100pm, (B) = 200pm.
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Plate, 7: Distribution o f neurofilaments in uterine sections
o2 laminin chain o2 laminin chain
NeuroJUament 68kD Neurofilament 68kD
Plate, 7: (A 3 ) In highly magnified images, structures (arrows) resembling nerve fibres were observed. These 
structures were particularly obvious with the a2 laminin antibody. (C,D) The identity of these structures was 
confirmed by neurofilament immunolocalisation (arrows). Scale bar = 100pm.
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Plate, 8: Extracellular matrix deposition around the blood vessels in secretory sections 
p i  laminin chain yl laminin chain
p i  laminin chain
Plate, 8: (A-C) Extracellular matrix deposition was observed around the blood vessels (arrows) of the superficial 
endometrium in secretory sections. This was not observed in specimen from the menstrual and proliferative phases 
of the normal menstrual cycle. Scale bar = 100pm.
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Table.4 Distribution o f the o2, ply p2y yl laminin chains and collagen IV  in uterine sections
Laminin o2 Laminin Laminin 32 Laminin yl Collagen IV
Endometrium
Glandular
epithelium
Only in the basal 
portion
Present Only in the basal 
portion
Present Present
Stroma
functionalis
Absent H eterogeneous
distribution
Absent Absent Heterogeneous
distribution
Stroma basalis Absent Present Absent Absent Present
Vascular S.M Absent Absent Present Present Present
Endothelium Absent Present Variable Present Present
Myometrium
Smooth muscle Present Present Present
(gradient)
Present Present
Vascular S.M Absent Absent Present Present Present
Endothelium Absent Present Present Present Present
Stroma peri- 
arteriolar
Absent Absent Absent Present Present
Nerve fibres Present Present * * *
Key: S.M = smooth muscle
* = due to the abundance o f these chains in the smooth muscle, it was difficult to visualise nerve fibres
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3.1.2 a2y ply p2y yl laminin chains and collagen IV  expression in the myometrium and 
endometrium o f uteri after exposure to intrauterine levonorgestrel (Mirena(s>)
Following treatment with intrauterine levonorgestrel (Mirena®), the myométrial gradient of the 
p2 laminin chain already described {PlateJ A) appeared to remain {Plate. 9, A), whilst the yl 
laminin chain {Plate. 9B) and collagen IV {Plate.9C) showed a more uniform distribution 
throughout the smooth muscle of the myometrium.
The a2 laminin chain was present in the smooth muscle of the inner myometrium, but was 
absent from the vascular smooth muscle {Plate. lOA). The pi laminin chain was 
immunolocalised in the smooth muscle of the inner myometrium but was absent from the 
vascular smooth muscle {Plate,lOB). In the inner myometrium the P2 laminin chain was 
expressed in the vascular smooth muscle and weakly expressed in the smooth muscle and 
{Plate.IOC). The yl laminin chain {Plate.lOD) and collagen IV {Plate,lOE) were present in the 
smooth muscle and vascular smooth muscle of the inner myometrium.
In the outer myometrium the ct2 laminin chain was present in the smooth muscle but was absent 
from the vascular smooth muscle {Plate.llA). The pi laminin chain was present in the smooth 
muscle, vascular endothelium but was absent from the vascular smooth muscle {Plate. 1 IB). In 
the outer myometrium the P2 laminin chain was present in the smooth muscle and vascular 
smooth muscle but was absent from the per-arteriolar stroma {Plate. 11C). The P2 laminin chain 
staining in the smooth muscle of the outer myometrium {Plate. 11C) was more intense than that 
seen in the smooth muscle of the inner myometrium {Plate.IOC)y illustrating the gradient 
observed in the low magnification scan {Plate.9A). The yl laminin chain {Plate. 1 ID) and 
collagen IV {Plate.llE) were immunolocalised in the smooth muscle and vascular smooth 
muscle of the outer myometrium. Collagen IV distribution was similar to the yl laminin chain, 
however collagen IV was present in the stroma surrounding the blood vessels {Plate. HE), as 
seen in untreated patients {Plate. 2A,B).
In the endometrium of one specimen obtained after exposure to intrauterine levonorgestrel 
(Mirena®), the pi laminin chain was present in the highly decidualised areas but was less widely 
distributed within the basal endometrial stroma {Plate. 12A). The pi laminin chain was also 
present in the glandular BM and in the wall of the arteries and capillaries of the basal part of the 
endometrium {Plate. 12A). The yl laminin chain was immunolocalised in the areas o f 
decidualised tissue, in the wall of the endometrial vessels and in the glandular BM {Plate. 12B). 
However, it was absent from the stroma o f the basal part of the endometrium {Plate. 12B). 
Collagen IV was present in highly decidualised areas as well as m the stroma of the basal part of
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the endometrium {Plate. 12C). It was also expressed in the BM of the glands and in the wall o f  
arteries and capillaries {Plate. 12C). More extensive peri-cellular staining was observed with the 
pi and yl laminin chains.
Staining was absent from the negative controls (not shown).
Plate. 9: Distribution o f  fi2 and yl laminin chains and collagen IV in uterine sections after 
exposure to exogenous levonorgestrel
p2 laminin chain yl laminin chain collagen IV
Plate. 9i Low magnification scanned images of cryosections consisting of endometrium and myometrium. Sections 
from the same specimen after exposure of 9 months to exogenous levonorgestrel (LNG) where the laminin chain 
(A), yl laminin chain (B) and collagen IV (C) have been immunolocalised. The blue colour is Haematoxylin 
staining of the nuclei. There is a gradient in the myométrial (m) distribution of the P2 laminin chain (A) in contrast 
to the more uniform myométrial {m) distribution of the yl laminin chain (B) and collagen IV (C). The area enclosed 
by the dashed line represents the basal portion of the endometrium {e). No endometrium is present in the first section 
(A). Within the more decidualised areas (</) the yl laminin chain (B) and collagen IV (C) are very widely 
distributed. Scale bar = 5mm.
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Plate, 10: Following exposure to exogenous levonorgestrel (Mirena®) the distribution of the a2, p i, P2, yl 
laminin chains and collagen IV in the inner myometrium remained the same as that observed in untreated patients. 
(A) In tlie inner myometrium the a2 laminin chain is present in the smooth muscle (sm) but absent from the vascular 
smooth muscle (vsm), after exposure for 10 weeks. (B) After exposure to 36 weeks the pi laminin chain is present 
in the smooth muscle (sm) but absent from the but absent from the vascular smooth muscle (vsm) o f the inner 
myometrium. (C) In the inner myometrium the P2 laminin chain is present in the vascular smooth muscle (vsm) but 
is weakly expressed in the smooth muscle (sm% after exposure for 10 weeks. (D) After exposure for 36 weeks, the 
yl laminin chain is present in the smooth muscle (sm), vascular smooth muscle (vsm) o f the inner myometrium but 
absent from the peri-arteriolar stroma, (E) Collagen IV is present in the smooth muscle (sm), vascular smooth 
muscle (vsm) and stroma surrounding the blood vessels, after exposure for 9 months. Scale bars = 200pm,
Plate.ll : There was no difference before or after treatment with the LNG-IUS in tlie distribution of the a2, p i, P2 
and yl laminin chains and collagen IV in tlie outer myometrium. (A) hi the outer myometrium the a2 laminin chain 
is present in the smooth muscle (sm) but absent from the vascular smooth muscle (vsm), following 36 weeks o f  
exposure. (B) hi the outer myometrium the pi laminin chain is present in the smooth muscle (sm), endothelium of 
the blood vessels (en) but absent from tlie vascular smooth muscle (vsm) o f the outer myometirum, after 10 weeks 
o f  exposure. (C) The p2 laminin chain is present in the smooth muscle (sm) and vascular smooth muscle (vsm) of 
the outer myometrium but.absent from the stroma surrounding the blood vessels, after 36 weeks o f exposure. (D) In 
the outer myometrium the yl laminin chain is present in the smooth muscle (sm) and vascular smooth muscle (vsm) 
but absent from the peri-arteriolar stroma, after 10 weeks o f exposure. (E) Collagen IV is present in the smooth 
muscle (sm) and vascular smooth muscle (vsm) of the outer myometrium. It is also present in the stroma 
surrounding the blood vessels, o f the same specimen as (D). Scale bars = 200pm.
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3.1.3 Quantitative analysis o f the p2 laminin chain and collagen IV  distribution in the 
myometrium
Qualitative analysis of the human myometrium revealed layering only in the distribution of the 
P2 laminin chain. The remaining a2, (51, y 1 laminin chains and collagen IV showed a uniform 
distribution throughout the smooth muscle of the myometrium. A quantitative examination was 
undertaken to support the qualitative observations. Line profiles for the intensity of the (52 
laminin chain and collagen IV where obtained from twelve higher quality full (1 menstrual, 2 
secretory, 1 Mirena®) {Plate. 13A~D) and partial (1 menstrual, 3 proliferative, 1 secretory, 3 
Mirena®) {Plate.l4A~D) myométrial thickness specimens, where the (52 laminin chain and 
collagen IV had been immunolocalised without Haematoxylin counterstaining.
All plots {Plate.l3A,C;Plate.l4A;Appendix.4AyC,EyG,IyKjMyO) with the exception o f one 
{Appendix.4L) showed a steep increase in the myométrial distribution of the p2 laminin chain, 
from the inner towards the outer myometrium. The average of the inner part of these data sets 
{Plate.l3AyC;Plate.l4.B) clearly shows an outer plateau and a decrease in the intensity of the p2 
laminin chain immuno-reaction towards the inner myometrium. There was no difference in the 
distribution of the P2 laminin chain either during the course of the menstrual cycle or after 
exposure to exogenous levonorgestrel {Appendix.4). By contrast, the myométrial distribution of 
collagen IV {Plate. 13ByD;Plate.l4C;Appendix.4) was relatively invariant. The average of the 
truncated data sets {Plate. 14D) was also relatively constant Line profiles for the myométrial 
distribution of collagen IV obtained, revealed a uniform distribution {Appendix.4),
The sectional thickness (inner myometrium) was calculated from both the individual and average 
data sets {Plate.l5A-F). The width values range from 14.76-2.09mm and are shown to exhibit 
both intra and inter-patient variability {Table. 5). The average sectional thickness of the inner 
myometrium was approximately 7-8mm, depending on the method of calculation used {Table. S).
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Plaie. 13: Quantitative analysis o f the p2 laminin chain and collagen IV distribution in two full 
thickness myométrial cryosections
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Plate. 13: Line profiles for the intensity of p2 laminin chain and collagen IV from low magnification scans of full 
thickness myométrial sections. Two examples out of the four specimens used are shown. The others had a similar 
pattern. A gradient is observed in the myométrial distribution of the P2 laminin chain in contrast with the more 
uniform distribution of the yl laminin chain and collagen IV. No endometrial data are shown. (A) p2 laminin 
distribution in a menstrual phase specimen of 22 mm length. (B) collagen IV distribution in a consecutive section of 
22 mm length. (C) p2 laminin distribution after 22 weeks of exposure to intrauterine levonorgestrel in a specimen of 
20 mm length. (D) collagen IV distribution in a consecutive section of 21 mm length. The X-axis represents distance 
in mm and the Y-axis measures density in arbitrary units. The peaks are areas of high intensity staining.
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Plate. 14: Quantitative analysis o f the laminin chain and collagen IV myométrial
distribution in cryosections
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Plate. 14: Line profiles for the intensity of the P2 laminin chain and collagen IV from low magnification scans. All 
data sets were aligned using the position of the endometrium/myometrium boundary and truncated at a length equal 
to the length of the shortest myométrial specimen (11.40mm for the P2 laminin chain data sets, 10.89mm for the 
collagen IV data sets), so that the average reflects all specimens. A gradient is observed in the myométrial 
distribution of the P2 laminin chain in contrast to the more uniform distribution of collagen IV. Endometrial data are 
shown in Appendix.4. (A) P2 laminin chain myométrial distribution in 13 specimens (2 menstrual, 4 proliferative, 3 
secretory, 4 exposed to intrauterine levonorgestrel for a period of 8 weeks to 9 months. (B) the average data set for 
the myométrial distribution of the P2 laminin chain from all specimens. (C) collagen IV myométrial distribution in 
11 specimens (2 menstrual, 4 proliferative, 3 secretory, 2 exposed to intrauterine levonorgestrel for a period of 8 
weeks and 9 months respectively. (D) the average data set for the myométrial distribution of collagen IV from all 11 
specimens. The X-axis represents the distance in mm and the Y-axis measures density in arbitrary units. The 
coloured line in (A) and (C) represent the individual patients and bare no relation to the stage of the cycle.
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Plate. 15 (Plate. 14 continued): Sectional thickness measurements in four cryosections with 
partial myométrial thickness
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Plate. 1 Si Objective methods were used to define the transition point between in the inner and outer myometrium. 
Data averaging techniques were used to define the point at which the intensity of the immuno-reaction started to 
decline, within the outer myometrium. For the non-truncated data sets {Plaie.15A-D), a region of the outer 
myometrium at least 1.25mm from the edge of the sections and approximately 7mm in length, was selected to 
represent the average density value of the outer myometrium. The average of the 7mm region is marked by the 
height of the thick horizontal line. However, for the average truncated data sets {Plate.ISE) a region of 
approximately 3.5mm was selected. The ratio of the P2 laminin chain to collagen IV was also calculated and both a 
quadratic (R^=98.5%) and a linear fit ( not shown, R^=90.3%) were applied. The point at which the continuous 
smoothed data set achieved the same value as the outer average, counting from the inner towards the outer 
myometrium, was define as the point at which the immuno-reaction intensity began to decline, (green dashed line). 
'Hie distance (two sided arrows) between this point and the endometriai-myometrial Junction (red dashed line) was 
defined as the sectional thickness of the inner myometrium. (A) a menstrual phase specimen of 13 mm length. (B) a 
proliferative phase specimen of 20 mm length. (C) a secretory phase specimen of 19 mm length. (D) a specimen of 
16 mm length, exposed to intrauterine levonorgestrel for a period of 8 weeks. The purple line represents the 
maximum of the theoretical quadratic fit. The peaks are areas of high intensity of the P2 laminin chain antibody. 
Measurement of layer data from full thickness averages
(E) the average data set for the P2 laminin chain myométrial distribution from all 13 specimen. (F) the ratio of the 
P2 laminin chain to collagen IV average myométrial distribution. The purple line represents the maximum of the 
theoretical quadratic fit. The peaks are areas of higher abundance of P2 laminin.
Table. 5 Sectional thickness values o f  the inner layer in fu ll thickness myométrial specimens
Patient Code Sectional thickness (mm) Parity Medication State
BMM29 10.51 1 \5 Nil Decidualisation
BMM33 5.92 Mef.acid Proliferative
BMM34 7.35 3+1 Nil Menstrual
BMM35 4.82 3+1 Nil Secretory
BMM35(2) 7.53 3+1 Nil Secretory
BMM47 5.89 N/A Nil Inactive
BMM49 3.75 N/A Nil Proliferative
BMM52 2.09 1 FeS04 Proliferative
BMM55 8.59 2+0 Nil Decidualisation
BMM60 7.7& 2+0 Nil Secretory
BMM65 11.09 2+1 Asthmatic Decidualisation
BMM68 14.76 3+1 Nil Weakly Prolif.
Sectional thickness
Calculated from individual data sets
• Median {Table.5): 7.440mm
• Ql(quartile): 5.088
• Q3(quartile): 10.03
Calculated from the average data sets
• P2 laminin chain {Plate.15E): 8.46mm
• P2 laminin to collagen IV ratio {Plate.ISF):
6.99mm
• Ratio value of the 99% of the maximum of the 
quadratic function {Plate.ISF): 8.82mm
I he blue text represents the sectional thickness in specimen after exposure to exogenous progestagen (Mirena®) for 
a period of 8 weeks to 9 months. BMM29 = 9 months of exposure, BMM55 = 8 weeks of exposure, BMM65 = 22 
weeks of exposure, BMM68 = 9 weeks of exposure.
N/A: not available, Mef.acid: Mefanamic acid. Weakly Prolif: Weakly Proliferative, n+n: births+miscarriages.
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3.1.4 Reverse transcrîptase-polymerase chain reaction (RT-PCR) for the detection o f the f52 
and yl laminin chain in the human myometrium
Total RNA was extracted from 4 full thickness hysterectomy specimens. The endometrium was 
discarded and the remaining myometrium was divided into inner and outer. The integrity of the 
RNA was confirmed by the presence of intact 18S and 28S (ribosomal RNA) on the agarose gels 
in all but one of the samples.
The RT-PCR for the yl laminin chain gene amplified a major band consisted with the predicted 
product of 315base pairs (bp) (Plate. 16A,B), A faint band of approximately lOOObp was 
observed in the outer, inner and total DNA of the second specimen (Plate. 16A). The reverse 
transcribed mRNA free PGR water control was negative (Plate.l6A lane S).
For the p2 laminin chain gene the RT-PCR amplified a major band consistent with the predicted 
product of 305 bp (Plate. 16QD), No bands were observed for the fourth specimen total DNA 
(Plate. 16Dy lanesly2,3). The reverse transcribed mRNA free PCR water control was negative 
(Plate. 16C lane 8; D lane 10). The RT-PCR data show the presence of the yl and p2 laminin 
gene expression chains within the human myometrium, confrrming the ICC results.
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Plate. 16: RT-PRCfor yl and p2 laminin chains
RT-PCR products o f the yl (A,B) gene separated by 1% agarose gel eiectophoresis. The major 
product is close to the predicted size o f 315bp
DNA ladder
inner myometrium 1*' specimen
(A) Lane 1:
L.ane 2:
Lane 3: outer myometrium P' specimen 
Lane 4: total myometrium 1*' specimen 
Lane 5: inner myometrium 2"^  specimen 
Lane 6:
Lane 7:
Lane 8:
outer myometrium specimen 
total myometrium 2"^  specimen 
water negative control
(B) Land: DNA ladder
Lane 2: total myometrium 4"' specimen 
Lane 3: outer myometrium 4'*’ specimen 
L.ane 4: inner myometrium 4'^  specimen 
Lane 5: total myometrium 3'^ '^  specimen 
Lane 6: outer myometrium 3'^ * specimen 
Lane 7: inner myometrium 3'*^  specimen 
Lane 8: empty
RT-PCR products of the P2 gene (C,D) separated by 
product is close to the predicted size o f 305bp
1% agarose gel electrophoresis The
(C) Lane 1 
Lane 2: 
Lane 3 : 
Lane 4: 
Lane 5: 
Lane 6: 
Lane 7: 
Lane 8:
: DNA ladder
inner myometrium 1“' specimen 
outer myometrium P‘ specimen 
total myometrium 1*' specimen 
inner myometrium 2"*^ specimen 
outer myometrium 2™* specimen 
total myometrium 2"^  specimen 
water negative control
(D) Lane 1: DNA ladder
Lane 2: inner myometrium 2"^  specimen 
Lane 3: outer myometrium 2"^  specimen 
Lane 4: total myometrium 2"^  specimen 
Lane 5: outer myometrium 3'*^  specimen 
Lane 6: total myometrium 3'^ *^ specimen 
Lane 7: inner myometrium 4'*’ specimen 
Lane 8: outer myometrium 4'^  specimen 
Lane 9: total myometrimn 4“’ specimen 
Lane 10: water negative control
No inner myométrial sample was used for the 3"* specimen because no RNA was left
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3.2 Elastin expression in the human uterus
Elastin was immunolocalised in paraffin embedded sections (n=51) from all stages of the 
menstrual cycle (14 proliferative, 13 secretory, 7 menstrual, 1 inactive, 1 postmenopausal, 15 
Mirena®). The duration of exposure to intrauterine levonorgestrel was 1-48 months.
3.2.1 Elastin expression in the myometrium and endometrium o f normal uteri 
Microscopic examination of sections where sufficient myométrial thickness was available for 
assessment (n=40, 12 proliferative, 10 secretory, 5 menstrual, 13 Mirena®), suggested a 
decreasing gradient in the distribution of elastin from the outer towards the outer myometrium 
(Plate. 17A,B,C). The remaining 11, mainly inner myométrial sections (2 proliferative. 3 
secretory, 2 menstrual, 1 inactive, 1 postmenopausal, 2 Mirena®) were only used for endometrial 
examination. In the smooth muscle of the inner myometrium of all 40 sections, elastin was 
absent (Plate. 18A) or of low abundance (Plate. 18B). The walls and internal elastic laminae of 
the myométrial arteries were however hnmunoreactive (Plate. 18A,B) whereas elastin was absent 
from the thin walled vessels of the inner myometrium (Plate. 18B). In the outer myometrium, of 
all 40 sections, elastin was present in the peri-vascular tissue particularly near the large vessels 
(Plate. 18QDyE). However elastin was absent from the thin walled vessels of the outer 
myometrium (Plate. 18D). More peri-vascular and extra-vascular staining was present in the 
outer myometrium of all cases (Plate. 18E). Elastin was also located in the smooth muscle of the 
outer myometrium (Plate.l8F). Elastin deposition within the smooth muscle of the outer 
myometrium was neither peri-vascular nor associated with large vessels containing an obviously 
muscularised wall. No change was observed in the myométrial distribution o f elastin during the 
course of the normal menstrual cycle.
Within the normal human endometrium (n=40) elastin was present in the basal portion of the 
spiral arterioles (Plate. 19A) but was absent from the surface epithelium, glandular BM and 
stroma (Plate. 19B). Elastin was also absent from thin walled vessels close to the surface 
epithelium (Plate, 19B) and from spaces in the basalis assumed to be blood vessels (Plate. 19C). 
Despite the absence of elastin in the stroma, 78% (95/122) of cross-sections of lymphoid 
aggregates had traces of elastin (Plate. 19D). No difference was observed in the endometrial 
expression of elastin during the course of the normal menstrual cycle.
Consecutive paired sections (n=24, 2 proliferative, 2 secretory, 2 menstrual, 6 Mirena®) were 
stained with elastin (n=12) and with a vascular endothelium marker (CD31, n=12) to identify the 
nature of the presumed vascular spaces seen close to the surface epithelium and within the 
basalis. The sections were selected on the basis of good quality full thickness endometrium and 
myometrium being present.
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In the inner myometrium small arterioles and thin walled vessels not expressing elastin 
{Plate. 20A) were shown to express CD31 within their endothelium {Plate.20B). Elastin was 
absent from the micro vessels of the inner myometrium {Plate. 2 OC). However similar 
micro vessels were shown to express CD 31 in their endothelium {Plate. 2 OD). Because of an 
abundance of elastin staining within the smooth muscle of the outer myometrium, it was difficult 
to define the wall of the vein and accurately state the presence or absence of elastin 
{Plate.20EjG). However, there seemed to be very little elastin associated with the veins of the 
outer myometrium {Plate.20E,G). The endothelium of the veins or lymphatic vessels present in 
the outer myometrium was shown to express CD31 {Plate.20FyH), Small and large arterioles 
with little elastin present in their walls {Plate. 20G) were shown to express CD31 in their 
endothelium {Plate. 20H).
Within the endometrium elastin was absent from the thin walled vessels and arterioles close to 
the surface epithelium {Plate.21 A)  ^ whilst CD31 was expressed within their endothelium 
(Plate.21B). The spaces in the basalis assumed to be blood vessels {Plate.21CyE) were shown to 
express CD31 in their endothelium {Plate.21DyF). Elastin was also present in the walls of the 
basal portions o f the spiral arterioles (Plate.21G) the endothelium of which was shown to 
express CD2)\{Plate.21H).
No staining was observed in the negative controls (not shown).
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Plate. 17: Distribution o f elastin in uterine sections
m m
Plate. 17: Low magnification scanned images of full thickness endometrial and myométrial paraffin embedded 
sections. (A) secretory (B) menstrual (C) secretory phase specimens in which elastin has been immunolocalised. The 
blue colour is haematoxylin staining of the nuclei The area enclosed with the dotted line represents the 
endometrium (e). There is a gradient in the distribution of elastin within the myometrium (m) in each section 
(A3«C) as determined by inspection of the scanned images and direct microscopic examination of the sections. 
Elastin is present within the basal portion of the endometrial spiral arterioles but is only visible on the scan when 
examined at a high magnification. Scale bar = 5mm.
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Plate. 18 : Elastin distribution in the human myometrium
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Plate. 18l (A,B) Elastin is present within the arteriolar walls but absent or of low abundance in the smooth muscle 
of the inner myometrium (m) close to the endometrium (e). (B) Elastin is absent from the thin walled vessels in the 
endometrium (arrows). (C D) Elastin is present in the wall of arteries found in the outer myometrium but absent 
from the veins (arrows). (E) Elastin is widely distributed in areas of the outer myometrium with a high density of 
large vessel cross-sections (F) Elastin is present in the smooth muscle in areas of the outer myometrium close to the 
serosa. The reaction product is not associated with blood vessels. This is in contrast to the distribution seen within 
the smooth muscle of the inner myometrium (B). Scale bars =100pm
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Plate, 19: Elastin distribution in the human endometrium
* %
i f
Plate, 1 9: (A) Elastic laminae are present in the basal portions of the spiral arterioles, in an early secretory phase 
specimen. (B) Elastin is absent from the blood vessels (arrows) close to the surface epithelium in an early secretory 
specimen. (C) Elastin is expressed in endometrial arterioles but absent from spaces assumed to be veins or 
lymphatic vessels (arrows) (see Plate,21QE), in an early secretory specimen. (D) Traces of elastin were observed in 
the majority of cross sections of lymphoid aggregates throughout the menstrual cyele. The example shown (arrow) 
represents a cross-section with the elastin distribution greater than average. Scale bars = 100pm.
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Plate. 20: Elastin and CD3I expression in blood vessels o f the myometrium in consecutive
sections
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Plaie.21: Elastin and CD31 expression in blood vessel o f  the endometrium in consecutive
sections
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Plate,20: (A) Elastin is weakly distributed within the smooth muscle o f the inner myometrium but is absent from 
the small thin walled vessels (arrow) on the right hand side. Restricted expression o f elastin is observed in or near 
the small arterioles (arrows) o f the inner myometrium. (B) A consecutive section showing localization of CD31 in 
the endothelium of the small vessels o f the inner myometrium. (C) Elastin is absent from vessels (arrows) in the 
inner myometrium and surrounding smooth muscle. (D) The endothelium of similar vessels as those visible in (C) 
is shown to express CD31 in a consecutive section. (E) In the outer myometrium elastin is present in the smooth 
muscle but absent from spaces assumed to be veins (arrows). (F) In a consecutive section the spaces seen in (E) are 
lined with CD31 immunopositive endothelium. (G) The veins (arrows) of the outer myometrium do not express 
elastin whereas elastin is present in the internal elastic laminae, walls o f the large arterioles and peri-vascular tissue. 
Restricted expression of elastin is illustrated in the walls o f a small arteriole shown in the insert. (H) A consecutive 
section showing CD31 localization in the endothelium of the veins and arteries o f the outer myometrium. The insert 
shows a higher magnification image o f the small artery seen in (H). Scale bars = 100pm.
Plate.21: (A) Blood vessels (arrows) close to the surface epithelium do not express elastin. (B) fri a consecutive 
section, the endothelial lining o f the blood vessels seen in A is shown by CD31 immunolocalization. (C) Spaces 
(arrows) assumed to be veins do not express elastin. (D) A consecutive section confirming the vascular nature of the 
spaces seen in (C) by CD31 immunolocalization. (E) Elastin is absent from veins in the basal part of the 
endometrium. (F) The endothelium of veins is shown to express CD31. (G) Elastin is expressed in the basal portion 
of the endometrial arterioles seen in this specimen but is absent from veins (arrows). (H) A consecutive section 
showing the endothelium o f veins and arterioles by CD31 immunolocalization. Scale bars = 100pm.
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3.2.2 Elastin expression in the myometrium and endometrium o f uteri exposed to intrauterine 
levonorgestrel (Mirena 0).
After exposure to intrauterine levonorgestrel (Mirena®), there was no detectable difference in 
the myométrial expression of elastin. Within the endometrium (n=13) elastin remained in the 
basal portion o f the spiral arterioles (Plate,22A). In one endometrial section although there was 
elastin present within some spiral arterioles, there were other in which elastin was absent 
(Plate.22B). In 9 out of 12 sections elastin was absent from the stroma of the basalis 
(Plate,22AfB). In the remaining 3 sections elastin was widely distributed within the basal stroma 
(Plate.22C). Elastin was absent ft-om the surface epithelium, glandular BM, thin walled blood 
vessels and highly decidualised areas (Plate,22D). Staining was absent fi'om the negative 
controls (not shown).
3.2.3 Orcein staining for elastin detection in the human uterus
Additional sections (n=26) ft-om all phases of the menstrual cycle (7 proliferative, 6 secretory, 4 
menstrual, 1 inactive, 1 postmenopausal) and 7 sections exposed to exogenous progestagen 
(Mirena®) were stained with orcein. The intensely stained areas within the walls spiral arterioles 
of the endometrium {Plate,23A \  and the large and small arteries of the inner and outer 
myometrium {Plate,23B,C) resembled the pattern of elastin immunolocalisation. Nuclei, 
glandular secretion and red blood cells were also stained {Plate,23A) as orcein staining is not 
selective for the elastic fibre system. Nevertheless orcein stams the elastic components more 
intensely {Plate,23DfE,F). The negative controls (not shown) exhibited no staining
3.2.4 Quantitative analysis o f  the distribution o f elastin in myométrial sections
Full thickness sections (n= ll), where elastin was immunolocalised without Haematoxylin 
counterstairftng were scanned and then the blue channel was selected converting the color image 
to a monochrome one. Quantitative examination of the myométrial distribution of elastin in all 
11 full thickness sections (1 proliferative, 4 secretory, 2 menstrual, 4 Mirena®) supported the 
existence of a gradient previously qualitatively observed. However, considerable variability was 
observed between sections {Plate,24A~K). As this analysis was performed on a limited (11/40) 
set of sections, it was not possible to judge whether the myométrial distribution of elastin was 
affected by the stage of the menstrual cycle.
A gradient in the myométrial distribution of elastin was observed when the data sets were 
aligned using the position of the outer myometrium {Plate,25A). The outer myometrium is 
shown to be more elastic than the inner myometrium. However, the analysis was restricted to the 
outer myometrium. In the second method when the data were normalised by width {Plate,25B) a 
decreasing gradient, ftrom the outer towards the inner myometrium, was observed in the
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distribution of elastin. For the second method the analysis was not restricted by the myométrial 
length and the values from the inner myometrium were included. For both data sets a linear 
rather than a quadratic fit was statistically justified.
Plate, 22: Distribution o f  elastin in the endometrium o f  specimens exposed to exogenous 
levonorgestrel (Mirena ®) over a period o f  1 month to 3 years
m
Plate, 22: (A) Elastin is present in the basal portions of the spiral arterioles but absent from the endometrial stroma 
after 4 weeks of exposure. (B) Elastin is absent from spiral arterioles (arrows) in another region of the same section. 
This was not observed in tissue obtained from untreated patients (see Plate. 19). (C) Elastin is present in the basal 
stroma after 10 weeks of exposure. Only 1 out of 2 specimens after this time of exposure displayed this pattern. (D) 
The superficial stroma of this 3-year-treated specimen lacks elastin. The blood vessels (arrows) close to the surface 
epithelium do not express elastin. Elastin is absent from highly decidualised areas of stroma. Scale bars =100pm.
80
Plate, 23: Orcein staining in uterine paraffin embedded sections
m'.mm
Plate, 23: (A-C) Orcein staining of endometrium and myometrium. (D-F) Binary images showing corresponding 
areas of high intensity. (A) Orcein stains the endometrial spiral arterioles. (B) Arteries in the inner myometrium 
stained with orcein. (C) Intense staining is present in the internal elastic laminae, the vessels walls and the adjoining 
peri-vascular tissue and smooth muscle of the outer myometrium. Scale bar = 100pm.
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Plate. 24 : Quantitative analysis o f elastin distribution in eleven full thickness endometrial and 
myométrial paraffin embedded sections^for the distribution o f elastin within the uterus
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Plate, 24 {continued)
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Plate.24: Line profiles for the intensity of elastin staining obtained from 11 low magnification scans of full 
thickness myométrial and endometrial sections. Elastin distribution in (A) a menstrual phase specimen of 25 mm 
length, (B) a menstrual phase specimen of 28 mm length, (C) a proliferative phase specimen of 21 mm length, (D) 
an early secretory phase specimen of 28 mm length, (E) an early secretory phase specimen of 25 mm length, (F) a 
secretory phase specimen of 25 mm length (G) a secretory phase specimen of 25 mm length (H) a specimen of 29 
mm length after exposure to exogenous levonorgestrel (LNG) for 10 months, (I) a specimen of 24 mm length after 
exposure to exogenous LNG for 10 weeks (J) a specimen of 26 mm length after exposure to exogenous LNG for 9 
weeks, (K) a specimen of 26 mm length after exposure to exogenous LNG for 6 weeks. A decrease in the underlying 
trend, from the outer towards the inner myometrium, is apparent in most sections. There is nevertheless variability 
between patients. The X axis represents the distance in mm and the Y axis measures inverted brightness in arbitrary 
gray level units (0-255). The dashed red line marks the boundary between the endometrium and myometrium. The 
peaks in the myometrium are areas of intense elastin staining associated with blood vessels and peri-vascular tissue. 
1 he peaks in the endometrium represent spiral arterioles stained with elastin.
83
Plate.25: Average elastin distribution within the human myometrium
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Plate.25: When two methods (A,B) were used to average the data from the eleven data set a decrease in the 
distribution of elastin, from outer towards inner myometrium. (A) The data sets were aligned using the position of 
the outer myometrium and truncated at the length equivalent to the shortest myométrial length (18.8mm). This 
restricts the analysis to the outer myometrium. Only a linear fit to the data set was statistically justified. The X axis 
represent distance in mm and the Y axis represents the average density values in arbitrary units. Pearson correlation 
= -0.740, R^ = 54.7%, P=0.000. The red dotted lines represent the 95% confidence interval. (B) A second method 
was devised in which the complete data set could be used. This permitted the analysis of the inner myometrium and 
was not restricted by myométrial length. Each specimen was divided into an equal number of slices (n=93). The 
average for all slices was computed. The data represent the average of approximately 30,000 density values. The X 
axis represents the slice number and the V axis represent the average elastin density values in arbitrary units. 
Pearson correlation = -0.925, R^ = 85.6%, P=0.000. The red dotted lines represent the 95% confidence interval.
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Chapter.4 Discussion
4.1 Distribution of the a2, |31, P2, yl laminin chains and collagen IV within the human
uterus
Low magnification scanned images of frozen sections revealed the presence of a gradient in the 
myométrial distribution of the (32 laminin chain, whereas the remaining laminin chains (a2, (31, 
yl) and collagen IV exhibited a more uniform myométrial distribution. Immunostaining with the 
(32 laminin chain was weak in the inner myometrium compared to the more intense staining of 
the outer myometrium.
It was postulated that the observed gradient in the myométrial distribution of the (32 laminin 
chain provides additional evidence for myométrial layering. So far there are three lines of 
evidence of myométrial layering MRI, transvaginal ultrasound and histology. Uterine zonal 
anatomy of women of reproductive age, as visualised on T2-weighted MR images consists of a 
high-signal-intensity endometrial strip, a subjacent low-signal-intensity junctional zone and a 
medium-signal-intensity outer myometrium. The low-signal-intensity inner myometrium seen in 
MRI possibly correlates with the area of the myometrium where weak staining of the (32 laminin 
chain is observed.
The gradient observed in the myométrial distribution of the (32 laminin chain suggests that the 
composition of the basement membrane surrounding the myométrial smooth muscle cells varies 
between inner and outer myometrium. This difference might serve to restrict trophoblast 
invasion to superficial myometrium overlying the placental bed, or affect the contractile 
properties of the muscle. This is further discussed below.
McCarthy et al. (1989), in an MRI study examining the water content and relaxation properties
of the human uterus, also examined the myométrial distribution of laminin and collagen. It was
reported that the amount of collagen did differ between the junctional zone and the adjacent
myometrium (McCarthy et al., 1989), which is in accordance to the results of this study although
it is not stated which type o f collagen they were investigating. The same authors also reported
that there was no change in the myométrial distribution of laminin. However, once again it was
not stated which laminin type was investigated or which chains were used, so no direct
comparison could be made with the findings of this study. It is possible that there was no chain
specificity of the probes, therefore the authors may have been unable to detect any differences.
Another MRI study, looking for a correlation of MRI and histologic examination of
hysterectomy specimens, reported a normal distribution, between the junctional zone and outer
myometrium, of collagen IV and laminin (Scoutt et al., 1991). The collagen IV findings are
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consistent with the findings of this study. Therefore, a direct comparison between the Scoutt et 
a/, (1991) study and this study could not be made on the laminin findings.
In both the studies (McCarthy et al, 1989; Scoutt et al., 1991), no observation about the 
distribution of collagen and laminin in other cellular compartments, besides the smooth muscle, 
were not made, possibly because the investigators were only interested in the smooth muscle 
myométrial distribution of collagen and laminin.
Microscopic images allowed a more detailed examination of the a2, (31, (32, yl laminin chains 
and collagen IV distribution within the human myometrium. Both the yl laminin chain and 
collagen IV were found to be present in smooth muscle, vascular smooth muscle and 
endothelium. The a2 and (31 laminin chains were present myométrial smooth muscle but absent 
from the vascular smooth muscle suggesting that there is a phenotypic difference between the 
VSM and SMC hence a possible functional difference. It is postulated that the mechanical 
properties of the BM of the VSM maybe different and directly affect the SMC, however at 
present there is no literature to support this postulation. As well as the postulated phenotypic 
difference between the VSM and SMC it has been shown that there is tissue specificity of 
laminin expression.
It has been clear for years that the ECM plays a role in regulating the differentiated phenotype o f 
cells (Watt, 1986). But the mechanisms involved remained largely a mystery until cell-binding 
on individual ECM glycoproteins and specific ECM receptors were identified (Adams et al.,
1993). There are at least three mechanisms by which the ECM can regulate cells behaviour.
One is through the composition of the extracellular matrix. There are several sources of ECM 
variation one being the diversity in the composition of the ECM in different tissues and at 
different stages of development arises not only through expression of different matrix molecules 
but also from the existence of multiple forms of individual molecules (Adams et al., 1993). 
Different laminin heterotrimers differ in their diversity towards specific cell types (Hunter et al., 
1992). Additionally the composition of the ECM is not static, and changing patterns of 
expression of individual components are observed during development (Leivo & Engvall, 1988; 
Sanes et al., 1990; Hunter et al., 1992). The existence of these somces of variation makes it clear 
that, at a given time and place, the ECM has the potential to provide specific enviromnental 
information to cells.
The second mechanism by which the ECM can regulate cell behaviour is through synergistic 
interactions between growth factors and matrix molecules. One type of interaction is the binding 
of growth factors to the ECM, which affects the local availability and biological activity of 
growth factors (Adams et al., 1993). The second type of interaction involves regulation of gene
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expression and finally ECM molecules can themselves be mitogenic or can influence the 
responsiveness to growth factors. It is postulated that growth factors and the ECM proteins 
collaborate in creating distinct cellular environments that regulate proliferation and 
differentiation (Schofield, 1978).
The third and final mechanism by which the ECM can regulate cell behaviour is through the cell 
surface receptors that mediate adhesion to ECM components. There are two types of receptors, 
non-integrin receptors and the integrins (Adams et aL, 1993). The ligand specificity of certain 
integrins appears to be cell-type dependent, for example the a2(3l integrin acts as a collagen 
receptor in platelets but is a collagen and laminin receptor in endothelial cells (Hynes, 1992). It 
is possible that there could be a difference in the activation of the receptor thus maintaining or 
stabilising a different phenotype in muscle cells.
Within the human endometrium, collagen IV and the yl laminin chain were found in the 
glandular BM and endothelium. Collagen IV was also present within the endometrial stromal 
cells of the both the superficial and basal part. The a2 and (32 laminin chain were present only in 
the basal portion of the glandular BM and absent from the endometrial stromal cells. The 
absence o f these two laminin chains from the superficial glandular BM, could be a genuine result 
thus suggesting a possible difference between basement membrane in basal and apical portions 
of the gland. The reasons for such a change are not defined. Nevertheless, care must be taken 
when interpreting results from the endometrium of frozen sections because of the relative poor 
condition. Howerver, these antibodies do not recognise antigens on paraffin embedded sections, 
ever after antigen retrieval (personal communication A.Young and Dr S.Campbell). The a2  
laminin chain was absent from the endometrial blood vessels whereas the expression of the (32 
laminin chain was variable. The variability observed in the expression of the P2 laminin chain 
could be due to the condition of the sections. Once again tissue specificity in laminin expression 
is exhibited.
The results of this study are in accordance with the preliminary results obtained within the same 
department (Campbell et ah, 1998, abstract). However, I would like to take this opportunity to 
correct a typing mistake. In the published abstract it was reported that the a l  laminin chain was 
present throughout the vascular smooth muscle, when it should have read that the p2 laminin 
chain was present in throughout the vascular smooth muscle.
In secretory sections ECM was deposited around the endometrial blood vessels, compared to the 
proliferative sections. This ECM deposition was more obvious around blood vessels of the 
superficial endometrium because o f the less dense endometrial stroma. Faber et al. (1986), in a 
immunocytochemical study examining laminin production by human endometrial stromal cells
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during the normal menstrual cycle and in pathological condition of the endometrium, reported 
that laminin immuno staining was observed close to the endometrial small arteries. The same 
authors also reported that the immuno staining with anti-laminin antibodies failed to identify 
detectable amounts of laminin associated with the stromal cells, either within the cytoplasm or in 
the peri-cellular matrix (Faber et al., 1986). Nevertheless, scattered immunoreactive laminin was 
seen in the cytoplasm of stromal cells, in secretory specimens. However, in this study 
comparison between in the stromal distribution of the different laminin chains used was not 
possible due to the poor condition of the endometrial from frozen sections.
Aplin et al. (1988) in a immunohistochemical study of human endometrial ECM during the 
menstrual cycle and first trimester pregnancy, also reported that in secretory specimens laminin 
immuno staining was seen in the endometrial cells as streaks and spots around the periphery of 
the cells. The same authors reported that the only immunoreactive endometrial structures with 
laminin 1 (a ip iy l)  and collagen IV, in proliferative specimen, were the blood vessel walls and 
the glandular BM. The latter statement is in accordance with the results of this study. However, 
in the Aplin et al. (1988) study the antibody used for laminin immunostaining was directed to 
laminin 1 (a lp ly l)  and not to specific laminin chains. One discrepancy between the Aplin et al. 
(1988) study and this study was the absence of collagen IV in the endometrial stroma. This study 
has shown that collagen IV was present in the superficial endometrial stroma in a punctate 
pattern as well as in the basal stroma but in a more compact pattern, due to a higher stromal cell 
density of the endometrial basal portion.
In a more recent immunocytochemical and ultrastructural study, it was reported that the a2 
laminin chain and collagen IV were present glandular basement membrane, luminal epithelium, 
micro vascular endothelium and smooth muscle (Kohnen et al., 1998). However, in this study the 
a l  laminin chain was shown to be absent from the vascular smooth muscle and microvascular 
endothelium, using the same antibody as that used by Kohnen et al. (1998) study. Since the same 
antibody was used and the sections used were of endometrium with attached myometrium, it is 
difficult to accept the claim that Kohnen and colleagues (1998) made regarding the presence of 
the a l  laminin chain in the vascular smooth muscle and microvascular endothelium, since no 
evidence is presented in the published paper.
From the results obtained for the distribution of the a l,  Pl, P2 and yl laminin chains, potential, 
hypothetical and infeasible laminin types can be postulated (Table.6). The potential laminin 
types are based on combinations between the different laminin chains present whereas the 
hypothetical included laminin chains not examined in this study. The infeasible laminin types 
were based on the documented absence of the specific laminin chains.
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Table. 6 Possible, hypothetical and infeasible laminin types in different cellular compartments 
o f  the myometrium and endometrium.
Possible laminin types Hypothetical laminin chains Infeasible laminin types
Myometrium
Inner smooth muscle Laminin 2 ,  4 Laminin 1, 3, 6-11
Outer smooth muscle Laminin 2 ,  4 Laminin 1, 3, 6-11
Vascular smooth muscle Laminin 3, 7 ,9 , 11 Laminin 2, 4
Endothelium Laminin 3, 7 ,9 ,1 1 Laminin 2, 4
Endometrium
Glandular BM (Functionalis) Laminin 3, 7 ,9 , 11 Laminin 2, 4
Glandular BM (Basalis) Laminin 2, 4 Ivaminin 1, 3, 6-11
Stroma Basalis Laminin 1, 6, 8, 10 Laminin 2, 3, 4, 7, 9
Stroma functionalis Laminin 1, 6, 8, 10 Laminin 2, 3, 4, 7, 9
Endothelium Laminin 1, 3, 6-11 Laminin 2, 4
The cross-hatched box indicate an absence o f laminin a2, therefore no laminin trimers.
Key: Laminin 1 - a l p l y l  
Laminin 2 - a 2 p iy l  
Laminin 3 - a l  P2yl 
Laminin 4 - a2p2y l 
Laminin 6 - a 3 p ly l  
Laminin 7 - a3p2y l 
Laminin 8 - a 4 p iy l  
Laminin 9 - a4p2y l 
Laminin 10 - a 5 p ly l  
Laminin 11 - a5p2y l
4.1.1 Quantitative analysis o f  the J32 laminin chain and collagen IV myométrial distribution
Before discussing the two methods of analysing the distribution of the P2 laminin chain and 
collagen IV in frozen sections, it should be noted that the analysis was based on the transition 
between the inner and outer part of the muscle. By contrast, full thickness sections in paraffin 
embedded sections were used for the analysis of the myométrial distribution of elastin. This 
difference in specimen thickness was due to technical difficulties encountered in obtaining high 
quality full thickness myométrial frozen sections.
The difference observed in the intensity of the individual sections might be attributed to the 
variability in thickness within the sections. Another reason is that it was not possible to carry out 
the study in distinct phases of collection and ICC, hence ICC was carried out in an on going 
basis using batches of specimens. A combination of the latter reason and the change in the
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secondary antibody and detection system could have resulted in the difference in the intensity of 
staining.
Nevertheless, a small number o f high quality full and partial thickness frozen sections was 
obtained and the analysis was carried out. In order to quantitatively analyse the gradient 
observed in the myométrial distribution of the P2 laminin chain, two methods were devised. In 
the first method, all data sets were aligned using the position of the outer myometrium and 
truncated at a length equal to the shortest myométrial distance. Although this method restricted 
the analysis to the outer part of the muscle, a decreasing gradient was observed in the myométrial 
distribution of the p2 laminin chain, from outer towards inner myometrium. The second method 
involved aligning all data sets using the position of the endometrial/myometrial boundary and 
truncating them at a length equal to the shortest myométrial distance. In contrast to the first 
method, the second method restricted the analysis to the inner myometrium. However, it also 
allowed observation and examination of the gradient. When the second method was applied to 
analyse the myométrial distribution of collagen IV, it revealed a more uniform distribution 
compared to the gradient observed in the P2 laminin chain.
A combined average was calculated for both the P2 laminin chain and collagen IV myométrial 
distribution, clearly showing the decreasing gradient in the myométrial distribution of the p2 
laminin in contrast to the more uniform distribution of collagen IV. The ratio of the p2 laminin 
to collagen IV was also calculated.
4.1.2 Sectional thickness o f the inner myometrium
Measurements for the sectional thickness of the inner myometrium were carried out only in 
sections where the P2 laminin chain and collagen IV were immunolocalised. Sections 
immuno stained with collagen IV were used as controls. In the method devised the sectional 
thickness was defined as the difference between the point at which the intensity of staining 
started to decrease from the plateau value and the endometrial/myometrial boundary. However, 
this method was not dependent on an estimate of the density o f the endometrial/myometrial 
boundary.
In an ideal situation, where high quality frozen sections could be obtained, it might be better to 
express the sectional thickness as a proportion of the total myométrial thickness. Non-parametric 
statistical methods could then be used to compare different groups of patients.
The method devised for measuring the sectional thickness of the inner myometrium, was slightly 
different for the full and partial myométrial thickness sections, the reason for it being the 
variation in myométrial length (see Materials & Methods). The results obtained from the 
sectional thickness measurements revealed intra and inter patient variability. Sections obtained
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from patients after exposure to intrauterine levonorgestrel were also included in the sectional 
thickness measurements. Surprisingly the highest values were obtained from these patients, 
ranging from 8.59-14.76 mm. Two reasons can be given for these high values. One could 
postulate that the LNG-IUS affects the myometrium as well as the endometrium. A recent study 
investigating the treatment of grossly enlarged adenomyotic uteri, reported that a marked 
decrease in uterine size occurred within 12 months of insertion o f the LNG-IUS. This result 
suggests that the LNG-IUS might have an effect on the gross uterine anatomy (Fong & Singh, 
1999). The second reason could be that these patients might had a wider inner myometrium 
before treatment, hence the LNG-IUS might not have a dramatic effect on the thickness of the 
inner myometrium.
However, the patients exposed to the intrauterine levonorgestrel represented a small number and 
therefore it can not be treated as a concrete result. In order to investigate if the LNG-IUS has 
indeed an effect on the myométrial sectional thickness, a larger number of patients should be 
examined.
The sectional thickness measurements for the rest of the patients ranged between 2.09-7.78mm. 
Based on the variability of the results a question arises as to what constitutes normal thickness. 
There is a broad agreement in the literature that the “normal” junctional zone on MR imaging, is 
regular and measures <5mm (Mark et al., 1987) in thickness although there is no consensus on 
what constitutes and “abnormal” junctional zone. Width between 6 and 12 mm have been 
reported (Mark et al., 1987). It has also been reported that irregular thickening of the junctional 
zone is a common finding in women suffering from menstrual dysfunction (deSouza et al., 
1995). The latter statement might help to explain numbers above 5 mm obtained, for the 
sectional thickness, in this study. However, this does not explain sectional thickness values 
below 5mm, since all the patients included in this study reported a complaint of menorrhagia and 
dysmenorrhoea.
Nevertheless, caution should be taken when comparing the histological findings of this study and 
the MRI results of inner myométrial thickness. It is possible that there is no direct biological 
correspondence between histology and MRI, hence explaining values less than 5mm. However, 
if there is a direct biological correspondence, these values could be due to the orientation of the 
section and the way the thickness of the inner myometrium was calculated.
Another factor that affects myométrial zonal anatomy is ovarian steroids. In postmenopausal 
women and pre-pubertal girls the zonal anatomy is often indistinct with a comparatively low 
signal intensity from the myometrium (Brosens et al., 1998). Gonadotrophin releasing hormone
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analogues were shown to lead to an MR appearance o f the uterus similar to that of the 
postmenopausal women (Demas et al., 1985).
At the day of collection, important patient information was also collected such as the age, LMP, 
parity, medication and other (not shown). Of the patients from which sectional thickness 
measurements were obtained, none were reported to have received gonadotrophin releasing 
hormone analogues and none were post-menopausal. Hence all o f the women where sectional 
thickness measurements were carried out could have been expected to exhibit an MR myométrial 
layering pattern. However, it should be noted that the reported complain of menorrahgia was not 
objectively proven.
Further MRI evidence for hormonal responsiveness of the junctional zone is provided by Wiczyk 
et al. (1988). It was demonstrated that the junctional thickness changed throughout the menstrual 
cycle in conjunction with endometrial thickness changes (Wiczyk et ah, 1988). In this study the 
stage of the cycle was recorded for every patient, however it was not possible to make any 
conclusions about the effect of cycle stage on the sectional thickness. Firstly because 
hysterectomy specimens of the type used in this study could only be obtained at a given stage of 
the menstrual cycle. Secondly no pre-hysterectomy MRI or ultrasound images were taken.
The median for sectional thickness of the inner myometrium was calculated from the individual 
patients, the average of all patients, the ratio of the p2 laminin chain to collagen IV and from the 
99% of the maximum of the quadratic. The advantage of calculating the median from the 
individual patients was that it gives a better estimate of the biological variability, whereas the 
average of all patients formulates a picture of the transition, between inner and outer 
myometrium, that would have been difficult to obtain just by looking at individual data sets. 
However, calculating the median using the average of all patients could restrict the analysis by 
not properly defining the true nature of the transition between inner and outer myometrium. 
Experimental caused variability in the starting and plateau points were used and so the shape of 
the average transition should not be over-interpreted. The median value obtained from the 
individual patients (n=7.440mm) and average of all patients (n~8.460mm) were very similar.
The advantage of using the ratio of the p2 laminin chain to collagen IV was that it allowed 24 
different data sets to be compressed into one, and so the transition pattern was easier to 
comprehend. The value for the median obtained (n=6.99mm) using the ratio was closer to the 
median value calculated from the individual patients than that calculated from the average of all 
patients. The maximum of the quadratic fît gave an imprecise estimate as it approached its 
maximum. The 99% of the maximum of the quadratic corresponded more closely to the sectional
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thickens estimated by other means. The value obtained in this way (n=8.82mm) was closer to 
that of the average of all patients.
A quadratic fit was statistically justified for the ratio of the (32 laminin chain to collagen IV. In 
principal the quadratic function reaches a maximum and then declines, however there were no 
qualitative experimental evidence of this decline, therefore a better mathematical model of the 
data might be justified.
4.2 Expression of laminin chain in neurons
The survival and development of neurons are influenced not only by soluble molecules such as 
neurotransmitters and trophic factors, but also by cells adhesion molecules anchored either on 
cell membranes or in the extracellular matrix (Nurcombe, 1992).
When motor axons regenerate to denervated muscles after nerve injury, they preferentially re- 
innervate the original synaptic sites and differentiate there into nerve terminals (Sanes et al., 
1990). It was reported that the axons also preferentially form contacts and differentiate at 
synaptic sites on BL sheaths from which muscle fibres have been removed, implicating 
components of B1 in the remarkable topographic specificity of re-innervation (Sanes et al., 1978; 
Glicksman & Sanes, 1983). The laminin a l ,  p i, yl (laminin 1) trimer is adhesive to neurons of 
many types and is a potent promoter of neurite outgrowth (Sanes, 1989).
Laminin can act synergistically with appropriate target-derived neurotrophic factors to promote 
neuronal survival during early development both in vivo and in vitro (Edgar, 1989). It may also 
play important roles in maintaining the transmitter phenotype of neurons (Acheson et al., 1986). 
Nevertheless, the intracellular mechanisms responsible for these various activities of laminin 
remain incompletely understood, although the potency and specificity o f laminin effects on 
neurons point to the existence of a specific transduction mechanism on neural cell surfaces 
(Nurcombe, 1992).
In this study, nerve-like structures were particularly obvious with the a2 and pl laminin chains 
due to the absence of these particular laminin chains from the vascular smooth muscle and peri­
vascular stroma. Nerves were visualized, after immuno staining with specific antibodies (NF-68 
and NF-200kD) as nerve fibres within the myométrial smooth muscle or iimervating large blood 
vessels localised in the outer part of the myometrium. Nerve bundles were also seen in within the 
smooth muscle o f the myometrium. However, not many nerve fibres and bundles were observed 
within the sections possibly because of the orientation of the sections.
The rarity of the nerve fibres and bundles preclude the use of the present analytical methods to 
describe the a variation in the neuronal distribution between inner and outer myometrium.
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4.3 Extracellular matrix deposition after exposure to intrauterine levonorgestrel 
(Mirena®)
The gradient observed in the myométrial distribution of the p2 laminin chain in untreated 
patients was also observed after exposure to intrauterine levonorgestrel, for a period of 10 weeks 
to 9 months. The myométrial distribution of p l and yl laminin chains was more uniform and 
resembled that of the untreated patients. In the individual cellular compartments of both the inner 
and outer myometrium, the distribution of the ct2, p l, P2, yl laminin chains was the same as that 
before exposure to the intrauterine levonorgestrel, suggesting that treatment with the LNG-IUS 
does not affect the extracellular matrix distribution of the myometrium.
After exposure to intrauterine levonorgestrel, areas of highly decidualised tissue were observed 
within the superficial part of human endometrium. This is consistent with known effects of the 
device on the endometrium (Silverberg et ah, 1986). In the highly decidualised areas of the 
superficial endometrium, more extensive peri-cellular staining was observed with the p i and yl 
laminin chains.
It must be bourn in mind that results for endometrial examination of the extracellular matrix after 
exposure to the intrauterine levonorgestrel, were reported only fi-om one specimen. As the a2, 
p i, P2 and yl laminin chain antibodies do not react with antigens on wax sections, even after 
antigen retrieval methods were applied (personal communication A.Young & Dr S.Campbell), 
analysis was limited by the quality of the frozen sections.
Nevertheless, the results of this study are in accordance to the results of Wewer et ah, (1985); 
Aplin et ah, (1988) and Kohnen et ah, (1998), who demonstrated that decidualisation of the 
endometrium o f early pregnancy is associated with the new accumulation of peri-cellular BM 
containing at least type IV collagen and laminin. This cyclical variation suggests that some 
hormonal influence at or shortly following ovulation may be the stimulus for the laminin 
synthesis. It was reported that in the non-pregnant endometrium, laminin around the stromal cells 
cannot be detected in the proliferative phase of the menstrual cycle but this matrix protein begins 
to accumulate in the cytoplasm and as a peri-cellular layer in stromal cells at the early secretory 
phase (Loke & King, 1995). However, detailed observation o f cyclical variation in laminin 
expression could not be made in this study.
Additionally, after 1-6 months of exposure to LNG-IUS, extensive peri-cellular laminin and 
collagen IV were present in some areas of the endometrial stroma in 29 out of 30 biopsies 
(personal communication. Dr S. Campbell). In other areas, deposition of BM was less extensive. 
On this basis, an observer with no knowledge of the treatment protocol, was able to deduce the
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treatment status of 98% (45/46) of the pipelle biopsies used in a study of the Mirena® effects 
(personal communication, Dr S. Campbell).
However, the function of the peri-cellular aura of the basement membrane is not clear. It has 
been speculated that the appearance of the BM material with the onset of the process of 
decidualisation may have important functional implications for the decidual cells (Wewer et ah, 
1985). Such functions may include selective permeability of macromolecules and structural 
support or modulation of other cellular functions essential for the maintenance of pregnancy. The 
presence of a peri-cellular basement membrane may contribute to the anchorage required by the 
extra-villous trophoblasts or maternal bone marrow derived cells and to the segregation of 
decidual cells from other cell populations. The peri-cellular BM may also play a role in the 
organisation of interstitial matrix (Aplin et al, 1988).
In the basal part of the endometrium, the distribution of the p l, yl laminin chains and collagen 
IV was the same as that observed in the untreated patients. Both laminin chains and collagen IV 
were found to be present in the glandular basement membranes and vascular smooth muscle but 
they were less widely distributed in the non-decidualised basal portion of the endometrium, with 
the exception of collagen IV which was widely distributed. This suggests that possibly the 
effects of the intrauterine levonorgestrel device might be restricted to the superficial part of the 
human endometrium.
Collagen IV is a ubiquitous component of basement membranes and the yl laminin chain is 
found in most of the laminin types. As both of theses molecules are components of the BM a 
question arises as to why collagen IV in widely distributed in the endometrial stroma and peri­
vascular myométrial tissue whereas the yl laminin chain is spatially more restricted. One 
possible explanation is that collagen IV might genuinely exist without the production of a 
defined basement membrane. Another reason could the sensitivity levels of the detection system 
used in immunocytochemistry. It might be possible that staining could not be detected below a 
certain threshold value for the yl laminin chain. Several parameters during 
immunocytochemistry, such as the affinity and concentration o f the primary antibodies, 
temperature, the time of antibody and substrate incubation, might produce the difference seen in 
the yl laminin chain and collagen IV distribution within the peri-vascular myométrial tissue.
Even after exposure to the LNG-IUS where there is considerable increase in the distribution of 
laminin, the yl laminin chain was less widely distributed. Therefore it seems reasonable to 
postulate that this reflects a genuine difference between collagen IV and the yl laminin chain 
expression in the stroma and peri-vascular tissue.
95
4.4 RT-PCR analysis
The use of RT-PCR in this study confirmed the expression of the LAMB2 and LAMCl genes in 
the inner and outer myometrium. However, after 30 cycles the reaction in both the inner and 
outer myometrium could have reached a plateau, therefore it was not possible to make any 
quantitative inferences. The size of the products from the gene amplification for both laminin 
chains was close to the predicted size.
Based on the gradient observed in the myométrial distribution of the p2 laminin chain by ICC, a 
difference in the amount of RNA present in the inner and outer myometrium was postulated. In 
order to examine the amount of RNA in the two different myométrial layers, the endometrium 
had to be separated from the myometrium and the remainmg myometrium was divided into inner 
and outer. In this study the division between inner and outer myometrium was estimated 
visually. However, visually estimating the transition between inner and outer myometrium is not 
a reliable method therefore, for future work, the myometrium could be divided into inner and 
outer, using the ICC on parallel blocks. In other words, once the specimen is collected it could be 
transversally cut into two specimens, one stored in an RNA stabilising solution and the other 
used for immuno localisation of the P2 laminin antibody. After ICC, the specimen intended for 
RNA isolation could be brought side to side with the sections where the p2 laminin antibody was 
immuno localised, and based on the observed gradient the specimen should then be divided into 
inner and outer myometrium. RT-PCR could then take place and a quantitative RT-PCR could be 
used to detect differences in the amount of RNA present between the inner and outer 
myometrium.
4.5 Importance of laminin and collagen IV
Based on the early expression of the a l ,  p i laminin chains and the ubiquitous expression of the 
yl laminin chain, it was speculated that mutation causing absence or highly altered structure of 
these chains would be lethal (Aumailley & Smyth, 1998). This has been confirmed by deletion of 
functional LAMA or LAMCl gene in drosophila (Henchcliffe et al., 1993) leading to early 
embryonic lethality. Similarly, targeted extinction of the ITGBI gene encoding the pl laminin 
integrin chain is not compatible with embryonic development and leads to prei-implantation 
lethality (Stephens et al., 1995). These observations strengthen the absolute prerequisite of 
functional laminin and lamitiin-integrin interactions from embryonic development.
In man, laminin and integrin defects cause a subset of skin blistering diseases known as the 
junctional types of epidermolysis bullosa (Kuster et al., 1997). Laminin and laminin receptor 
defects are responsible for diseases such as congenital muscular dystrophy (Arahata et al., 1997). 
Laminins and theirs are presumably involved in other pathologies affecting the basement
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membranes, such as diabetes or the invasive growth and metastasis of tumours (Aumailley & 
Smyth, 1998).
Collagen IV has been involved in a number of human diseases such as the Goodpasture 
syndrome, which is a lethal form of autoimmune disease, Alport syndrome and diffuse 
esophageal leiomyomatosis (Hudson et al., 1993). By contrast to the laminin family, collagen IV 
has been related to a disease affecting the normal function of the uterus. The Ehlers-Danlos 
syndrome (EDS) is a groups of connective tissue disorders involving defects in collagen 
synthesis. So far, 10 different types have been described (Brees, 1995). The most lethal of these 
is type IV EDS with up to 25% maternal mortality (Brees, 1995). Obstetrical complications 
include premature rupture of membranes, rupture of blood vessels and gravid uterus, tearing of 
perineum, vagina, urethra and bladder (DePaepe et al., 1989).
Sorokin et al. (1994), in a study examining the obstetrics and gynaecologic dysfunction in the 
EDS, reported that women with EDS were found to have high rates of abortion, preterm 
delivery, pregnancy-related bleeding and stillbirth. In the same study it was also reported that 
women with EDS also have high frequency of anovulation, vaginal infections, abnormal 
cytologic smears and dyspareunia.
All of the above diseases demonstrate the importance of a fully formed basement membrane, 
either for a normal embryonic development or for later stages in life.
4.6 Elastin expression in the human uterus
4.6.1 Myométrial gradient of the elastin distribution in the human myometrium
Quantitative and qualitative analysis carried out in this study revealed a decreasing gradient, 
from the outer towards the inner myometrium, in the distribution o f elastin. Two methods were 
devised to quantitatively analyse the observed gradient. In the first method the average data sets 
were aligned using the position of the outer myometrium and truncated at distance equal to the 
length of the shortest myométrial specimen. However this method restricted the analysis to the 
outer myometrium. In the second method the data sets were normalised by width and therefore 
the complete data sets were analysed regardless of myometrium length. The second method of 
analysis involved dividing the sections into slices and this in itself produced a smoothing effect 
as it employed a consecutive average. Because the positional data are recorded as slice number, 
there is an inevitable loss of spatial information.
Both methods demonstrated the presence of a decreasing gradient from the outer towards the 
inner myometrium and hence verified and supported the qualitative analysis. A linear fit was
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statistically justified for the average elastin data in contrast to the non-linear distribution of the 
(32 laminin chain, where a quadratic fit was statistically justified.
McCarthy and colleagues (1989), undertaking an MRI study of the relaxation properties and 
water content in the human uteri, reported that the content and nature of elastin did not differ 
between the junctional zone (inner myometrium) and the adjacent myometrium. There is an 
apparent discrepancy between the study by McCarthy et al. (1989) and the present study. There 
may be four technical reasons explaining this discrepancy. In the published study it was stated 
that the uterine sections were taken from the posterior and anterior uterine walls, but it was not 
specified whether the sections were o f full or partial myométrial thickness. The selection of a 
histochemical stain (elastic-Van Gieson) instead of a monoclonal antibody means that the 
authors used a less specific detection system with background staining. In addition the use of the 
elastica kit according to Van Gieson could have made it very difficult to see a gradient in the 
myométrial distribution of elastin (see Materials and Methods). By contrast orcein staining used 
in this study produced a clearer distinction between elastic and non-elastic components. 
McCarthy et al. (1989) may have failed to observe a gradient in the myométrial distribution of 
elastin because their aim was to find a more distinct layering pattern, consistent with MRI. It 
must be bourn in mind that the myométrial distribution of elastin exhibits a gradient and not 
layering, as in the case of the (32 laminin chain.
There are three possible components to the observed gradient. The first is a gradient in the 
distribution of elastin within the smooth muscle. It was demonstrated that in the inner 
myométrial smooth muscle elastin was absent or of low abundance, whereas in the outer 
myometrium the average intensity of elastin immuno localization increased. Additionally, in 
more superficial parts of the tissue close to the serosal surface, elastin was observed in the 
smooth muscle of areas remote from arterioles and larger blood vessels. The gradient in the 
smooth muscle cells of the myometrium suggests a phenotypic difference between the SMC of 
the inner and outer myometrium (discussed in detail below).
The second component of the gradient is in the peri-vascular tissue. Peri-vascular elastin was 
predominantly associated with large blood vessels, which are located in the outer and not the 
inner myometrium. Nevertheless, traces of elastin were observed in the inner myometrium in 
areas surrounding the largest of the arteries and sometimes close to the thin walled vessels. The 
difference in the blood size between the inner and outer myometrium may partially explain the 
variation in peri-vascular elastin {Diagram. 1 A,B).
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Diagram. I A conceptual representation of the 
elastin gradient within the myometrium in 
relation to the arterial tree. (A) The arterial tree as 
observed in a microradiograph of a transverse 
uterine slice by Farrer-Brown et al. (1970a). (B) 
The three postulated components of the gradient 
are shown independently. The vascular 
component is represented by the larger vessels of 
the arterial tree. The cross-hatching depicts the 
peri-vascular volume surrounding the coiled 
vessels. The grey background portrays the 
gradient of elastin within the myométrial smooth 
muscle.
(Part (A): used with permission from the 
publishers, Blackwell Scientific 
Part (B): is reproduced, courtesy of Dr S. 
Campbell)
The third and final component of the gradient is in the vessel walls per se. As the arcuate and 
radial arteries branch, the cross-section of the individual vessels becomes smaller hence less 
elastin may be present per cross-sectional unit area of vessel, compared to the highly 
muscularised larger vessels of the outer myometrium. In other words, there is more elastin in the 
vascular smooth muscle cells of the large arteries found in the outer myometrium than the thin 
walled vessels. In addition the images published by Farrer-Brown el al. (1970a), suggest that 
there may be a gradient in the total arteriolar cross-sectional area.
It would not be easily possible to reliably measure the individual components of the gradient 
using the present methods.
Elastin within the uterus could provide a dynamic function and play a significant role during 
pregnancy by allowing the uterus to enlarge so that it can accommodate the growing fetus. It has 
been suggested that elastin may assist in closing the cervix after delivery and thereafter returning 
it to its non-pregnant configuration (Calder, 1994). This could apply to the whole uterus after 
parturition. However, the return to the non-gravid size also involves muscular contraction. A 
combination of passive elastic forces and smooth muscle induced tone, might be necessary to 
help maintain uterine size and shape, in the gravid and non-gravid state.
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The present study suggests that the outer part of the muscle is more elastic compared to the inner 
part. If the distending force is resolved within the outer part of the muscle it maybe more 
appropriate for the outer part to be more elastic. This suggestion could be further investigated by 
devising a method to analyse the elasticity of the uterine muscle.
However, it maybe more appropriate to ask why the inner myometrium is less elastic. Several 
studies (deVries et ah, 1990; Lyons et ah, 1991; Chalubinski et al., 1993; Kunz et al., 1996) 
showed myométrial peristalsis in the human uterus, during the course of the menstrual cycle. 
These waves emanate from the inner and not the outer myometrium. It appears that the non- 
peristaltic tissue (outer myometrium) is more elastic than the inner myometrium. The decrease in 
the amount of elastin present in the inner myometrium may be responsible for a more efficient 
propagation of the peristaltic waves.
Farrer-Brovm et al. (1970a,b) in microradiographic studies described the blood supply of the 
uterus and showed that the anterior and posterior arcuate divisions o f the uterine artery and their 
branches, from which the whole arterial tree is derived, run a markedly tortuous course towards 
the midline. The branches from the contralateral sides of the uterus then anastomose. These 
authors postulated that the tortuosity of the myométrial arteries allows expansion of the gravid 
uterus, which would otherwise be subject to excessive tension. However, it should be noted that 
the less muscularised venous system does not show similar spiral morphology (Farrer-Brown et 
al., 1970b). Greater force could be required to distend a muscularised artery than a vein therefore 
the spiral nature of the arteries may reduce the force required to produce linear elongation of the 
arcuate artery. Lateral forces acting perpendicularly on the radial arteries may change the pitch 
of the spiral arteries during pregnancy.
Almost 30 years later, this study has provided the evidence to support the postulation of Farrer- 
Brown and colleagues (1970a) for it has been demonstrated that the blood vessels of the outer 
myometrium contain elastin in their walls and does the peri-vascular tissue. Nevertheless, elastin 
The elastic nature of the blood vessels in combination with the peri-vascular scaffolding of 
elastin within the arterial walls may not be, by itself, sufficient for very extensive blood vessel 
stretching. The peri-vascular scaffolding of elastin may be required for the blood vessels to 
extend during pregnancy.
Gunja-Smith et al. (1985), reported that the during pregnancy the elastin content increases 
fourfold to fivefold and that in the non-gravid uteri the elastin content increased with successive 
pregnancies. Quantitative analysis of the myométrial distribution o f elastin suggested that there 
is variability within patients. Therefore it was not possible to conclude if successive pregnancies 
increased the amount of elastin present in the uterus.
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The stage of the normal menstrual cycle did not affect the presence o f the gradient in the 
myométrial distribution of elastin. Patients treated with intrauterine levonorgestrel were also 
included in this study and no differences were observed in the myométrial distribution of elastin 
when compared to that of the untreated patients. No differences were observed in the myométrial 
distribution of the different laminin chains and collagen IV myométrial distribution, clearly 
showing that the intrauterine levonorgestrel system does not affect the gross structure of the 
myometrium.
Elastin expression in the human endometrium
Within the human endometrium elastin was shown to be restricted in the basal portion of the 
endometrial arterioles. Elastin was found to be absent from the basal and superficial stroma, the 
surface epithelium and the muscularised and thin walled blood vessels close to the surface 
epithelium.
Fleming & Bell, (1997) reported that the human endometrium was free from elastin, while 
investigating the presence of fibrillin-1, a component of the elastic fibres, in the human 
endometrium and decidua during the menstrual cycle. Endometrial specimens were collected 
from regularly cycling women undergoing curettage of hysterectomy. In the published paper the 
authors do not specify which type of sections (hysterectomy or curettages) they used for the 
immunolocalization o f elastin, which inevitably plays and important role in the interpretation of 
the results.
If Fleming & Bell (1997) based their description largely on the curettage sections or from 
hysterectomy specimens with little basal endometrium it is possible that they failed to detect any 
elastin in the basal part of the endometrium, simply because the part of the tissue is missing. 
However, if full thickness hysterectomy sections were indeed used, their method for elastin 
immunolocalization was probably defective. In the published paper the method used for 
immunolocalization of elastin lacks important details and therefore a direct comparison between 
their method and the method used in the present study cannot be made.
4.6.2 Elastin expression in the myométrial and endometrial vascular system 
Elastin was shown to be present in the wall o f myométrial arteries. Like most blood vessels, the 
arterial wall consists of three layers; tunica intima, tunica media and tunica adventitia. In the 
large arteries, found m the outer part of the muscle, the internal elastic lamina was well marked 
as a refractile wavy band {Diagram, 2). The internal elastic lamina is the last layer of the tunica 
intima. There are different definitions of the composition of the adventitia within standard 
textbooks In the muscular arteries the tunica adventitia consists of loose connective tissue 
containing vasa vasorum, nerve fibres, adipose cells, fibroblasts and elastic fibres.
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Longitudinally arranged collagen fibres are found in the deeper portion of the adventitia (Zhang, 
1999). The tunica adventitia does not have “a clearly defined outer edge”, it gradually merges 
with the loose connective tissue accompanying the vessel (Garven, 1957). However, it proved to 
be very difficult to distinguish the external elastic lamina because of the elastic fibres found in 
the arterial wall and peri-vascular area {Diagram.2). In the smaller arteries of the outer and 
inner myometrium elastin was present in the arterial wall but due to the size of the blood vessels 
it was difficult to distinguish the internal elastic lamina.
Diagram.2 Diagrammatic representation of the internal 
elastic lamina (black) of large arteries found in the outer 
myometrium. The elastin present in the arterial walls and peri­
vascular area is also shown (brown).
Despite the presence of elastin in the myométrial arteries and in the basal portion of the 
endometrial arterioles, spaces assumed to be blood vessels were shown to lack elastin. These 
assumed vascular spaces were seen in both the endometrium and myometrium. The vascular 
identity of these spaces was verified using an endothelial marker (CD31). However, a more 
specific indication of vascular identity was not possible. In other words it was not possible to 
determine whether these thin walled vessels were veins or lymphatic vessels. One way to 
distinguish between veins and lymphatic vessels would be the presence or not, respectively, of 
red blood cells. Nevertheless, a more reliable way to specifically identify the vascular spaces as 
veins would be to identify endothelial markers, which are spatially restricted within the vascular 
tree.
4.6.3 Elastin in uterine sections after exposure to intrauterine levonorgestrel (Mirena ®)
Within the human endometrium, after exposure to intrauterine levonorgestrel (Mirena®), elastin 
remained in the basal portion of the endometrial arterioles but was absent fi’om the endometrial 
stroma in 9 out of 12 sections examined. In the remaining 3 sections elastin was shown to be 
present in the basal endometrial stroma. Kohnen et a i (2000) reported that the stromal cells of 
the basal endometrium produce a-smooth actin suggesting that endometrial cells have a 
myofibroblastic phenotype. It may be possible that the presence o f the progestagen make these 
myofibroblasts elastogenic. It seems reasonable to postulate that this is an abnormal feature.
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In the human myometrium no differences were observed in the distribution of elastin within the 
smooth muscle, walls of arteries and in the peri-vascular tissue, when compared to the untreated 
patients. The vascular abnormalities observed after exposure to the intrauterine levonorgestrel 
(Campbell et a i, 2000 abstract) suggest that the effects of the LNG-IUD may be restricted to the 
superficial endometrium. However, a recent study examining enlarged adenomyotic uteri, 
reported a marked decrease in uterine size was observed after 12 months o f insertion. Therefore 
it is possible that the intrauterine levonorgestrel system has an effect on uterine muscle. The 
myométrial features being examined in this study may not have been sensitive to the effects of 
the intrauterine levonorgestrel system.
4.6.4 Importance o f elastin in tissue organisation
Alterations affecting elastin may either be heritable or acquired and a variety of extrinsic 
processes may modify elastin during the lifetime of an individual and compromise the fimciton 
of the elastic fibre (Rosenbloom, 1984). However, because of its crucial role in the 
cardiopulmonary system, the absence of elastin is incompatible with human life. Therefore no 
diseases in which there is a total absence of elastin have been reported. A literature search 
carried out for the involvement of elastin in diseases related to the human uterus showed no 
records so far.
Nevertheless elastin has been reported to play an important role in the pathogenesis of several 
diseases. Knockout mice lacking elastin died perinatally following obstructive arterial 
development resulting from sub-endothelial cell proliferation and reorganisation o f the smooth 
muscle. Arterial development in mice lacking elastin was indistinguishable fi-om that of the 
control mice until 17.5 embryonic day, indicating that elastin is important in the later stages of 
development. (Dean a/., 1998).
Other diseases in which the involvement of elastin has been implicated include Pseudoxanthoma 
Elasticum (Altman et al., 1974), Cutis Laxa (Hashimoto & Kanzaki, 1975), and Menses kinky 
hair syndrome (Menkes et al., 1962), Moyamoya (Yamamoto et al., 1997), supravalvular aortic 
stenosis (SVAS) (Boeckel et al., 1999) and arteriosclerosis (Yamamoto et al., 1994).
Based on the observed gradient in the uterine myométrial distribution of elastin a literature 
search for a similar gradient was undertaken in a number of other organs. Although elastic fibre 
orientation has been described in detail in many tissues such as lung (Starcher et al., 2000) and 
the bladder (Murakumo et al., 1995) the kind of microscopic description produced in this study 
does not appear to be available, at least in the research literature.
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4.7 Conclusion
The results presented in this thesis suggest that there are important structural differences between 
the inner and outer myométrial smooth muscle. The anatomy o f the human myometrium 
therefore appears to be more complex than previously reported. In the MRI literature, the muscle 
of women of reproductive age is said to consist of two distinct layers. As a result o f the work 
carried out in this study, the layering appears to be more subtle and does have an obvious 
morphological correlate. In addition to layering, within the myométrial smooth muscle, gradients 
o f various kinds may also be present. As a consequence of these findings it is postulated that the 
outer myometrium is more elastic than the inner and that the variation in BM composition may 
influence the contractile properties of the muscle.
Although this has been an anatomical study, there is scope for further functional, developmental 
and molecular genetics studies, to elaborate the basis of human myométrial anatomy.
104
References
Abraham son D.R. Recent studies on the structure and pathology of basement membranes. 
Journal o f Pathology. 1986; 149: 257-278.
Ache son A.L., et al. Laminin increases levels and activity of tyrosine hydroxylase in calf adrenal 
medullary cells. Journal o f Cell Biology. 1986; 102: 151-159.
Adams J.C & Watt F.M. Regulation of development and differentiation by the extracellular 
matrix. Development. 1993; 117:1183-1198.
Alberts B., et al. (1994). The extracellular matrix of animals. In Molecular biology o f the cell 
(ed. Alberts B., Bray D., Lewis J., Raff M., Roberts K. and Watson J.D.), pp.971-973. Garland 
Publishing Inc. New York & London.
Allonen H. The levonorgestrel lUD. In Bardin CW, Mishell DR Jr, eds. Proceedings from the 
International Conference on lUDs. Newton, MA, USA: Butterworth Heinemann, 1994; 284- 
292.
Altman L.K., et al. Pseudoxanthoma elasticum: and inderdiagnosed genetically heterogeneous 
disorder with protean manifestations. Arc/î/ves in Internal Medicine. 1974; 134: 1048.
Anders son K., et al. Levonorgestrel-releasing and copper-releasing (Nova T) lUCDs during five 
years of use: a randomized comparative trial. Contraception 1994; 49: 56-72.
Andreyko JL., et al. Use of an agonistic analog of GnRH (nafarelin) to treat leiomyomata: 
assessment by magnetic resonance imaging. American Journal o f Obstetrics and Gynaecology. 
1988;158:903-910.
Aplin J.D., et al. An immunocytohistochemical study of human endometrial extracellular matrix 
during the menstrual cycle and first trimester of pregnancy. Cell and Tissue Research. 1988; 
253:231-240.
Arahata K., et al. Congenital muscular dystrophies. Current Opinion in Neurology. 1995; 8: 385- 
390.
Aumailley M., et al. The cellular interactions of laminin fragments. Cell adhesion conelates with 
two jfragment-specific high affinity binding sites. Journal o f Biological Chemistry. 1987; 262: 
11532-11538.
Aumailley M., et al. Antibody to integrin a6 subunit specifically inhibits cell-binding to laminin 
fragment 8. Experimental Cell Research. 1990a; 188: 55-60,
105
Aumailley M., et al. Identification of the Arg-Gly-Asp sequence in laminin A chain as a latent 
cell-binding site being exposed in jfragment P I . FEBSLetters. 1990b; 262: 82-86.
Aumailley M. & Smyth N. Review. The role of laminins in basement membrane fimction. 
Journal of Anatomy. 1998; 193: 1-21.
Autio-Harmainen H., et al. Synthesis of laminin and type IV collagen by trophoblastic cells and 
fibroblastic stromal cells in the early human placenta. Laboratory Investigation 1991; 64(4): 
483-491.
Autio-Harmainen H., et al. Simultaneous expression of 70 kilodalton type IV collagenase ans 
type IV collagen oil (TV) chain genes by cells of eai'ly human placenta and gestational 
endometrium. Laboratory Investigation. 1992; 67(2): 191-200.
Azziz R. Adenomyosis: current perspectives. Obstetric & Gynaecological Clinics of North 
America. 1989; 16:221-235.
Barondes S.H., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell. 1994; 
76: 597-598.
Battaglia C., et al. Basement membrane heparan sulfate proteoglycan binds to laminin by its 
heparan sulfate chains and to nidogen by sites in the protein core. European Journal of 
Biochemistry. 1992; 208: 359-366.
Beck K., et al. Ionic interactions in the coiled-coil domain of laminin determine the specificity of 
chain assembly. Journal o f Molecular Biology. 1993; 231: 311 -323.
Beyer E.C., et al. Antisera directed against connexin 43 peptides react with a 43-kD protein 
localized to gap junctions in myocardium and other tissues. Journal of Cell Biology. 1989; 108: 
595.
Boeckel T., et al. A new mutation in the elastin gene causing supravascular aortic stenosis. The 
American Journal of Cardiology. 1999; 83(7): 1141-1143.
Bounds W., et al. Clinical experience with a levonorgestrel-releasing intrauterine contraceptive 
device (LNG-IUCD) as a contraceptive and in the treatment of menorrhagia. British Journal of 
Family Planning 1993; 19:193-194.
Brandenberger R., et al. Native chick laminin-4 containing the (32 chain (s-laminin) promotes 
motor axon growth. Journal of Cell Science. 1991; 135: 1583-1592.
Brees C.K. Rupture of the external iliac artery during pregnancy: a case of type IV Ehlers- 
Danlos syndrome. Journal of the Kentucky Medical Association. 1995; 93(12): 553-559.
106
■ Brosens JJ., et al. Uterine junctional zone: fimction and disease. The Lancet. 1995; 346(8974): 
558-560.
“ Brosens J.J., et al. Myométrial zonal differentiation and uterine junctional zone hyperplasia in 
the non-pregnant uterus. Human Reproduction Update. 1998; 4(5): 496-502.
■ Brosens J.J. & Brosens I.A. (1998) Adenomyosis uteri. In In Clinical disorders o f  the 
endometrium and menstrual cycle (ed. Cameron I.T., Fraser I.S and Smith S.K.), pp.3297-299. 
Oxford University Press.
■ Brown H.K., et al. Uterine junctional zone: correlation between histologic findings and MRI. 
Radiology. 1991; 179:409-413.
■ Brown J.C., et al. Protein binding and cell adhesion properties of two laminin isoforms 
(AmB 1 eB2e. AmB 1 sB2e) from human placenta. Journal o f Cell Science. 1994; 107: 384-391.
■ Burgeson R.E., et al. A new nomenclature for laminins. Matrix Biology. 1994; 14; 209-211.
■ Calder A.A. (1994). The cervix during pregnancy. In The uterus (ed. Chard T. & Grudzinskas 
C.), pp.295-296. Cambridge University Press.
■ Carter W.G., et al. Distinct functions for integrins aapi in focal adhesions and a6p4/bullous 
pemphigoid antigen in a new stable anchoring contact (SAC) of kératinocytes: relation to 
hemidesmosomes. Journal o f Cell Biology. 1990; 111: 3141-3154.
" Chalubinski K., et al. Vaginosonography for recording of cycle-related myometiial contractions. 
Fertility and Sterility. 1993; 59: 225-228.
■ Campbell S., et al. Laminin p2 distinguishes inner and outer layer of the human myometrium. 
Journal o f Reproduction and Fertility. Abstract Series. 1998; 22: 12.
■ Campbell S., et al. Variations in laminin expression in uterine blood vessels and smooth muscle. 
Journal o f  Reproduction and Fertility. Abstract Series. 2000; 26: 17.
■ Chamley-Campbell J., et al. The smooth muscle cell in culture. Physiological Reviews. 1979; 
59(1): 1-61.
■ Champliaud M.F., et al. Human amnion contains a novel laminin variant, laminin 7, which like 
laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. 
Journal o f Cell Biology. 1996; 132:1189-1198.
107
■ Chan F.L., et al. The basement membranes of cryofixed or aldehyde-fixed, freeze-substituted 
tissues are composed of a lamina den sa and do not contain a lamina lue id a. Cell Tissue 
Research. 1993; 273: 41-52.
■ Chan F.L. & Wong Y.C. Ultrastmctural localization of proteoglycans by cationic dyes in the 
epithelial-stroma interface of the guinea pig lateral prostate. Prostate. 1989; 14:147-162.
■ Chen M., et al. Interactions of the amino-terminal noncollagenous (NCI) domain of type VII 
collagen with extracellular matrix components. A potential role in epidermal-dermal adherence 
in human skin. Journal o f Biological Chemistry. 1997; 272; 14516-14522.
■ Cheng Y.S., et al. Self-assembly of laminin isoforms. Journal o f Biological Chemistry. 1997; 
272:31525-31532.
" Church J. Heather., et al. Laminin 2 and 4 are expressed by human decidual cells. Laboratory
Investigations. 1996; 74(1): 21-32.
■ Cochat P., et al. Journal o f Pediatrics. 1988; 113: 339-343.
■ Cooper A.R., et al. Studies on the biosynthesis of laminin by murine parietal endoderm cells.
European Journal o f Biochemistry. 1981; 119: 189-197.
■ Csapo A.I. Smooth muscle as a contractile unit. Physiology Reviews. 1962; 5: 7-33.
■ Csapo A.I. (1981) Force of labour. In Principles and Practice o f Obstetrics and Perinatology
(ed. Iffy L. & Kamientzky H.A.), pp.761-799. John Wiley and Sons, NY.
■ Daels J., Uterine contractility patterns of the outer and inner zones of the myometrium. Journal 
o f Obstetrics and Gynaecology. 1974; 44: 315-326.
■ Daga-Gordini D., et al. Detection of elastin by immunoelectronmiscroscopy. A comparison of 
different procedures. Hhistochemsitry. 1987; 87: 573-578.
" Dallenbach G. & Hellweg. (1981). The normal histology of the endometrium. In Histopathology
o f the Endometrium (ed ), pp.23-83.
" Damiano V., et al. Secretion of elastin in the embryonic chick aorta as visualised by
immunoelectron microscopy. Collagen related Research. 1984; 4: 153-164.
■ Dean Li, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998; 
393(6682): 276-280.
■ DeLuca M., et al. Polarized integrin mediates human keratinocyte adhesion to basal lamina. 
Proceedings o f the National Academy o f Sciences o f the USA. 1990; 87:6888-6892.
108
Demas B.E., et al. Uterine MR imaging; effects of hormonal stimulation. Radiology. 1985; 159: 
123-126.
De Paepe A. et al. Obstetrical problems in patients with Ehlers-Danlos syndrome type IV; a case 
report. European Journal o f Obstetrics, Gynaecology & Reproductive Biology. 1989; 33(2): 
189-193.
deSouza N.M. et al. The potential value of magnetic resonance imaging in infertility. Journal o f  
Radiology. 1995; 50: 75-79.
Deutzmann R., et al. Cell adhesion, spreading and neurite stimulation by laminin fragment E8 
depends on maintenance of secondary and tertiary structure in its rod and globular domain. 
European Journal o f Biochemistry. 1990; 191: 513-522.
De Vries K., et al. Contractions of the inner third of the myometrium. American Journal o f 
Obstetrics and Gynaecology. 1990; 162: 679-682.
Dolz R., et al. Folding of collagen IV. European Journal o f Biochemistry. 1988; 178: 357-366. 
Dziadek M. & Timpl R. Expression of nidogen and laminin in basement membranes during 
mouse embryo genesis and in teratocarcinoma cells. Developmental Biology. 1985; 111: 372- 
382.
Eble J.A., et al. The a l  pi integrin recognition site for the basement membrane collagen 
molecule [al(IV)]2a2(IV). EMBO Journal. 1993; 12:4795-4802.
Edgar D. Neuronal laminin receptors. Trends in Neuroscience. 1989; 12:248-251.
Ehrig K., et al. Merosin, a tissue-specific basement membrane protein is a laminin-like protein. 
Sciences o f the USA. 1990; 87: 3264-3268.
Ekblom P., et al. Laminin isoforms and their receptors in the developing kidney. American 
Journal o f Kidney Diseases. 1990; 17: 603-605.
Engvall E., et al. Distribution and isolation of four laminin variants: tissue restricted distribution 
ofheterotrimers assembled from five different subunits. Cell Regulation. 1990; 1: 731-740.
Faber M., et al. Laminin production by human endometrial stromal cells relates to the cyclic and 
pathologic state of the endometrium. American Journal o f Pathology. 1986; 124(3): 384-391. 
Falk B., et al. Reduction by progesterone of the estrogen-induced increase in tiansmitter level of 
the short adrenergic neurons innervating the uterus. Endocrinology. 1975; 84: 958-969. 
Farrer-Brown G., et al. The blood supply of the uterus. I. Arterial vasculature. Journal o f  
Obstetrics and Gynaecology. 1970a; 77: 673-681.
109
Farrer-Brown G. & Tarbit M.H. The blood supply of the uterus. II Venous pattern. Journal o f 
Obstetrics and Gynaecology. 1970b; 77: 682-689.
Fleming S. & Bell. S.C. Localization of fibrillin-1 in human endometrium and decidua during 
the menstrual cycle and pregnancy. Human Reproduction. 1997; 12(9): 2051-2056.
Fong Y.F. & Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the 
levonorgestrel-releasing intrauterine system. Contraception. 1999; 60(3): 173-175.
Fox J., et al. Recombinant nidogen consists of three globular domains and mediates binding of 
laminin to collage IV. EMBO Journal. 1991; 10: 3137-3146.
Gardner R.M. & Stancel G.M. Blockade of epidermal growth factor-induced uterine contractions 
by indomethacin and nordihydroguaritic acid. Journal o f Pharmacological Experimental Theory. 
1989;258:882-886.
Garfield R.E., et al. Control of myométrial contractility: role and regulation of gap junctions. 
Oxford Reviews in Reproductive Biology. 1988; 10:436.
Garfield R.E. & Yallampalli C. (1994). Structure and fimction of uterine muscle. In The uterus 
(ed. Chard T. & Grudzinskas C.), pp.54-84. Cambridge University Press.
Garven H.S.D. (1957). The circulatory system. In A student’s Histology, (ed. Garven H.S.D.), 
pp. 145-224. E. & S. Liningstone Ltd. Edinburgh.
Glicksman M. & Sanes J.R Development of motor nerve terminals formed in the absence of 
muscle &OTQS. Journal o f  Neurocytology. 1983; 12: 661-671.
Goldberg M. & Esgaig-Haye F. Is the lamina lusida of the basement membrane a fixation 
artifact? European Journal o f Cell Biology. 1986; 42; 365-368.
Goodman S.L., et al. Two distinct cell-binding domains in laminin can independently promote 
nonneural cell adhesion and spreading. Journal o f Cell Biology. 1987; 105: 589-598.
Grosso L. & Mecham R.P. In vitro processing of tropoelastin: Investigation of a possible 
transport function associated with the carboxy-terminal domain. Biochemical and 
Biophysiological Research Communications. 1988; 151: 822-826.
Gunja-Smith Z. & Woessner J.F. Content of the collagen and elastin cross-links pyridinoline and 
the desmosines in the human uterus in various reproductive states. American Journal o f  
Obstetrics and Gynaecology. 1985; 153; 92-95.
1 10
Hall H., et al. HNK-1 carbohydrate-mediated cell adhesion to laminin-1 is different from 
heparin-mediated and sulfatide-mediated cell adhesion. European Journal o f Biochemistry. 
1997;246:233-242.
Hashimoto K. & Kanzaki T. Cutis laxa: ultrastructural and biochemical studies. Archives o f 
Dermatology. 1975; 111: 861.
Heinricius G. En metod att grafiskt atergiva Kontraktioner hos en icke gravid livmoder. Finsk 
Lakaresallsk Handl. 1889; 31: 349.
Henchcliffe C. et al. Genetic analysis of laminin A reveals diverse functions during 
morphogenesis in Drosophila. Development. 1995; 118: 325-337.
Hendrickson M.R. & Kemmson R.E. The differential diagnosis of endometrial adenocarcinoma. 
Some viewpoints concerning a common diagnostic problem. Pathology. 1980; 12(1): 35-61. 
Henry M.D. & Campbell K.P. Dystroglycan-an extracellular matrix receptor linked to the 
cytoskeleton. Current Opinion in Cell Biology. 1996; 8: 625-631.
Hieber A.D., et al. Detection of elastin in the human fetal membranes: Proposed molecular basis 
of elasticity. P/oce??m. 1997; 18: 301-312.
Hinek A., et al. The elastin receptor is a galactoside binding protein. Science (Washington, D.C.) 
1988; 239: 1539-1541.
Hinek A., et al. The 67-kD elastin/laminin-binding protein is related to an enzymatically 
incative, alternatively spliced form of beta-galactosidase. The Journal o f Clinical Investigation. 
1993; 91(3): 1198-1205.
Hostikka S.L., et al. Identification of a distinct type IV collagen alpha chain with restricted 
kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport 
syndrome. Proceedings o f the National Academy o f Science USA. 1990; 87:1606-1610.
Hricak H., et al. Magnetic resonance imaging of the female pelvis initial experience. American 
Journal o f Obstetrics and Gynaecology. 1983; 141: 1119-1128.
Hudson B., et al. Type IV collagen: Structure, Gene Organization and Role in human diseases. 
The Journal o f Biological Chemistry. 1993; 268(35): 26033-26036.
Hunter D.D. et al. S-laminin expression in adult and developing retinae; a potential cue for 
photoreceptor morphogenesis. Vewrow. 1992; 8: 399-413.
Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69: 11- 
25.
I l l
■ Inove S, & Leblond C.P. Three-dimensional network of cords: the main component of basement 
membvmes. American Journal o f Anatomy. 1988; 181:341-358.
■ Iwahashi M., et al. Alterations in distribution and composition of the extracellular matrix during 
decidualization of the human endometrium. Journal o f Reproduction and Fertility. 1996; 108: 
147-155.
■ Janne O. & Ylostalo P. Endometrial oestrogen and progestin receptors in women bearing a 
progesterone-releasing intrauterine device. Contraception 1980; 22:19-23.
■ Jaques A. & Serafini-Francassini A. Morphogenesis of elastic fibers: An
immunoelectronmicroscopy investigation. Journal o f Ultrastructural Research. 1985; 92: 201- 
210 .
■ Kao C.Y. (1989) Electrophysiological properties of uterine smooth muscle. In Biology o f the 
Uterus 2”^  edition (ed. Wynn R.M. & Jollie W.P.), pp.403. Plenum Press, New York.
■ Karr S.R. & Foster J.A. Primary structure of the signal peptide of tropoelastin b. Journal o f
Biological Chemistry. 1981; 265: 5946-5949.
■ Kohnen G. et al. Endothelin receptor expression in human deciduas. Molecular Human 
Reproduction. 1998; 4(2): 185-193.
■ Kohnen G. et al. Spatially regulated differentiation of endometrial vascular smooth muscle 
cells. Human Reproduction. 2000; 15(2): 284-292.
■ Kramer R.H., et al. Laminin-binding integrin a7(31: functional characterization and expression
in normal and malignant melanocytes. Cell Regulation. 1991; 2: 805-817.
■ Kreidberg J.A., et al. a3p l integrin has a crucial role in kidney and lung organogenesis. 
Development. 1996; 122:3537-3547.
■ Kuhn K. Basement Membrane (Type IV) collagen. Matrix Biology. 1994; 14:439-445.
■ Kunz G., et al. The dynamics of rapid sperm transport through the female genital tract: evidence 
fi"om vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Human 
Reproduction. 1996; 11(3): 627-632.
■ Kuster J.E., et al. LAP insertion in the murine LamB3 gene results in junctional epidermolysis 
hwX\os?i. Mammalian Genome. 1997; 8: 673-681.
■ Laurie G.W. et al. Fine structure of the glomerular basement membrane and immunolocalization 
of five basement membrane components to the lamina densa (basal lamina) and its extensions in 
both glomeruli and tubules of the rat kidney. American Journal o f Anatomy. 1984; 169: 463-481.
112
Lee J.K.T., et al. The utérus; in vitro MR-anatomic correlation of normal and abnormal 
sipecimens. Radiology. 1985; 157; 175-179.
Leivo I. & Engvall E. Merosin, a protein specific for basement membrane of Schwann cells, 
striated muscle and trophobalsts, is expressed late in nerve and muscle development. 
Proceedings o f the National Academy o f Science o f USA. 1988; 85:1544-1548.
Leppert P.C. & Shiu Y eh Yu. Three-dimensional structures of uterine elastic fibers: Scanning 
electron microscopic studies. Connective Tissue. 1991; 27:15-31.
Lodge S. & Sproat J.E. Resting membrane potentials of pacemaker and nonpacemaker areas in 
rat uterus. Life Science. 1981 ; 28:2251.
Loke Y.W. & King A. (1996) In: Humam Implantation: Cellular Immunology, (ed. Loke Y.W. 
& King A). Cambridge University Press.
Ludwig et al. (1990). Endometrium: tissue remodeling and regeneration. In Contraception and 
mechanisms o f endometrial bleeding (ed. D’Arcangues C.D., Fraser I.S., Newton J.R. and 
Odlind V.), pp.441-446. Cambridge University Press.
Luukkainen T., et al. Levonorgestrel-releasing intrauterine device. Annals in Medicine 1990; 22: 
85-90.
Lyons A.E., et al. Characterization of subendometrial myométrial contractions throughout the 
menstrual cycle in normal fertile women. Fertility and Sterility. 1991 ; 55(4): 771-774.
MacKenzie L.W. & Garfield R.E. Hormonal control of gap junctions in the myometrium. 
American Journal o f Physiology. 1985; 248: C296-308.
Malak M.T. & Stephen C.B. Distribution of fibrillin-containing microfibrils and elastin in 
human fetal membranes: A novel molecular basis for membrane elasticity. American Journal o f 
Obstetrics and Gynaecology. 1994; 171(1); 195-205.
Marinkovich M.P., et al. The dermal-epidermal junction of human skin contains a novel laminin 
variant. The Journal o f Cell Biology. 1992; 119(3): 695-703.
Mariyama M., et al. Co localization of the genes for the a3(IV) and a4(IV) chains of type IV 
collagen to chromosome 2 bands q35-q37. Genomics. 1992; 13: 809-812.
Mark A.S. et al. Adenomyosis and leiomyoma: differential diagnosis by means of magnetic 
resonance imaging. Radiology. 1987; 163: 527-529.
Marshall J.M. Regulation of activity in uterine smooth muscle. Physiology Reviews. 1962; 42: 
213.
113
■ Mayer U., et al. A single EGF-like motif of laminin is responsible for high affinity nidogen 
binding. FENS Letters. 1993;12:1879-1885.
■ Mayer U., et al. Low nidogen affinity of laminin-5 can be attributed to two serine residues in 
EGF-like motify2III4. FEBS. 1995; 365:129-132.
■ McCarthy S. et al. Female pelvic anatomy: MR assessment of variations during the menstrual 
cycle with use of oral contraceptive. Radiology. 1986; 160: 119-123.
■ McCarthy S., et al. Uterine junctional zone: MR study of water content and relaxation 
properties. Radiology. 1989; 171: 241-243.
■ Mecham R.P. et al. Ligand affinity of 67kD elastin/laminin binding protein is modulated by the 
protein’s lectin domain: visulaisation if elastin/laminin-receptor complexes with gold-tagged 
Wgànàs. Journal o f Cell Biology. 1991; 113: 187-194.
■ Mecham R.P. & Davis E.C. Elastic fiber structure and assembly. In Extracellular matrix 
assembly and structure (ed.Yurchenko P.D., Birk D.E. and Mecham R.P.), pp.281-310. 
Academic Press.
■ Menkes J.H et al. A sex linked recessive disorder with retardation of growth, peculiar hair and 
focal cerebral and cerebellar degeneration. Pediatrics. 1962; 29: 764.
■ Minner J.H., et al. The laminin a  chains: expression, developmental transitions and 
chromosomal locations of a l-5 , identification of heterotrimeric laminins 8-11 and cloning of a 
novel a3 isoform. Journal o f Cell Biology. 1997; 137:685-701.
“ Mosler K., editor (1968). The dynamic of uterine muscle. Basel-New York: S. Karger-Verlag.
■ Murakumo M. et al. Three-dimensional arrangement of collagen and elastin fibers in the human 
urinary bladder: a scanning electron microscopic study. Journal o f Urology. 1995; 154(1): 251- 
6 .
■ Nakamura H. Electron microscopic study of the prenatal development of the thoracic aorta in the 
rat. American Journal o f Anatomy. 1988; 181: 406-418.
■ Niessen C.M., et al. Deficiency of the integrin |34 subunit in junctional epidermolysis bullosa 
with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. 
Journal o f Cell Science. 1996; 109: 1695-1706.
■ Nilsson CG., et al. Endometrial morphology of women using a d-norgestrel-releasing 
intrauterine device. Fertility and Sterility. 1978; 21: 155-164.
■ Noes R.W. et al. Dating the endometrial biopsy. Fertility & Sterility. 1950; 1(1): 3-25.
114
Nomizu M., et al. Identification of cell binding sequences in mouse laminin yl chain by 
systematic peptide screening. Journal o f Biological Chemistry. 1997; 272: 32198-322205. 
Nurcombe V., et al. The high affinity binding of laminin to cells. Assignation of a major cell- 
binding site to the long arm of laminin and a latent cell-binding site to its short arms. European 
Journal o f Biochemistry. 1989; 180:9-14.
Nurcombe V. Laminin in neural development. Pharmaceutical Theories. 1992; 56:247-264. 
Odlind V. Long-term experience of a levonorgestrel-releasing intrauterine system. The 
European Journal o f  Contraception and Reproductive Health Care. 1996; 1: 319-323.
Okkels H. & Engle E.T. Studies on the finer structure of the uterine blood vessels of the 
macacus monkey. Acta Pathologica Microbiolical Scandinavia. 1938; 15:150-168.
Ortiz, Maria Elena; Croxatto, Horacio B.; Bardin, C. Wayne. Mechanisms of action of 
intrauterine devices. Obstetrical & Gynecological Survey. 1996; 51(12)Supplement; 428-51 S. 
Osa T. & Katase T. Physiological comparison of the longitudinal and circular muscles of the 
pregnant rat uterus. Japan Journal o f Physiology. 1975; 25: 153-164.
Ott U., et al. Protease resistance and conformation of laminin. European Journal o f  
Biochemistry. 1982; 123: 63-72.
Pauls son M., et al. Structure of the low density heparan sulfate proteoglycan isolated fi*om a 
mouse tumour basement membrane. Journal o f Molecular Biology. 1987; 197:297-313.
Paulsson M., et al. Structure of laminin variants. The 300-kDa chains of murine and bovine heart 
laminin are related to the human placenta merosin heavy chain and replace the a  chain in some 
laminin fveigcuQnts,. Journal o f Biological Chemistry. 1991; 266:17545-17551.
Piez K.A. (1984) Molecular and aggregate structures of the collagens. In Extracellular Matrix 
Biochemistry (ed. Piez K.A. and Reddi A.H.), pp.1-39.
Pijenborg R., et al. The pattern of interstitial trophoblastic invasion of the myometrium in early 
human pregnancy. Placenta. 1981; 2: 303-316.
Pijenborg R. Trophoblast invasion and placentation in the human: morphological aspects. 
Trophoblast Research. 1990; 4: 33-47.
Ramsey M.E. (1967). Vascular anatomy of the uterus. In Cellular biology o f the uterus 
(ed.Wynn R.M.), pp.33-39. North Holland, Amsterdam.
Ramsey M.E. (1994). Anatomy of the human uteus. In The uterus (ed. Chard T. & Grudzinskas 
G.), pp.18-29. Cambridge University Press.
115
Raudaskoski T., et al. Transderm al oestrogen with a levonorgestrel-releasing intrauterine device 
for climacteric complains: Clinical and endometrial responses. American Journal o f Obstetrics 
& Gynecology. 1994; 179; 114-119.
Reale E. & Luciano L. The laminae rarae of the glomerular basement membrane. Their 
manifestation depends on the histochemical and histological techniques. In Hereditary Nephritis 
(ed. Sessa A., Meroni M. and Battini G), pp.32-40. Contridutions in Nephrology, vol.80. Karger, 
Basel.
Richards P.A. & Tiltman A.J. Anatomical variation of the oestrogen-receptor in normal 
myometrium. Virchows Arch., Abt. A, Pathol. Anat. 1995; 427: 303-307.
Rogers P. (1998). The endometrial vascular bed. In Clinical disorders o f the endometrium and 
menstrual cycle (ed. Cameron I.T., Fraser I.S and Smith S.K.), pp.31-37. Oxford University 
Press.
Rosenbloom J. Elastin: Relation of protein and gene structure to disease. Laboratory 
Investigation. 1984; 51(6): 605-623.
Ross R. & Klebanoff S.J. Fine structural changes in uterine smooth muscle and fibroblasts in 
response to oestrogen. Journal o f Cell Biology. 1967; 32:155-167.
Russell P. & Fraser S. (1998). The practical assessment of endometrial morphology and 
function. In Clinical disorders o f the endometrium and menstrual cycle (ed. Cameron I.T., 
Fraser I.S and Smith S.K.), pp.53-59. Oxford University Press.
Ryan M.C., et al. Cloning of the LamA3 gene encoding the a3 chain of the adhesive ligand 
epiligrin. Expression in wound repair. Journal o f Biological Chemistry. 1994; 269: 22779- 
22787.
Saez J.C., et al. Gap junctions: multiplicity of controls in differentiated and undifferentiated cells 
and possible functional implications. Advances in second messenger and phosphoprotein 
research. 1993; 27: 163-198.
Sanes J.R., et al. Reinnervation of muscle fibre basal laminin after removal of myofibres. 
Differentiation of regenerating axons at original synaptic clefts. Journal o f Cell Biology. 1978; 
102:420-431.
Sanes J.R. Extracellular matrix molecules that influence neural development. Annual Reviews o f 
Neuroscience. 1989; 12: 491-497.
116
Sanes J.R., et al. Molecular heterogeneity of basal laminae: Iso forms of laminin and collagen IV 
at the neuromuscular junction and elsewhere. The Journal o f Cell Biology. 1990; 111: 1685- 
1699.
Sasaki T., et al. Binding of mouse and human fibulin-2 to extracellular matrix ligands. Journal 
o f Molecular Biology. 1995; 254; 892-899.
Saunders N.A. & Grant M.E. The secretion of tropoelastin by chick embryo artery cells. 
Biochemistry Journal. 1985; 230: 217-225.
Scarcelli G., et al. Levonorgestrel-Nova-T and precancerous lesions of the endometrium. 
European Journal o f Gynaecological Oncology. 1987; 9:284-286.
Schofield R. The relationship between the spleen-colony forming cell and the haematopoietic 
stem cell. Blood Cells. 1978; 4: 7-25.
Schuler F. & Sorokin L.M. Expression of laminin isoforms in mouse myogenic cells in vitro and 
in vivo. Journal o f Cell Science. 1995; 108: 3795-3805.
Scoutt L.M., et al. Junctional zone of the uterus: Correlation of MR Imaging and histologic 
examination of hysterectomy specimens. Radiology. 1991; 179:403-407.
SeifM.W. et al. A novel approach for monitoring the endometrial cycle and detecting ovulation. 
American Journal o f Obstetrics & Gynecology. 1989; 160(2): 357-362.
Seif M.W. et al. Luteal phase defect: the possibility of an immunohistochemical diagnosis. 
Fertility & Sterility. 1989; 51(2): 273-279.
Shearman R.P (1985). Endocrine response in the female genital tract. In: Clinical Reproductive 
Endocrinology, (ed. Shearman R.P.), pp.109-163. Churchill Livingstone, Edinburgh.
Siebold B., et al. Construction of a model for the aggregation and cross-linking region (7S 
domain) of type IV collagen based upon an evaluation of the primaiy structure of the a l  and a2 
chains in this region. European Journal o f Biochemistry. 1987; 168: 569-575.
Siebold B., et al. The arrangement of intra- and intermolecular disulfide bonds in the carboxy- 
terminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV 
collagen. European Journal o f  Biochemistry. 1988; 176: 617-624.
Silverberg S.G., et al. Endometrial morphology during long-term use of levonorgestrel-releasing 
devices. International Journal o f Gynaecological Pathology.\9^6\ 5:234-241.
117
Snijder M.P.M.L., et al. Use of immunocytochemistry of oestrogen receptors and progesterone 
receptors in the human uterus throughout the menstrual cycle and after the menopause. Journal 
o f Reproduction and Fertility. 1992; 94: 363-371.
Somlyo A.V. (1980). Ultrastructure of vascular smooth muscle. In Handbook o f Physiology. The 
Cardiovascular System Vol.2 (ed. Bohr D.F., Somlyo A.P. and Sparks H.V.), pp. 33-71. 
American Physiology Society, Bethesda, MD.
Sonnenberg A., et al. Integrin recognition of different cell-binding fragments of laminin (PI, E3, 
E8) and evidence that a6(31 but not a6p4 fimctions as a major receptor for fragment E8. Journal 
o f Cell Biology. 1990;110:2145-2155.
Sorokin L., et al. Recognition of the laminin E8 cell-binding site by an integrin possessing the 
a6 subunit is essential for epithelial polarization in developing kidney tubules. Journal o f Cell 
Biology. 1990; 111: 1265-1273.
Sorokin L., et al. Monoclonal antibodies against laminin A chain fragment E3 and their effects 
on binding to cells and proteoglycan and on kidney development. Experimental Cell Research. 
1992; 201:137-144.
Sorokin L., et al. Expression of the novel 400-kDa laminin chain by mouse and bovine 
endothelial cells, European Journal o f Biochemistry. 1994; 223: 603-610.
Sorokin L.M., et al. Developmental regulation of the laminin a5 chain suggests a role in 
epithelial and endothelia cell maturation. Developmental Biology. 1997a; 189: 285-300.
Starcher BC. Lung elastin and matrix. Chest. 2000; 117(5)(Supplement 1): 229-34.
Stephens L.E. et al. Deletion of pi integrins in mice results in inner cell mass failure and per- 
implantation lethality. Genes & Development. 1995; 9:1883-1895.
Stjemquist M. & Sjoberg N.O. Neurotrasmitters in the myometrium. In The uterus (ed. Chard T. 
& Grudzinskas C.), pp.193-229. Cambridge University Press.
Sturridge F. & Guillebaud J. Gynaecological aspects of the levonorgestrel-releasing intrauterine 
system. British Journal o f Obstetrics & Gynaecology. 1997; 104(3): 285-289.
Sung U. et al. Cell and heparin binding in the distal long arm of the laminin: identification of 
active and cryptic sites with recombinant and hybrid glycoprotein. Journal o f Cell Biology. 
1993; 123: 1255-1268.
118
Takada Y., et al. Molecular cloning and expression of the cDNA for a3 subunit of human a3pl 
(VLA-3) an integrin receptor for fibronectin, laminin, and collagen. Journal o f Cell Biology. 
1991;115:257-266.
Terranova D., et al. Role of laminin in attachment of PAM212 (epithelial) cells to basement 
membrane collagen. Cell. 1980;22:719-726.
Thorbert G. Regional changes in structure and function of adrenergic nerves in guinea pig uterus 
during pregnancy. Acta Obstetrica Gynecologica Scandinavica. 1978; 305(Supplement): 1-32. 
Thyberg J., et al. Regulation of differentiated properties and proliferation of arterial smooth 
muscle cells. Arteriosclerosis. 1990; 10(6): 966-989.
Timpl R-, et al. Laminin-a glycoprotein from basement membranes. Journal o f Biological 
Chemistry. 1979;254:9933-9937.
Timpl R., et al. A network model for the organization of type IV collagen molecules in basement 
membranes. European Journal o f Biochemistry. 1981; 120: 203-211.
Timpl R., et al. Characterization of protease-resistant fragments of laminin mediating attachment 
and spreading of rat hepatocytes. Journal o f Biological Chemistry. 1983; 258: 8922-8927.
Timpl R. Structure and biological activity of basement membrane proteins. European Journal o f  
Biochemistry. 1989; 180: 487-502.
Timpl R. & Brown C. Judith. Supramolecular assembly of basement membranes. BioEssays. 
1995; 18(2): 123-132.
Turnbull L.W., et al. Magnetic resonance imaging changes in uterine zonal anatomy during a 
conception cycle. British Journal o f Obstetrics and Gynaecology. 1995; 102:330-331. 
Vanderberg P., et al. Characterization of a type IV collagen major cell binding site with affinity 
to the a ip i  and the a2pi integrins. Journal o f Cell Biology. 1991 ; 113; 1475-1483.
Utani A., et al. Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved 
amino acid sequences. Journal o f Biological Chemistry. 1997; 272:2814-2820.
Watt F.M. The extracellular matrix and cell shape. TIBS. 1986; 5: 287-294.
Wewer U.M., et al. Immunochemical and ultrastructural assessment of the nature of the 
pericellular basement membrane of human decidual cells. Laboratory Investigation. 1985; 53(6): 
624-632.
Wiczyk H.P., et al. Comparison of MRI and US in evaluating follicular and endometrial 
development throughout the normal cycle. Fertility and Sterility. 1988; 49: 969-972.
119
Willms A.B., et al. Anatomie changes in the pelvis after uncomplicated vaginal delivery: 
evaluation with serial MR imaging. Radiology. 1995; 195: 91-94.
Woessner J.F. Jr. & Brewer T.H. Formation and breakdown of collagen and elastin in the 
humna uterus during pregnancy and post-partum involution. Biochemistry Journal. 1963; 89: 75. 
Worthington B.S. et al. The low-intensity band on spin-echo images of the uterus: an anatomic 
and clinicopathologic study. Radiology. 1985; 157(F): 310.
Xiao B.L., et al. Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing 
intrauterine device. Contraception. 1990; 41: 353-362.
Yamamoto Kiyotaka, et al. Role of elastin in the differentiated properties of vascular smooth 
muscle cells in culture. Connective Tissue. 1994; 26:245-254.
Yamamoto M., et al. Increase in elastin gene expression and protein synthesis in arterial smooth 
muscle cells derived from patients with Moyamoya disease. Stroke. 1997; 28(9): 1733-1738. 
Yaoita H., et al. Localization of the collagenous component in skin basement membrane. 
Journal o f Investigation in Dermatology. 1978; 70:191-193.
Yurchenko P.D. & Schittny J.C. Molecular architecture of basement membranes. FASEB 
Journal. 1990; 4; 1577-1590.
Yurchenko P.D. & Cheng Yi-Shan. Self-assembly and calcium-binding sites in laminin. The 
Journal o f Biological Chemistry. 1993; 268(23): 17286-17299.
Yurchenko P.D. (1994) Assembly of laminin and type IV collagen into basement membrane 
networks. In Extracellular matrix assembly and structure (ed.Yurchenko P.D., Birk D.E. and 
Mecham R.P.), pp351-380.
Zhang Shu-Xin (1999). Circulatory System. In An Atlas o f Histology, (ed Zhang Shu-Xin), 
pp.l 18-127. Springer-Verlag New York, Inc.
Zhao Gu., et al. A morphometric study on the endometrial activity of women before and after 
one year with LNG-IUD in situ. Contraception. 1995; 52: 51-56.
Zhou J., et al. Deletion of the paired a5(IV) and a6(IV) collagen genes in inherited smooth 
muscle tumours. Science. 1993; 261: 1167-1169.
120
Appendix. 1
E n d o îv ie t r ia l  B r e a k t h r o u g h  B l e e d in g
Uterine Sampling Protocol
If the pathologist feels the uterus is grossly noonah and that it 
does not need to be sampled otherwise* please trim the specimen 
as illustrated below:
• Please cut the utems transversely and provide the researcher 
with a slice that is 0,5 - 1 cm diick
* The researcher will divide the slice into pieces for wax 
embedding and cryo-sectioning
# The researcher will ensure that relevant clinical details are 
provided on die request form
Mid Corpus Slice
I I 
i I
I I 
I I
DfColîftStfiwM 
Cqnsuîfaitt PaîhQlogiïii 
Royai ïntlrmary
Dr Rodney Burnett 
Conswlmm PaUtoîogîst 
Western Infirmary
0.5-1 cm
Dr Margaret Burgoyne 
Consuitam PaKiologist 
Somhera Ocrtcral llospliai
Dr Ian Gibson 
Consultant Pathologist 
Victoria Infirmary
Dr David MtUen 
Consultant Pathologist 
Stohhill Hospital
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P r o c e s s i n g  o f  T r a n s v e r s e  U t e r i n e  S l i c e  b y  R e s e a r c h e r s
"Flattened Cavity"
Pathologist
\
Researcher
Tmasverse section of Uterus
cryc
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Transverse section of Uterus
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Appendix.2
CoUecflan of Human Endomatrium for Research: Patient Infomtnatton and Consent
The University Department of Obstetrics and Oynaecoîogy at the Royal Infirmary has a specialist 
interest in the lining of the womb (endomeenum)* We arc actively involved with research in this area in 
the hope o f acquiring a better understanding o f a variety o f disorders related to the endometrium, 
mcludmg heavy periods (menorabagia), painfiti periods (dysmenorrhoea)» and early miscarriage.
Pact o f this research involves the study o f  tissue samples removed at tiie time of operation. At the time 
o f your operation (hysterectomy) the tissue that is removed is sent to tlte Pathology Laboratory for 
analysis. Quite often not ail the tissue is needed by foe Pathologist and therefore some tissue left over 
and could he used for research. I would therefore like to ask your pemtission for us to keep a small piece 
of the tissue which is not required by the Pathologist so tliat we can use it for research purposes. The 
type o f research to be carried out will usually involve examining foe tissue under a microscope to detect 
foe presence o f molecules winch may play a part in foe control o f foe blood supply to foe endometrium. 
In addition, some studies will involve culturing cells to observe foe effocts o f hormones. Cells would 
normally be cultured for a few days but on occasion might be cultured for up to six weeks. The 
proposed mseamh wofod not involve foe long temi culture or growth o f living cells.
In making fois request 1 would like to stress to you that the tissue that we would collect would be only 
that removed in foe normal course o f your operation and which was not subsequently needed by foe 
Patliologist. Any tissue samples that we would store or use would be anonymous and would not be 
linked to your name in any way. I would also like to reassure you that there is no question of us 
removing my em a tissue above font which is necessary for your treatment.
If you are willing to participate in this study please s i^  foe consent slip below. If you do so, your OP 
will be informed o f this. Finally, I should point out foai if  you do not wish to allow some o f your 
endometrium to be used for resmeh you do not need to do so, and fois decision will not affect your 
medical treatment in any way.
Professor Î*A, Greer
of..
have discussed fois research project with ............................. ................................. .............. .....................
and have read and understood foe above letter and hereby give my consent for the Department of  
Obstetrics and Gynaecology to obtain a small sample o f tissue removed during foe normal course o f my 
operation for foe purposes o f research.
Signed..,,,..,......         Date..,
Wimess .......             Date..
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Tissue Collection Form
RrecoreciNo,............. ........................ .— *...... ..............
NAME ................ ................. ................... ....... .
Collected by ........................................... .
Consuitanc ........................ .........................................
DOB..................................... ....... ...............................................
Parity......................... ......................... .........................................
LMP.......................... ........ ................. ...... ................................
Cycle length.............. ........ ....... ...............................................
GRIorWîG
Reasons for surgery  ............ .......... ........... ...................... .
Date of collection ........... ......................................... ............
Samples collected  .......................................................
Samples stored .................................... ............................
Medication ............................................................... .
PATHOLOGY
menstrual { ) proliferative ( ) early secretory ( ) late secretory ( ) 
Other comments . . . .— .— ............... .................. ............. .
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Qualitative analysis o f the p2 laminin chain and collagen IV in 8 partial myométrial thickness
cryosections
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E n d o m e t r ia l  B r e a k t h r o u g h  B l e e d in g
Uterine Sampling Protocol
If the pathologist feels the utems is grossly nomial, and that it 
does not need to be sampled otherwise, please trim the specimen 
as illustrated below:
• Please cut the utems transversely and provide the researcher 
with a slice that is 0,5 - 1 cm thick
# The researcher will divide the slice into pieces for wax 
embedding and cryo-sectioning
The researcher will ensure that relevant clinical details are 
provided on the request form
Mid Corpus Slice
I I
I I
I I
I
Dr Colin Stewart 
ConisuEtant PathQjogist 
Royal înürcnaïy
Or Rodney Bumelt 
ConsuUam Padtologisi 
Western Infirmary
0.5" 1 cm
Of Margnrnt Burgoyne 
Coîtsuitam ï^ihologîst 
Southern Gencrnl Hospital
Of Ian Gibson 
Consutont Pathologist 
Victoria Infînîiîiry
Of David Milton
Consultant Wiologis* 
StobhtW Hospital
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P r o c e s s i n g  o f  T r a n s v e r s e  U t e r i n e  S l i c e  b y  R e s e a r c h e r s
"Flattened Cavity"
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Appendix.2
CoUeelîon of Hunnaa EndometHum for Research? Patient Infotmadon and Consent
Tlie University Department o f Obstetrics and Gytiaecology at the Royal Infirmary has a specialist 
interest in the lining of die womb (endometrium). We are actively involved wiiiv research in this area in 
the hope o f acquiring a better understanding of a variety o f disorders related to the endometrium, 
inciuding heavy periods (menonbagia), painful periods (dysmenorrfeoea), and early miscarriage.
Part o f this research involves the shtdy o f  ti^ue samples removed at the time o f operation. At the time 
o f your operarion (hysterectomy) the tissue that is removed is sent W the Pathology Laboratory for 
mWysis. Quito often not all the tissue is needed by the Pathologist and therefore some tissue left over 
and could be used for research. I would therefore life to ask your permission for us to keep a small piece 
of the tissue which is not required by the Pathologist so tliat we cm  use it for research purposes. The 
type o f research to be carried out will usually involve esamining the rissue under a microscope to detect 
the presence of molecules which may play a pan in die control of the blood supply to the endometrium. 
In addition, some studies will involve culturing cells to observe the eftects o f hormones. Cells would 
normally be cultured for a few days but on occasion might be cultured for up to six: weeks. The 
proposed research would not involve die long term culture or growth o f living ceils.
In making this request Î would like to stress to you that tiie tissue that we would collect would be only 
that removed in the normal course o f your operation and which vm  not subsequently needed by die 
Pathologist. Any tissue samples diat we would store or use would be anonymous and would not be 
linked to your name in any way. I would also like to reassure you that there is no question o f us 
removing any emra tissue above that which is necessary for your treatment
If you are willing to participate in this study please sign the consent slip below. If you do so, your GP 
will be informed of this. Finally, I should point out that if  you do not wish to allow some o f your 
endometrium to be used for research you do not need to do so, and this decision will not alTect your 
medical ueatraent in any way.
Professor f*A. Greer
I.,,..............            of..
Imve discussed this research project with  ..................................... ............. .......... ....................
and have read and understood dt@ above letter and hereby give my consent for the Department of 
Obstetrics and Gynaecology to obtain a small sample of tissue removed during the nonsal course of my 
opération for the purposes of researeh.
Signed..,....,,.,.,,  .....        Date.,,
Witness ..............         Date..
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Tissue Coiiectioa Form
RrecorectMo,............. ........... ....... ...................... .............
NAME .............. .................... ................... .........
Collected by  -.......    — ........ ........
Consultant .................... ................................. ..................
DOB................................................... ....................... ............. .
Parity......................... .................................................................
LMP.......................... .................................... ............... ..........
Cycle length.............. ................................ .................. ....... .
GRlorWIG
Reasons focsurgery ....... ....... ...................... .................. .
Date or’coUecüon ........... ........... ......................... .— .. .. ..
Samples collected  ............................................... .
Samples stored  ...........................
Medication................ .................................... ............... ..............
PATHOLOGY
menstrual ( ) proliferative ( ) early secretory ( ) late secretory ( ) 
Other comments  .............. ............... .............. ...........
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Qualitative analysis o f the p2 laminin chain and collagen IV in 8 partial myométrial thickness
cryosections
f$2 laminin chain Collagen IV
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Appendix.4 Line profiles for the intensity of the P2 laminin chain and collagen IV from low magnification scans 
o f partial myométrial thickness. A gradient is observed in the myométrial distribution o f the P2 laminin chain in 
contrast to the more uniform distribution of collagen IV. No endometrial data ai-e shown. (A) p2 laminin chain 
distribution in a menstrual phase section of 13mm length. (B) collagen IV distribution in a consecutive sections of  
22 mm length. (C) P2 laminin chain distribution in a proliferative phase sections o f 20 mm lengtli. (D) collagen IV 
distribution in a consecutive section o f 19 mm length. (E) P2 laminin chain distribution in a proliferative phase 
section o f 12mm length. (F) collagen IV distribution in a consecutive section o f 12 mm lengtli. (G) P2 laminin chain 
distribution in a proliferative phase section o f 14mm length. (H) collagen IV distribution in a consecutive section of 
12mm length. (I) p2 laminin chain distribution in a secretory phase section o f 19mm length. (J) collagen IV 
distribution in a consecutive section o f 18mm length. (K) p2 laminin chain distribution after exposure to exogenous 
levonorgestrel for 10 months in a sections o f 14mm length. (L) collagen IV distribution in a consecutive section o f  
12mm length. (M) P2 laminin chain distribution after exposure to exogenous levonorgestrel for 9 months in a 
section of 20mm lengtli. (N) collagen IV distribution in a consecutive section o f 17mm length. (O) P2 laminin chain 
distribution after exposure to exogenous levonorgestrel for 8 weeks in a section of 16mm length. (P) collagen IV 
distribution in a consecutive section of 18mm length.
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